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Abstract
Reactive Oxygen Species (ROS) are known as important intracellular signaling
molecules. These are also well known for their role in oxidative stress and
cellular damage, leading to their involvement in several pathologies. Despite the
widespread postulation of ROS mechanisms, little is actually known about the
immediate response in living cells to the generation of these highly reactive com-
pounds. The development of nanoplatforms incorporating photosensitizers would
permit the generation of ROS at specific sub-cellular locations and determine the
in situ cellular response.
The work presented in this thesis describes the development of porphyrinic
nanoplatforms for the controlled generation of ROS and investigates their impact
on the surface marker expression of human Mesenchymal Stem Cells (hMSCs).
Surface tailoring of polyacrylamide nanoparticles with alkyne and amine func-
tionalities were exploited to achieve stable reactive chemical groups for further
conjugation. Nanoplatforms surface was also modulated with trimethylam-
monium functionalities for the development of nanosystems for sub-cellular
targeting and facilitated uptake. Physicochemical characterisation of alkyne and
alkyne/trimethylammonium functionalised constructs showed sizes in the range of
40 nm with a positive surface charge. Alkyne/trimethylammonium nanosystems
2
were found to be stable over long periods of time, whilst amino functionalised
nanosystems were found to be prone to aggregation.
Mechanisms of conjugation were exploited to create covalent linkage of por-
phyrinic photosensitizers to mono and dually functionalised constructs. Con-
jugation through ”click chemistry” allowed stable coupling with alkyne and
alkyne/trimethylammonium nanosystems. To overcome aggregation associated
with amino functionalised nanoplatforms, porphyrin conjugated monomers were
synthesised which resulted in stable polyacrylamide nanoparticles. The developed
conjugated nanosystems showed final sizes in the range 40-100 nm, while conjug-
ates with surface charges greater than + 20 mV have led to sizes higher than 100
nm.
The effect of surface charge on cellular delivery was investigated and nanosys-
tems with a surface charge in the range + 13 mV to + 18 mV proved optimal in
terms of cell delivery and viability. It was found that highly charged nanosystems
(above + 20 mV ) remained attached to the cellular membrane and had a negative
effect on cell viability. In addition, intracellular co-localisation studies showed
preferential mitochondrial targeting of the delivered nanosystems.
Production of ROS in nanoparticle treated hMSCs was achieved by exposure
to light at wavelength of 575 nm. For porphyrin conjugated nanosystems a single
light dosage resulted in a ”blast zone” in the irradiated area where significant
production of hydrogen peroxide was also observed. Titration of the amount of
porphyrin conjugated at the surface of nanoparticles resulted in systems with dif-
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ferent levels of ROS production. Control of ROS generation allowed development
of a nanoplatform that was used to expose cells to repeated exposure of ROS over
a time period of 100 minutes.
The surface marker expression of hMSCs treated with porphyrin conjugated
nanosystems was investigated. In the absence of light the surface marker ex-
pression of hMSCs was maintained, positive for CD29 and CD105 and negative for
CD34 and CD45. Increased generation ROS in hMSCs did not produce alterations
in the surface marker expression of cells, and over two generations of treated cells
(light and nanoparticles) no changes were detected in surface marker expression.
The developed nanoplatforms have the potential to be applied as a tool to in-
vestigate the cellular mechanisms and metabolism associated with different levels
of oxidative stress. In addition, these nanosystems could also represent an innov-
ative platform for theranostic applications (drug delivery/diagnostic).
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Chapter 1
General Introduction
1.1 Reactive Oxygen Species
Molecular oxygen is a basic and essential component of all living systems. A
portion of the oxygen taken into living cells can be converted into reactive oxygen
species [3–6].
Reactive oxygen species (ROS) is a term used to refer to the collective amount
of molecules or ions which are mainly formed by the incomplete one-electron
reduction of oxygen (e.g. superoxide) but also include non-radical derivatives of
molecular oxygen (e.g. hydrogen peroxide). The most relevant ROS in cellular
systems are superoxide (O2
• -), hydrogen peroxide (H2O2) hypochlorous acid
(HOCl), singlet oxygen (1O2), lipid peroxides (ROOH) and hydroxyl radical
(OH•).
Reactive oxygen species are seen as the angels and demons of cellular metabolism.
ROS are essential for cell survival by being intermediates of essential signalling
processes and defence against infections. On the other hand, excessive amounts
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of ROS contributes to cellular damage and modifications of molecules and DNA.
Figure 1.1: Main sources, formation and cellular responses to reactive oxygen spe-
cies. Under physiological conditions, reactive oxygen species are constantly produced,
mainly in mitochondria, endoplasmatic reticulum and cellular membranes. In addition,
in normal conditions, the ROS produced are highly regulated and metabolised by soph-
isticated enzymatic and non-enzymatic antioxidant defences, maintaining physiological
homeostasis. Increased ROS production may arise from exogenous sources, metabolic
disorders or mitochondrial diseases. When ROS production exceeds the antioxidant
capacity of the cellular system, oxidative stress, lead to an impaired physiological func-
tion affecting important signalling pathways and causing random cellular damage such as
lipid peroxidation and DNA damage. Oxidative stress is responsible for the development
of several diseases (e.g cancer, ageing and cell death). [6–9]
In general, superoxide is the primary ROS generated intracellularly and it is
believed that mitochondria are the main organelle of ROS generation. Figure 1.1
summarises the main processes of ROS reaction as well as the main antioxidant
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systems involved in ROS clearance. Increased ROS production with failure in its
clearance leads to an augmented oxidative environment, also known as oxidative
stress. Oxidative stress arises from the incapacity of antioxidant systems to remove
ROS. Accumulation of ROS leads to toxicity due to their high reactivity towards
DNA, proteins and lipids [9, 10].
Oxidative stress has been correlated with several conditions, such as inflam-
mation, cancer, Parkinsons and Alzheimers [9–12].
1.2 Photosensitizers
The word, photosensitizer has its origin in two main roots; the first, “photo”, is de-
rived from the Greek for “light”, while the second is a Latin-derived word, “sensus”
which represents the concept of something affected by external factors [13].
A photosensitizer (PS), is defined as a molecule that mediates the transference of
light energy into a chemical reaction (transfer of electrons) and/or to molecular
oxygen. Photosensitization reactions are simple and controllable, aiming for the
production of singlet oxygen (1O2). Photosensitization reactions require three com-
ponents: presence of oxygen, light of an appropriate wavelength and PS capable of
using energy absorbed from the light to excite oxygen to its singlet state [13, 14].
1.2.1 Photosensitizers Characteristics
Generally, photosensitizers share a common delocalised aromatic structure with
large conjugated systems of double bonds.
In the absence of photoactivation, the PS molecules do not present unpaired
electron spins [15]. Once activated by light energy (equation 1.1), the PS
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(absorption of photons), an electron is promoted to a higher-energy molecular
orbital leading to an excited, short-lived (≈ 1-100 ns) singlet state ( 1PS*),
without any changes in its electron spin [2, 15, 16]. The lifetime of the singlet
excited state is too short to allow significant interactions with the surrounding
molecules.
PS0 + h ν →
1PS* (1.1)
1PS* → PS0 + h νF (1.2)
1PS* → PS0 (1.3)
1PS* → 3PS* (1.4)
3PS* → PS0 + h νP (1.5)
3PS* → PS0 (1.6)
Subsequently, the excited state can either decay to the ground state by
emitting a fluorescent photon (reaction 1.2) or proceed via intersystem crossing
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(reaction 1.4)(ISC) to afford the excited triplet states (3PS*). The excited triplet
state via ISC is a spin-forbidden process, facilitated by a spin-orbit coupling;
thus at this stage, the spin of the electron is no longer conserved. From the
triplet excited state, the PS can either undergo a second spin-forbidden inversion,
returning to the ground state by emitting a phosphorescent photon (reaction
1.5), or it can lose energy through radiation-less transitions upon collisions with
other molecules (reaction 1.6) [2, 15–18].
1.2.2 Photosensitized Reactions
The longer lifetimes (≥ 500 ns) of the excited triplet state of the PS allow sig-
nificant interactions with surrounding molecules, which is essential for efficient
photosensitized reactions. Figure 1.2 is an illustrated schematic of a modified
Jablonski diagram of photosensitizer activation. From the excited triplet state in-
teractions with surrounding molecules two types of photosensitized reactions arise,
both involve interaction with molecular oxygen.
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Figure 1.2: Schematic illustration of photosensitizer activation by a modified Jablonski
diagram. The PS is primarily excited by the absorption of energy, which results in its
first excited singlet state. Subsequently, the PS can relax into a longer and more stable
triplet state through intersystem crossing (ISC). The interaction of PS triplet state with
molecular oxygen leads to two type of reactions, Type I and Type II, with the production
of reactive oxygen species and singlet oxygen, respectively.
1.2.2.1 Photosensitization Type I Reactions
Type I photosensitized reactions involve a radical or redox reaction of 3PS* with
surrounding substrate molecules (S), leading to two possible pathways. The first
(Reaction 1.7) involves the interaction of 3PS* (excited triplet state PS) with
the surrounding molecules by exchange of an electron (oxidation). Thus, a pho-
tosensitizer radical ion is formed, 3 PS•-, as well as an acceptor radical cation (S
• +
oxi). The substrate radical cation (S
•+
oxi) immediately reacts with molecular
oxygen 3O2 producing superoxide radical anion (O2
•-). The production of super-
oxide is not particularly reactive with biological systems, thus does not, by itself
cause much oxidative damage. However, the reaction of superoxide with itself
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(dismutation) mediated by the enzyme superoxide dismutase (SOD), leads to the
production of hydrogen peroxide. Superoxide also plays an important role in the
production of the hydroxyl radical. Superoxide is able to donate an electron to
metal ions, which further acts as catalysts to convert hydrogen peroxide into a
hydroxyl radical. Most of the radicals produced through these reactions interact
with molecular oxygen producing reactive oxygen species (ROS) such as (OH•-),
(HO2
•), (O2
•-) and (H2O2). The production of the hydroxyl radical (OH
•-), an
extremely reactive radical which oxidises a high number of biomolecules, activates
cytotoxic effects causing damage of fatty acids and lipids [2, 18–20].
3PS* + S → 3PS• - + S• +oxi (1.7)
3PS• - + 3O2 → PS +O2
• - (1.8)
3PS* + 3O2 → PS
• + +O2
• - (1.9)
A second Type I process involves the abstraction of a hydrogen from a substrate
molecule to the 3P* (reduction), reaction 1.10. This type of mechanism leads to
the production of free radicals which react immediately with molecular oxygen,
resulting in the formation of oxygen intermediates, reactions 1.11; 1.12. This
second mechanism also leads to the production of reactive oxygen intermediates
which produce cytotoxic events.
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3PS* + SH → PS −H• + S• (1.10)
S• +O2 → SO2
• (1.11)
SO2
• + S −H → SO2H + S
• (1.12)
1.2.2.2 Photosensitization Type II Reactions
Type II reactions are dependent on the presence of ground state molecular oxygen
and are energy transfer dependent. The excited photosensitizer reacts with ground
state oxygen by energy transfer, yielding singlet oxygen (Reaction 1.13) [2,15,16,
18,21,22].
3PS* + 3O2 →
1PS + 1O2 (1.13)
1O2 + S → Sox (1.14)
Collisions between the excited triplet state photosensitizer and ground state
molecular oxygen lead to the production of two low-lying singlet excited states;
1∆g (95 kJ/mol) and
1Σg
+ (158 kJ/mol). The main difference between these
two states relates to the electronic configuration of the π-antibonding orbitals, as
schematically represented in Figure 1.3 [1, 2, 15].
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Figure 1.3: Diagrammatic representation of the molecular orbitals of oxygen [1, 2].
The second excited state of oxygen is similar to the one of ground state, except
the last two electrons have antiparallel spins. The longer life of the first excited
state of oxygen, 1∆gO2, is due to spin-forbidden transitions from this state to the
ground state one (3ΣgO2). The opposite happens to the second excited state, due
to spin-allowed transitions from the second to the first excited state (1∆gO2) its
species are short lived [1, 2].
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Similar Type I reactions, ROS produced via Type II mechanisms also results in
intermediates which can react with biological molecules. Proteins are primary
targets of oxidative degradation. That is due to the high reactivity of some amino
acids (e.g. cystein, metheonine, tyrosine) [23–25]. Similarly, DNA can also be
extensively affected by oxidative damage [19, 20,25].
1.3 Photosensitizers Applications
The use of light alone or in combination with chemical compounds (photo-
sensitizers) was long known as a therapeutic methodology. Light as a treatment
vehicle can be traced back to ancient China, Egypt and India. At that time,
light was used to treat various diseases such as psoriasis, rickets vitiligo and skin
cancer [2, 25–28]. In 1903, Finsen was awarded with a Nobel Prize in Physiology
and Medicine resulting from his studies showing that light could be used for the
treatment of subcutaneous tuberculosis, known a Lupus vulgaris [18, 28, 29].
Many others further contributed to the use of light and photosensitizers as a
therapeutic methodology, introducing the concept of photodynamic therapy. In
1903, Oscar Raah showed that combination of acridines and light could be lethal
to protozoam paramecium. Subsequently, von Tappeiner and Jesionek reported
on the use of eosin and light (topically administered) for the treatment of skin
cancer, this being the first evidence of photodynamic therapy [18,29].
Several years passed until a significant breakthrough appeared. In 1975,
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Dougherty, et al. reported on the administration of HpD (Hematoporphyrin IX)
and light for the complete eradication of mammary tumour growth, which was
subsequently also observed for bladder carcinoma. In Canada, in 1993, an HpD
derivative, photofrin R©-(purer form) received approval for the treatment of bladder
cancer. Later, in 1995, photofrin R©use was approved in the United States for the
treatment of esophageal cancer [18].
1.3.1 Photodynamic therapy
The principle of photodynamic therapy is schematically represented in Figure
1.4. The photosensitizer is administrated intravenously or topically and con-
centrated at the tumour site. The affected region is then irradiated with light
of an appropriate wavelength (dependent on the absorption wavelength of the
phototsensitizer). The short lifetime of ROS limits their cytotoxic action to
the surrounding area of their generation, thus the diseased cells are selectively
eradicated [2, 28, 30].
One of the main aspects of photodynamic therapy is the penetration of light into
the diseased tissue. Light absorption through the tissue is known to be optimal
in the range of 650-850 nm, designated as a phototherapeutic window. For
wavelengths below 650 nm, skin photosensitivity and endogenous chromophores
(e.g. reduced form of collagen, deoxyhemoglobin and melanin) are the main
disadvantages. On the other hand, absorption band wavelengths longer than 850
nm are not of sufficient energy for singlet oxygen production. Furthermore, the
absorption of water at 1300 nm interferes with photodynamic efficiency [2,28,30].
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Figure 1.4: Schematic diagram of photodynamic therapy. [28]modified
With increased interest in photodynamic activity as a therapeutic agent,
some disadvantages were found with the photosensitizers being used at that time.
Poor solubility, sub-optimal tumour selectivity and; poor light penetration (due
to the small extinction coefficient at 630 nm wavelengths) were the main major
limitations associated with the first generation of photosensitizers. In order to
overcome these disadvantages, several new photosensitizers were developed and
their essential characteristics for optimal photodynamic activity were defined as
follows:
• The photosensitizer needs to be chemically pure, of known composition and
of high stability [25, 27, 28,30];
12
• Low levels of dark toxicity for both animals and humans [25,27, 28,30];
• Accumulation preferential at the target tissue [25, 27, 28,30];
• It should have strong absorption and high extinction coefficient (>20.000-
30.000 M-1 cm-1) in the red region of the electromagnetic spectrum to allow
deeper tissue penetration. Optimum tissue penetration depth between 650-
850 nm [2,28];
• Rapid clearance from the body [2, 28];
• Appropriate photophysical characteristics: high quantum yield of triplet
formation (ΦT ≥ 0.5); high singlet oxygen quantum yield (Φ∆ ≥ 0.5); long
triplet state lifetime [2, 28];
• Ideally, it should be water soluble or soluble in harmless aqueous solvent
mixture [25, 27, 28,30];
• No aggregation in biological environments, as this decreases its photochem-
ical activity [25, 27, 28,30];
• Facile synthesis and scale up.
1.4 Porphyrins as photosensitizers
Porphyrins, an expression derived from the ancient Greek word porphura, used to
describe the colour purple, refer to a class of highly coloured naturally occurring
compounds [29]. Porphyrins are characterised by a hetrocycle macrocycle structure
of twenty carbons and four nitrogen atoms, of which porphine is the simplest of all;
Figure 1.5; (A). Porphine basic structure consists of tetrapyrrolic units (Figure
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1.5; B) interconnected by methine bridges (Figure 1.5; C). The pyrrolic unit is a
five-membered ring of four carbon atoms and one nitrogen atom [2,18,29].
Figure 1.5: Ball and stick representation of the X-ray crystal basic structure of a
porphine: macrocycle (A)- composed by four pyrrole rings (B)- linked together by
methine bridges (C). Atom numbering according to IUPAC systematic nomenclature
on macrocycle; (1-20) carbon numbering; (21-24) nitrogen numbering.
Due to their high complex structure, porphyrins present a very specific ultra-
violet visible spectrum. Characteristically, an intense band is observed around
400 nm; denominated as Soret band. Furthermore, four other bands are present,
denominated as Q-bands. Figure 1.7 shows a representative absorption spectrum
of porphyrin [16, 18,29].
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Figure 1.6: Typical absorption of porphyrins. (A)- Modified Jablonski energy diagram;
(B)- Representation of a typical porphyrin absorption spectra. Modified from [2].
The Soret band is a consequence of porphyrin’s strong electronic transitions
from the ground state to the singlet excited state. On the other hand, Q-bands
result from weak transitions to the first excited singlet state [29].
Due to the nitrogen atoms present on the porphyrinic ring, the binding of metal
atoms is facilitated, leading to the formation of metalloporphyrins. It is widely
recognised that metalloporphyrins play an important role in essential biological
processes, such as photosynthesis, oxygen transport and storage. The coordination
of porphyrins with metal ligands has been extensively explored and several metals
have been assembled with porphyrins. Such complexes have been applied as a
model for a biological electron transporter, oxygen transport and metalloenzymes
[2, 28, 29].
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1.4.1 Generations of porphyrinic based photosensitizers
From the various photosensitizers developed until 1980, porphyrins and
porphyrins-related compounds were the most relevant approaches from a clinical
point of view [18,27]. Therefore, three generations of photosensitizers were defined.
The first generation, referred to above, relates to the HpD derivative,
photofrin. These compounds presented many drawbacks, such as the weaker
absorptions at long wavelengths (e.g. 630 nm). It was also found that the
‘purified’ photofrin presented several porphyrin-containing products (≈ 60),
making their manufacture difficult [27, 28, 31].
The second generation of photosensitizers emerged around 1980, aiming
to develop porphyrin analogues that absorb in the far-red spectral region (to
increase tissue penetration). The photosensitizers of this generation were designed
and developed incorporating optimal photodynamic activity (described above).
Foscan and phatalocyanines are examples of porphyrin analogues with good
photodynamic activity. Figure 1.7 shows the structure of Foscan and Phthalo-
cyanine as examples of photosensitizers with good photodynamic activity. Many
more second generation porphyrin analogues were developed and are reviewed
elsewhere [27, 28, 31].
The third generation aimed to introduce porphyrin carriers. The photosensit-
izers were used by porphyrin analogues developed from the second generation,
but it were used by coupling with carriers to achieve selective targeting and
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accumulation. Figure 1.7 shows a protoporphyrin IX- cyclic RGD conjugate, a
system developed for the specific targeting of tumour endothelial cells. The cyclic
RGD (arginin-glycine-aspartic acid motif) presents high affinity with receptor
αv β3- integrin which is overexpressed in endothelial cells (in and around the
tumour). Thus, this system aims to potentiate the vascular effect of PDT by
speciffically targeting the tumour vessels [27, 31].
Figure 1.7: Selected examples of photosensitizers.
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1.4.2 Effects of photosensitizers.
The distribution of photosensitizers in the cell dictates their efficiency to produce
ROS. ROS are characterised by short-lifetimes, thus, their action will occur close to
the site of its location. Therefore, once the PS is activated, the type of photodam-
age depends on the exact subcellular localisation of the photosensitizers [25, 27].
The sub-cellular localisation of photosensitizers is mainly dependent on their physi-
cochemical characteristics (e.g. net charge, hydrophobycity, degree of symmetry
of the PS) [2, 15, 25].
The intracellular activity of photosensitizers is envisaged specifically to des-
troy diseased cells. In this perspective, porphyrin photosensitizers are known to
eliminate diseased cells through two types of cell death, necrosis or apoptosis. Nec-
rosis, is a mechanism accompanied of violent and quick cell degeneration which
results from extensive cellular damage. Necrosis is characterised by the disruption
of organelles and subsequent disruption of the plasma membrane, which later res-
ults in the release of cellular contents to the extracellular environment. On the
other hand, apoptosis is characterised as a genetically programmed cell death and,
occurs normally in physiological (programmed cell death) and pathological condi-
tions. This mechanism is accompanied of several biochemical and morphological
changes (e.g. chromatin condensation, formation of apoptotic bodies, etc) [27].
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1.5 Nanotechnology.
Nanotechnology was first introduced by Norio Taniguchi in 1974 to refer to ma-
terials in nanometers (1 nm= 1 x 10-9 m) [32, 33]. It is an area focused on the
development of synthetic and analytical tools in the submicrometer dimensions,
specifically dimensions up to 100 nm. In this size range, materials present im-
proved properties compared with the same material at greater sizes [32]. In addi-
tion, nanomaterials differ from other materials as a consequence of their increased
surface area and quantum effects, leading to enhanced reactivity, strength, shape,
electrical properties and in vivo behaviour [32, 34].
Figure 1.8: Schematic diagram of nanoparticle design and applications. Nanoplatforms
can be assembled from a variety of materials which confer different shapes and diverse
chemical and physical properties. The surface can be manipulated to accommodate
several ligands, e.g. for biological targeting. Such characteristics provide an applicability
of these systems in several areas. Adapted from reference [35].
Over recent years, several types of nanomaterials have been developed with
diverse chemical and physical characteristics (Figure 1.8); however, their advant-
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ages share common principles. Their small size and high surface-to-volume ratios
makes them highly tailorable, therefore surface charge, hydrophobicity, solubil-
ity and stability can be easily manipulated (Figure 1.8). In addition, the small
size also confers facilitated interaction with biological systems. This flexibility of
nanomaterials confers a high range of applicability, such as drug delivery, medical
imaging, sensing, diagnostics, etc [35, 36].
1.5.1 Polyacrylamide nanoparticles
In 1996 Kopelman, et al. introduced the concept of PEBBLEs (Probes En-
capsulated By Biologically Localised Embedding), which is a generic term used
to describe nanometre-sized spherical optical sensing devices manufactured by
techniques which exploit the use of biologically inert polymers. PEBBLEs
technology was developed for a non-invasive and real time monitoring of ions
and small molecules in biological systems [37–41]. Several types of matrix were
developed, polyacrylamide (PAA) [42], polydecylmethacrylate (PDMA), sol gel
and organic modified silicates (ormosils). Hydrophilic moieties are better suited
to PAA matrices, hydrophobic moieties in PMDA matrices, and amphiphilic dyes
in sol-gel or ormosils [38, 43, 44].
1.5.2 Polyacrylamide nanoparticles
Polyacrylamide nanoparticles have been recognised as being of high interest as
they offer unique physical, chemical and biological properties [34, 35, 45–47], the
main advantages being biocompatibility (hydrophilicity), low size (20-100nm) and
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inert and non-toxic matrix [2, 37]. Furthermore, due to their porosity, high sur-
face area and adaptable architecture, these nanoplatforms potentially have several
types of combinations with targeting moieties [34, 45, 48, 49]. On the one hand,
the porous matrix allows the entrapment of molecules, which otherwise may cause
cellular toxicity and/or diminished activity by interaction with cellular compon-
ents [39,42,43], while on the other, the adaptable large surface area allows the in-
troduction of multiple chemically reactive groups for covalent linkage of molecules
(i.e. targeting agents), conferring lower toxicity and adverse side reactions and im-
proving solubility, delivery and sub-cellular localisation. Such characteristics allow
a great diversity of applications, such as drug and gene delivery, biosensing, tissue
engineering, diagnostic and many others [34,50–52]. Polyacrylamide nanoparticles
have been main developed in a biosensing context, for intracellular real time mon-
itoring of analytes such as Cu2+ [53,54], Ca2+ [43,44], Mg2+, Zn2+ [55], glucose [56]
and pH [57–59], O2 [60,61] among many others. Furthermore, they have also been
considered of high interest in the delivery of DNA, proteins, enzymes, imaging and
therapeutic agents [62, 63].
1.5.2.1 Polyacrylamide nanoparticles and photosensitizers
Exploiting toxicity induced by ROS, photodynamic therapy has been given consid-
erable importance in the treatment of diseases such as cancer (several types) and
macular degeneration, among others. This approach uses photosensitizers, light
and molecular oxygen as the main therapeutic agents.
In a therapeutic context, photosensitizers present appealing features. However
some limitations arise, such as the low solubility of most photosensitizers (de-
creasing its photodynamic efficiency), low loading, low targeting of specific tissues
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and cytotoxicity. Several groups reported that the combination of nanoplatfoms
with photosensitizers has been associated with enhanced photodynamic efficiency
as a consequence of: (1) the increased amount of photosensitizer delivered; (2)
improved solubility of the photosensitizer (3) engineerable nanoplatform surface
allowing combination with multiple targeting moieties in order to improve charge,
delivery, and sub-cellular localisation.
An increased number of publications refer to the application of nanoparticles
in the context of targeted drug delivery, polyacrylamide nanoparticles were
previously applied as carriers for photosensitizers, for the increased delivery
of photosensitizers (e.g. methylene blue, porphyrins) to tumour cells. These
nanoplatforms contain photosensitizers aimed at faciliting external administration
and production of high levels of singlet oxygen, inducing the destruction of
tumour cells [63–67]. In addition, the encapsulation of photosensitizers in
the polyacrylamide porous matrix has also been directed to circumvent the
cytotoxicity of some photosensitizers [63, 68, 69]. Gupta, et al., also showed the
development of polyacrylamide nanoparticles containing dual functionality by
incorporating a fluorescent imaging agent for non-invasive detection of tumours
and delineation of tumour margins, as well as the presence of a photosensitizer
for selective photodynamic action under diseased cells [63, 67].
From a diagnosis/monitoring point of view, Josefsen, et al. have described the
development of a porphyrinic nanotool capable of reporting calcium mobility as a
consequence of photosensitizer activation and ROS generation [2,70]. The nanotool
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developed, incorporated surface conjugated photosensitizer (via amino functional-
isation). Furthermore, a calcium sensitive dye entrapped in the polymeric matrix
(protected from intracellular environment), was used to monitor calcium variations
as a consequence of increase in intracellular oxidative stress. The main limitation
of the reported work was the in situ production of identifiable levels of ROS [2,70]
upon photosensitizer activation with light of appropriate wavelength.
1.6 Aims
Although the use of nanoparticles as carriers of photosensitizers has been exploited
in several areas, the effectiveness of these therapeutics is still limited to the control
and knowledge of biological signalling pathways involved in disease.
Based on the work previously developed by Josefsen, the present project aims
for the development of porphyrinic nanoplatforms to stimulate hMSCs for the
intracellular production of ROS in a controlled manner. This technology intro-
duces a nanotool to study the real time effects of ROS in cells [2]. In addition,
as a proof of principle, these porphyrinic nanoplatforms are aimed at the specific
investigation of ROS impact on the differentiation state of primary foetal liver
hMSCs. Because of the high potential of hMSCs, the development of such a
system can present great knowledge and advance the area of cell therapy.
For the development of a nanotool for in situ ROS generation the main aims
were as given below.
The development of stable multifunctionalised nanoplatforms containing a
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chemical reactivity for further conjugation with porphyrinic moieties and a cationic
functionality to facilitate the interaction between nanoparticles and cellular mem-
brane for uptake and intracellular trafficking. The stability of these systems is
greatly important to preserve the photodynamic activity of photosensitizers as
well as the efficiency of conjugation.
The establishment of a protocol of conjugation between porphyrinic moieties
and multifunctionalised nanoplatforms. The importance of this step depends on
the preservation of the photosensitizer’s chemical structure and purity, which are
required for their optimal activity upon light exposure.
The determination of the efficient cellular uptake, cytotoxicity and intracellular
trafficking, with mitochondrial co-localisation. The accumulation of porphyrinic
nanoplatforms at the mitochondria relates to its importance, sensitivity and rela-
tion with ROS signalling pathways. In addition, it is also aimed to investigate the
possible cytotoxic effects of the cellular uptake of these nanoplatforms. Excluding
the cytotoxicity of these nanosystems, aims to isolate further toxic effects exclus-
ively to an increase in oxidative stress. The investigation of the real time effects of
ROS generation in hMSCs, providing evidence of identifiable and increasing levels
of ROS generation in hMSCs loaded with porphyrinic nanoplatforms and exposed
to light of appropriated wavelengths (for photosensitizer activation). It is also
aimed to isolate cytotxic effects and ROS, increasing the photodynamic activity
of photosensitizer.
The developed porphyrinic nanotool is intended to assist in the study of ROS
impact on the undifferentiated state of primary hMSCs.
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1.7 Thesis Structure
The present interdisciplinary PhD project details the development of a nanotool
for the in situ generation of reactive oxygen species and evaluates the impact of
these species in the hMSCs undiffrentiated state. The chapters are organised as
below:
Chapter two gives a brief overview of the techniques used for nanoparticle
characterisation, cellular imaging and immunofluorescence as well as detailed
methodologies used in the present thesis.
Chapter three details the development and characterisation of mono and
multifunctionalized polyacrylamide nanoparticles.
Chapter four entails the development and characterisation of linkage between
polyacrylamide nanoparticles and porphyrins.
Chapter five investigates the uptake in hMSCs of the nanoplatforms de-
veloped in chapters three and four, and also characterises their sub-cellular co-
localisation and cytotoxic effects.
Chapter six uses the porphyrinic nanotools developed in chapter four to gen-
erate reactive oxygen species endogenously in hMSCs.
Chapter seven combines all the knowledge developed in the thesis to in-
vestigate the impact of reactive oxygen species on the surface characterisation of
hMSCs.
Chapter eight provides an overall conclusion of the project and addresses
future perspectives
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The tables presented below aim to give an overall description and rational of
the design of the nanoplatforms developed along this thesis, as well as porphyrins
and functionalised monomers.
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Chapter 2
Instrumentation materials and
methods
2.1 Instrumentation
2.1.1 Size Characterization of nanoparticles.
2.1.1.1 Dynamic Light Scattering (DLS).
Size characterisation of nanoparticles is important for applications in nanomedi-
cine. The influence of nanoparticle size in particle uptake, circulation time, tissue
distribution and intracellular fate has been widely reported [45, 50, 71–75]. One
of the most explored techniques in particle size determination is dynamic light
scattering (DLS) also referred as or quasielastic light scattering (QELS).
DLS is a technique that allows the measurement of particle size at the
nanometer scale. The principle behind this technique is the measurement of the
scattering intensity of a laser light source from particles which are suspended
in solution [76]. This scattering is due to the random Brownian motion of
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the particles. Brownian motion is defined as the movement of particles as a
consequence of random collisions with the molecules of the liquid that surrounds
the particle. The theory of Brownian motion for DLS is that small particles move
quickly and large particles move more slowly. The relationship between the size of
a particle and its speed due to Brownian motion is defined in the Stokes-Einstein
equation 2.1.
d(H) =
kT
3πηD
(2.1)
where:
d(H)= Hydrodynamic diameter
D= Translational diffusion coefficient
k=Boltzmann’s constant
T= Absolute temperature
η= Viscosity
2.1.1.2 Disc Centrifuge (CPS)
Disc centrifuge is an instrument for particle size determination, based on the prin-
ciple of differential centrifugation with a resolution in size from 5 nm up to 75 µm.
Disc centrifuge is composed of a hollow optically clear disc and a monochromatic
light of 405 nm as shown in Figure 2.1.
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Figure 2.1: Schematic diagram of Disc centrifuge. A- front view, B- cross section.
The principle behind this technique is particle sedimentation under a gravit-
ational field according to Stoke’s Law. Upon sample application into the disc, a
thin layer is formed which accelerates radially to the surface of the fluid. The
sedimentation of the particles is dependent of their size and density and also in-
fluenced by the density of the gradient. The differences in size establish the time
taken to reach the detector beam.
The particle size is then calculated by the time that particles take to reach the
detector using a modified Stoke’s Law, corrected for gravitational force with the
distance from the center of rotation.
D =
√√√√ 18ηln(RfRi )
(ρP − ρF)ω2t
(2.2)
Where D is particle diameter (cm), η solvent viscosity (poise), ω is the rota-
tional speed (radians/sec), Ri is the starting radii of formation (cm), Rf is the
ending radii of formation, ρp the density of the particle (g/ml), ρF is the density
of the fluid (g/ml) and t the arrival time (sec).
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2.1.2 Surface characterization of nanoparticles: Zeta Po-
tential.
The surface charge characterization of a particle is achieved by the determination
of its zeta potential ξ, also called electrokinetic potential. The principle behind
this technique is a consequence of the fact that a charged particle in solution will
be surrounded by a liquid layer of opposite charge at its surface, called the double-
diffuse layer, Figure 2.2. The double diffused layer is composed of two regions, an
inner region (Stern layer) where the ions are strongly bound and a more diffuse
outer layer of charges. Within the outer layer exist a notional boundary responsible
for the stability between ions and particles, called slipping plane, within this plane
particles and ions move as a single entity. Zeta potential is the potential difference
between the slipping plane and the bulk solvent.
Figure 2.2: Schematic representation of Zeta Potential: The zeta potential is the charge
mV easured at the slipping plane.
Zeta potential determination is then achieved by applying an electric field
across a sample and determining the velocity of movement of particles towards
the electrode. This velocity will be proportional to the zeta potential and is meas-
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ured as a frequency shift in the incident light using the laser Doppler velocimetry
technique (LDV) Thus, the electrophoretic mobility µE is calculated from equa-
tion 2.3
µE =
V
E
(2.3)
where:
µE= electrophoretic mobility
V = velocity
E = applied field
Thus, zeta potential(ξ) is determined by applying the Henry equation 2.4
ξ =
3ηµE
2εf(ka)
(2.4)
where:
ξ = zeta potential
η = bulk viscosity
µE = electrophoretic mobility
ε = permitivity of the medium
f(ka) = Henry’s function
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2.1.3 Fluorescence Characterization
The process of fluorescence was first identified by the British scientist Sir George
Stokes in 1852 and is described as a process of luminescence. The process of
luminescence is divided in two groups, fluorescence and phosphorescence which
are distinguished by the nature of the excited state. Fluorescence arises from an
excited singlet state, where the electron of the excited orbital is paired with a
second electron, of opposite spin, in the ground-state orbital, due to the opposite
spin the electron from the excited orbital, returns to the ground state with the
emission of a photon represented in Figure 2.3. Phosphorescence is a result of the
emission of light from triplet excited states, opposite to fluorescence, in here the
electron of the excited orbital and from the ground state present the same spin,
which means that transitions to the ground state are not allowed, leading to low
emission rates (103-100) [77].
Figure 2.3: Jablonski Energy Diagram
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2.1.4 Fluorescence Microscopy
Fluorescence microscopy is an essential tool in biology; it allows identifying cells
and sub-cellular components and also single molecules [77].
The principle of fluorescence microscopy is the irradiation of a specimen (excitation
light) with adequate wavelengths, and then collects an emitted light, which is
separated from the excitation light. Fluorescent microscopes can use laser, mercury
-vapour or xenon arc lamps as light sources. Light of a specific wavelength or set
of wavelengths is produced by passing light through a wavelength selective exciter
filter. The resultant light reflects off a dichromatic mirror along the microscope
objective lens to the specimen. For fluorescent specimens the collected emission
light passes through a dichromatic mirror. Subsequently, the emitted light is
filtered by a barrier filter which block the excitation wavelength and the emitted
light irradiates spherically in all directions [77].
2.1.5 Flow cytometry (FCM).
Flow cytometry (FCM) is a laser-based methodology for the analysis of individual
biological particles [78–80]. The principle of flow cytometry is based on physics
laws (e.g. optics; fluids; electronics) which are applied for the detection of particles
and cells that move in a liquid stream through laser [79]. In Figure 2.4, a schem-
atic diagram of flow cytometry analysis is represented. The particles/cells are
pressurized directly into a isotonic fluid, under laminar flow, the sample becomes
hydro-dynamically focused within the sheath stream which allows single cells to
pass through a single file [79, 81]. At that point, a beam of monochromatic light
(normally a laser) crosses the cells.
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Figure 2.4: Schematic diagram of flow cytometry analysis. The single cell sample
laminar flow is hydro-dynamically focused through a nozzle tip. Cells pass individually
through an interrogation point. The scattered and fluorescent light are collected by
optical and electronic systems which translates light signal into data. Modified from [82]
Scattered and fluorescent light are collected by optical and electronic systems.
The scattered light relates to structural and morphological cell aspects. Forward-
scattered light (FSC) is collected just off the axis of the incident beam and relates
to the cell surface area and size. Side-scattered light (SSC) is collected at 90 ◦ of the
incident beam and is proportional to cell complexity and granularity [79,81,83,84]
.
The emitted light is collected at right angle of the incident beam via optics that
direct the given light thorough a series of dichronic mirrors that isolates the
light at specific wavelengths [81, 83]. The fluorescence measurements at different
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wavelengths provide quantitative and qualitative information about fluorochrome-
labelled cells. In flow cytometry, separated channels are used to detect fluorescent
light (FL). The number of detectors varies among the machines but are either sil-
icon photodiodes or photomultipliers tubes. The silicon photodiodes are normally
used for forward scatter measurements, if the signal is strong. On the other hand,
photomultiplier tubes are ideal for fluorescence reading, once are more sensitive to
light [79].
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2.2 Materials and Methods
2.2.1 Reagents
acrylamide, N,N’ -methylenebisacrylamide, ammonium persulphate (APS), tri-
ethylamine (TEA) N,N,N’,N’ -tetramethylethylenediamine (TEMED), Brij R©30,
dioctyl sulfosuccinate sodium salt (98%) (AOT), acryloyl chloride (97%),
N,N -diisopropylethylamine (99%), N -(3-aminopropyl)methacrylamide (APMA),
propargylamine (98%), 3-acrylamidopropyl tetramethyl ammonium chloride
were purchased from Sigma-Aldrich R©. hexane, absolute ethanol, ethyl acetate,
chloroform, methanol, acetonitrile were purchased from fischer Scientific R©.
dichloromethane (DCM, 99%) was purchased from Acros-Organics. HPLC grade
water obtained from a Maxima USF ELGA system (UK). Gases were purchased
from BOC (UK).
Culture media M199 (Cat No. M2154 [A]), media M199 without phenol red
(Cat No. M3769[B]), penicillin/streptomycin (Cat No.P4333) L-glutamine (Cat
No.G6392) trypsin/EDTA (Cat No. T4299), Hybri-MaxTM DMSO (dimethyl
sulfoxide) ≥ 99.7% (Cat NO. D2650), Freezing container Nalgene R©Mr Frosty (Cat
No. C1562) were purchased from Sigma-Aldrich R©.
Fetal Bovine Serum (FBS) was purchased from Biosera (Cat No.FB-1001H).
Hank’s Balanced Salt Solution (HBSS) Gibco R©(Cat No. 14185-045).
Antibodies Beckman Coulter: CD29 (FITC)- fluorescein isothiocyanate; PN
IM0791U (λex= 488 nm; λ em= 520 nm). CD105 (PE)- phycoerythrin; PN A07414
(λex= 488 nm; λ em= 565 nm). CD45 (ECD)-PhycoerythrinTexas Red-X; A07784
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(λex= 488 nm; λ em= 620 nm). CD34 (PC5)-phycoerythrin-cyanine5; PN IM2650U
(λex= 488 nm; λ em= 665 nm)
The porphyrins described along the thesis were developed and generously
provided by Dr. Francesca Giuntini, University of Hull, Chemistry department.
The dye 3-azidocoumarin was kindly provided and synthesized by Dr. Peter
Magennis based on the protocol developed by Sivakumar and colleagues [85, 86].
2.2.2 Exploiting the surface chemistry of polyacrylamide
nanoparticles
2.2.2.1 Synthesis of N -propargyl acrylamide (III)
N -propargyl acrylamide was synthesized according to a modified procedure de-
scribed by Malkoch, et al. [87]. Propargylamine (0.60 mL, 9.37 mmol) and N,N -
diisopropylethylamine (1.96 mL, 11.24 mmol) were added to a 2-neck round bottom
flask and dissolved in dry DCM (3 mL). To the mixture was then added dropwise a
solution of acryloyl chloride (0.91 mL, 11.20 mmol) in dry DCM (2 mL). The reac-
tion was left to stir overnight under a nitrogen atmosphere, after which the organic
phase was removed by rotary evaporation. The crude product was subsequently
dissolved in ethyl acetate (50 mL) and washed three times with an aqueous bicar-
bonate solution, twice with a brine solution and twice with distilled water. After
collecting and drying the organic phase over MgSO4, ethyl acetate was evaporated
in vacuo to dryness. The crude product was further purified by silica column chro-
matography eluting with a solvent mixture consisting of 60% n-hexane and 40%
of ethyl acetate, to give a yellow pale oil (yield 480 mg, 47%) ; the purity of the
final product was determined by NMR (see Appendix A).
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2.2.2.2 Synthesis of polyacrylamide nanoparticles (PANPs)
The methodology for the synthesis of polyacrylamide nanoparticles (V) was first
described by Clark, et al. [43] and is based on the free radical polymerisation of
acrylamide in a reverse phase microemulsion. The water-in-oil microemulsion was
prepared by dissolving the surfactants, polyethylene glycol dodecyl ether (3.08 g;
0.0026 mol) (Brij R©30) and dioctyl sulfosuccinate (AOT) (1.59 g; 0.0036 mol) in
deoxygenated hexane (42 ml purged with argon for 30 minutes). Separately, a
monomer solution was prepared by mixing acrylamide (0.54 g; 0.0076 mol) and
N,N’ -methylenebis(acrylamide) (0.16 g; 0.001 mol) in 1.8 ml of deionized water.
For nanoplatforms incorporating FITC-dextran entrapped, 30 µl of a 1 mg/ml
FITC-dextran (10 000 MW) solution in water was added to the monomer solution.
The reaction was then carried in complete absence of light.
The monomer solution was then added to the reverse-microemulsion which was
left to form (∼10 minutes) in a sealed argon environment. The polymerisation was
initiated by the addition an ice cold solution of ammonium persulphate (APS)
(10% w\v; 30 µl) in water and N,N,N’,N’ -tetramethylethylenediamine (TEMED)
(15 µl), the reaction was allowed to proceed for 2 hours. Hexane was removed by
rotary evaporation (Butchi Rotavapor R-200). To the remaining viscous solution
was added 50 ml of absolute ethanol which were divided into two centrifuge tubes
and then spun at 6000 rpm on a centrifuge (Hermle Z300 centrifuge) for 6 minutes
to pellet the nanoparticles. The washing procedure was repeated 6 times in order
to remove the excess of surfactant. Finally, the nanoplatforms were re-suspended
in 10 ml of absolute ethanol which was removed by vacuum filtration through a
0.02 µm filter (Sartorius Stedim Biotech, Anodisc 25). The dried nanoparticles
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were subsequently stored at −18◦C.
2.2.2.3 Amino Functionalised Polyacrylamide Nanoparticles (AmNPs)
Figure 2.5: Chemical structure of (3-aminopropyl)methacrylamide) (APMA).
Further conjugation possibilities were exploited by tailoring polyacrylamide nan-
oparticles with several functional groups. The method for surface modifica-
tion was according to Welser, et al. [87]. The generation of an NH2 func-
tionalization at the surface of polyacrylamide nanoparticles (VI) was achieved
by the replacement of 2 % (by mol) of acrylamide in the monomer solu-
tion by N -(3-aminopropyl)methacrylamide hydrochloride (APMA), Figure 2.5.
The monomer solution consisted of acrylamide (0.00745 mol; 529.5 mg), N -(3-
aminopropyl)methacrylamide hydrochloride (1.52 x 10-4 mol, 27.2 mg) and N,N’ -
methylenebis(acrylamide) (0.16 g; 1 mmol) in 1.8 ml of deionized water. The poly-
merisation was carried out in the same way as for polyacrylamide nanoparticles,
see section 2.2.2.2.
43
2.2.2.4 Polyacrylamide tetramethyl Ammonium Functionalised Nano-
particles (TNPs)
Figure 2.6: Chemical structure of 3-acrylamidopropyl trimethyl ammonium hydro-
chloride.
In order to modify the surface charge of polyacrylamide nanoparticles, tetramethyl
ammonium functionalities were used, Figure 2.6. The method for synthesis of tet-
ramethyl ammonium functionalised nanoparticles (VII) was according to a mod-
ified procedure described by Sun, et al. [59]. Briefly, the water-in-oil microemul-
sion was prepared by dissolving the surfactants, polyethylene glycol dodecyl ether
(3.08 g; 0.0026 mol) (Brij R©30) and dioctyl sulfosuccinate (AOT) (1.59 g; 0.0036
mol) in deoxygenated hexane (42 ml purged with argon for 30 minutes). The
monomer solution was prepared by replacing trimethyl ammonium total weight in
acrylamide (75 %) and N,N’ -methylenebisacrylamide (25 %). The final composi-
tion of the monomer solution varied according to values described on Table 2.1.
The monomers were diluted in deionized water, in a final volume of 1.8 ml. For
nanoplatforms incorporating FITC-dextran entrapped, 30 µl of a 1 mg/ml FITC-
dextran (10 000 MW) solution in water was added to the monomer solution. The
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reaction was then carried in complete absence of light.
The monomer solution was then added to the reverse-microemulsion which was
left to form (∼10 minutes) in a sealed argon environment. The polymerisation was
initiated by the addition an ice cold solution of ammonium persuphate (APS) (10%
w\v; 30 µl) in water and N,N,N’,N’ -tetramethylethylenediamine (TEMED) (15
µl), the reaction was allowed to proceed for 2 hours. Hexane was removed by
rotary evaporation (Buchi Rotavapor R-200). To the remaining viscous solution
was added 50 ml of absolute ethanol which were divided into two centrifuge tubes
and then spun at 6000 rpm on a centrifuge (Hermle Z300 centrifuge) for 6 minutes
to pellet the nanosensors. This washing procedure was repeated 6 times in order
to remove the excess of surfactant. Finally, the nanoplatforms were re-suspended
in 10 ml of absolute ethanol which was removed by vacuum filtration through a
0.02 µm filter (Sartorius Stedim Biotech, Anodisc 25). The dried nanosensors were
subsequently stored at −18◦C.
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Table 2.1: Chemical composition of the monomer solution of trimethyl ammonium
functionalised nanoparticles.
2.2.2.5 Synthesis of polyacrylamide alkyne functionalised nano-
particles (ANPs)
Figure 2.7: Chemical structure of N -propargyl acrylamide.
In order to introduce a alkyne functionality to the polyacrylamide nanoparticles
(VIII) the procedure firstly described byWelser, et al. [87], was used where 2 % (by
mol) of acrylamide was replaced in the monomer solution by N - propargyl acryl-
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amide. In Figure 2.7 is showed the chemical structure of N - propargyl acrylamide.
The procedure followed a similar path as for amino functionalised nanoparticles,
the monomer solution was then composed of acrylamide (3.73 mmol; 529.5 mg),
N,N’-methylenebis(acrylamide) (0.16 g; 1.0 mmol) and N -propargylacrylamide
(0.11 mmol, 25 mg). The process of polymerization and recovery of nanoparticles
was carried out in the same way as for polyacrylamide nanoparticles, see section
2.2.2.2.
2.2.2.6 Synthesis of alkyne-trimethyl ammonium polyacrylamide
nanoplatforms (ATNPs).
Figure 2.8: Chemical structure of (II) 3-acrylamidopropyl trimethyl ammonium hy-
drochloride and (III) N - propargyl acrylamide.
The synthesis of alkyne/trimethyl ammonium polyacrylamide nanoparticles (IX)
was based on the combination of the mono functionalised systems previously re-
ported [43, 59, 87]. The synthesis of ATNPs was based on a free radical polymer-
isation of acrylamide monomers in a reverse phase microemulsion. The water-in-
oil microemulsion was prepared by dissolving the surfactants, polyethylene glycol
dodecyl ether (3.08 g; 0.0026 mol) (Brij R©30) and dioctyl sulfosuccinate (AOT)
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(1.59 g; 0.0036 mol) in deoxygenated hexane (42 ml purged with argon for 30
minutes). The monomer solution was prepared by replacing trimethyl ammonium
total weight in acrylamide (75 %) and N,N’ -methylenebisacrylamide (25 %). The
final composition of the monomer solution varied according to values described on
Table 2.1. The monomers were diluted in deionized water, in a final volume of
1.8 ml. For nanoplatforms incorporating FITC-dextran entrapped, 30 µl of a 1
mg/ml FITC-dextran (10 000 MW) solution in water was added to the monomer
solution. The reaction was then carried in complete absence of light.
The monomer solution was then added to the reverse-microemulsion which was
left to form (∼ 10 minutes) in a sealed argon environment.
Table 2.2: Chemical composition of the monomer solution of alkyne/trimethyl am-
monium functionalised nanoparticles.
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The polymerisation was initiated by the addition of ammonium persuphate
(APS) (10 % w\v; 30 µl) in water and N,N,N’,N’ -tetramethylethylenediamine
(TEMED) (15 µl), the reaction was allowed to proceed for 2 hours. Hexane was
removed by rotary evaporation (Buchi Rotavapor R-200). To the remaining vis-
cous solution was added 50 ml of absolute ethanol which was split into along two
centrifuge tubes and then spun at 6000 rpm on a centrifuge (Hermle Z300 cent-
rifuge) for 6 minutes to pellet the nanosensors. This procedure was repeated 6
times in order to remove the excess of surfactant. Finally, the nanosensors were
re-suspended in 10 ml of absolute ethanol which was removed by vacuum filtra-
tion through a 0.02 µm filter (Sartorius Stedim Biotech, Anodisc 25). The dried
nanosensors were subsequently stored at −18◦C (yield 580 mg, 83%).
49
2.2.3 Development of porphyrin polyacrylamide nanosys-
tems
2.2.3.1 Development of porphyrin polyacrylamide nanosystems via
amino-isothiocyanate conjugation.
2.2.3.1.1 Optimization of conjugation reaction conditions: amino
functionalised nanoparticles. The incorporation of the amine functionality
at the surface of nanoparticles was investigated by the reaction with fluorescamine.
In order to confirm the presence of reactive amine groups onto amino functional-
ised nanoparticles a solution of fluorescamine in DMSO (5 mg/ml) was prepared
and subsequently added (300 µl) to suspensions of polyacrylamide nanoparticles
(non functionalised) and APMA nanoparticles (amino functionalised) in deonized
water (3 ml; 1 mg/ml), and allowed to react for 30 minutes. The fluorescence of
resulting solutions was measured following excitation at 385 nm using a Varian
Cary Eclipse fluorescence spectrometer (Varian, UK).
2.2.3.1.2 Conjugation of 5-(4-isothiocyanatophenyl)-10,15,20-tris-[(4-
N-methylpyridinium)yl] porphyrinato zinc(II)trichloride (ZnPNCS) to
amino functionalised polyacrylamide nanoparticles: PAmNPC The con-
jugation of isothiocyanate zinc porphyrin (XII) with amino functionalised poly-
acrylamide nanoparticles (VI) was achieved by suspending 50 mg of NPs in water
(1 ml) followed by the addition of zinc porphyrin (3.2 x 10-4 mmol). To confer
basicity to the reaction mixture, as required for the optimal conjugation of amines
with isothiocyanates, pure TEA (15 µl) was added. The volume of the reaction
50
mixture was completed with deionised water to a final volume of 2 ml with water,
and the reaction was allowed to proceed stirring for 18 hours at room temperature
in total absence of light.
Figure 2.9: Synthetic scheme to afford porphyrin-amino nanoparticle conjug-
ates (PAmNPC): (VI) Amino functionalised polyacrylamide nanoparticles; (XII) 5-
(4-isothiocyanatophenyl)-10,15,20-tris-[(4-N-methylpyridinium)yl]porphyrinato zinc(II)
trichloride (ZnPNCS); (XV) Porphyrin-amino nanoparticle conjugates.
Once the reaction time was completed, porphyrin nanoparticle conjugates were
purified using desalting columns. The reaction mixture was loaded into a PD10
(sephadex-25) column and eluted with 3 ml of deionized water. The resultant
nanoparticles were washed with ethanol (5 ml, 2 times) by centrifugation. The
resultant dark green porphyrin conjugated nanoparticles (XV) were subsequently
dried in vacuo (yield 45 mg, 90%).
2.2.3.1.3 Capping of porphyrin amino nanoparticles (ZnPCNPC) In
order to avoid aggregation, non-reacted amines in PAmNPC (XV) were blocked,
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Figure 4.7, by the use of acetic anhydride (1). To achieve this, PAmNPCs
(100 mg) were precipitated in absolute ethanol (5 ml) and incubated with acetic
anhydride (5 ml; 0.053 mol) stirring for 2 hours in the absence of light. The res-
ultant nanoparticles were washed with ethanol (5 ml, 5 times) by centrifugation.
Finally, the nanosensors were re-suspended in 10 ml of absolute ethanol which
was removed by vacuum filtration through a 0.02 µm filter (Sartorius Stedim
Biotech, Anodisc 25). The dried nanoparticles (XVI) were subsequently stored
at −18◦C (yield 75 mg, 75 %).
Figure 2.10: Capping reaction of porphyrin-amino nanoparticles with acetic anhydride.
(1)- acetic anhydride. (XV)- PAmNPC. (XVI)- ZnPCNPC.
In order to confirm the presence of any remaining amine groups following
the capping of amino functionalised nanoparticles a solution of fluorescamine in
DMSO (5 mg/ml) was prepared and subsequently added (300 µl) to suspensions
of polyacrylamide nanoparticles (non functionalised) and APMA nanoparticles
(amino functionalised) in deonized water (3 ml; 1 mg/ml), and allowed to react
for 30 minutes. The fluorescence of resulting solutions was measured following
excitation at 385 nm using a Varian Cary Eclipse fluorescence spectrometer
(Varian, UK).
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2.2.3.1.4 Synthesis of Porphyrin nanoparticles Synthesis of 5-[4-[(3-
(3-methylthioureido)propyl methacrylamide)phenyl)]-10,15,20-tris-[(4-
methylpyridynium)yl]] porphyrinato zinc(II) trichloride.
To avoid aggregation of PAmNPCs and aiming for the covalent attachment
of porphyrins to the polyacrylamide matrix, a porphyrin incorporating an acryl-
amide functionalisation was synthesized, as represented in Figure 2.11 (XIV).
The synthesis of (XIV) was achieved by reacting (7 mg; 7 x 10-3 mmol)
5-(4-isothiocyanatophenyl)-10,15,20-tris-[(4-N-methylpyridinium)yl] porphyrinato
zinc(II) trichloride (XII) with (1.27 mg; 7.11 x 10-3 mmol) of the monomer N -(3-
aminopropyl)methacrylamide hydrochloride (I) in deionized water (final volume
2 ml) in the presence of 5 µl of triethylamine, to increase the pH of the reaction
mixture.
Figure 2.11: Synthetic scheme to afford 5-[4-[(3-(3-methylthioureido) propyl methac-
rylamide) phenyl)]-10,15,20-tris-[(4-methylpyridynium)yl]]porphyrinato zinc(II) trichlor-
ide (ZnPNCS) (XIV). (I)- N -(3-aminopropyl)methacrylamide hydrochloride; (XII)- 5-
(4-isothiocyanatophenyl)-10,15,20-tris-[(4-N-methylpyridinium)yl]porphyrinato zinc(II)
trichloride.
The reaction was left stirring overnight at room temperature, protected from
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light. Once completed, the reaction mixture was freeze dried and a porphyrin
powder (dark brown) was achieved (see Appendix B).
2.2.3.1.5 Synthesis of porphyrin polyacrylamide nanoparticles (Zn-
PNPs) The synthesis of porphyrin polyacrylamide nanoparticles was achieved
by incorporating in the reaction mixture an acrylamide porphyrin monomer
(XIV), Figure 2.12. The acrylamide porphyrin monomer was further added
and polymerised in reverse micelles as previously referred in Section 2.2.2.2. The
final concentration of porphyrin monomer added to the monomer mixture was
based on the amount of porphyrin conjugated with amino functionalised NPs,
Section 2.2.3.1.2. Briefly, a water-in-oil microemulsion was formed by combining
the surfactants Brij R©30 (3.08 g; 0.0026 mol) and AOT (1.59 g; 0.0036 mol) in
deoxygenated hexane (42 ml). Subsequently, a monomer solution (in deionized
water) containing the monomers (i); (ii) and (XV) in the proportions described
in Figure 2.12 were added to the reverse microemulsion. The monomers polymer-
isation in reverse micelles was initiated by the addition of APS (10 % w/v; 30 µl)
and TEMED (15 µl) (yield 550 mg, 71%).
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Figure 2.12: Synthetic scheme to afford porphyrin polyacrylamide nano-
particles(ZnPNP): (i)- acrylamide; (ii)-N,N’ -methylenebis(acrylamide); (XIV)-
5-[4-[(3-(3-methylthioureido)propylmethacrylamide)phenyl]]-10,15,20-tris-[(4-
methylpiridynium)yl] porphyrinato zinc(II) trichloride. Monomers i, ii and XIV
were mixture (a) and subsequently added and reacted in reverse micelles (b) to form
nanoparticles containing porphyrins (XVII).
The reaction was allowed to proceed by 2 hours at room temperature under
argon environment, once completed the hexane was removed by rotary evaporation
(Buchi Rotavapor R-200). Therefore, the microemulsion was destabilized by the
precipitation of porphyrin entrapped polyacrylamide nanoparticles in ethanol (50
ml). The removal of unreacted monomers and surfactants was achieved by centri-
fugal washes with ethanol. Finally, the nanosensors were re-suspended in 10 ml of
absolute ethanol which was removed by vacuum filtration through a 0.02 µm filter
(Sartorius Stedim Biotech, Anodisc 25). The dried nanosensors were subsequently
stored at −18◦C (yield 620 mg, 89%).
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2.2.3.1.6 Synthesis of porphyrin trimethyl ammonium polyacrylamide
nanoparticles (ZnPTNPs) As demonstrated in Chapter 3, specific applica-
tions of nanoparticles can be attained by modulation of its surface characteristics.
A Variation on the surface charge of porphyrin nanoparticles was performed by in-
corporating the monomer 3-acrylamidopropyl tetramethyl ammonium chloride at
the time of synthesis. As described above for porphyrin nanoparticles, porphyrin
entrapped trimethyl ammonium nanoparticles were obtained following a similar
procedure.
Figure 2.13: Synthetic scheme to afford porphyrin trimethyl ammonium polyacryl-
amide nanoparticles(ZnPTNPs): (i)- acrylamide; (ii)-N,N’ -methylenebis(acrylamide);
(II)- 3-acrylamidopropyl trimethyl ammonium hydrochloride; (XIV)- 5-4-[(3-(3-
methylthioureido)propylmethacrylamide)phenyl]-10,15,20-tris-[(4-methylpiridynium)yl]
porphyrinato zinc(II)trichloride. Monomers i; ii; II and XIV were mixture (a) and
subsequently added and reacted in reverse micelles (b) to form trimethyl ammonium
nanoparticles containing porphyrins (XVIII).
Briefly, the monomer solution was prepared by combining the monomers (i),
(ii), (II) and (XIV) represented in Figure 2.13. The monomer solution was
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subsequently added to a reverse microemulsion created by the combination of AOT
(1.59 g; 0.0036 mol), Brij R©30 (3.08 g; 0.0026 mol) and deoxygenated n-hexane
(42 ml). The polymerisation and purification of the resultant nanoparticles were
according to the procedure described above, Section 2.2.3.1.5 (yield 580 mg, 83%).
57
2.2.4 Development of porphyrin polyacrylamide systems
via click chemistry methodologies.
2.2.4.1 Optimization of conjugation reaction conditions: alkyne func-
tionalised nanoparticles.
The incorporation of the alkyne functionality at the surface of nanoparticles
was investigated by reaction with 3-azidocoumarin [86]. In order to confirm the
presence of reactive alkyne groups a solution of 3-azidocoumarin in DMSO (5
mg/ml) was prepared and subsequently added (200 µl) to suspensions (50 mg/ml)
of polyacrylamide nanoparticles (non-functionalised) and alkyne functionalised.
The catalyst CuBr (0.05 mmol) was dissolved in DMSO (200 µl) and added to the
reaction mixture above. The final volume of the reaction mixture was completed
with deionised water to 2 ml with water, and the reaction was allowed to proceed
stirring for 1 hour at room temperature in total absence of light. The fluorescence
of resulting solutions was measured following excitation at 390 nm (λem= 478
nm) using a Varian Cary Eclipse fluorescence spectrometer (Varian, UK).
2.2.4.2 Conjugation of 5-4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-
[(4-methylpyridynium)yl] porphyrinato zinc(II)trichloride
(ZnPN3) via alkyne functionalised polyacrylamide nano-
particles (ZnPANPC)
The conjugation of azido zinc porphyrin (XIII) with alkyne polyacrylamide
nanoparticles (VIII) was achieved by the application Cu-catalysed azide-alkyne
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cycloaddition (CuAAC) method, also designated by “click reaction”. .
Figure 2.14: Synthetic scheme to afford Porphyrin-Alkyne nanoparticle con-
jugates: (VIII) Alkyne functionalised polyacrylamide nanoparticles; (XIII) 5-
4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-[(4-methylpyridynium)yl]porphyrinato
zinc(II)trichloride (ZnPN3); (XIX) Porphyrin alkyne nanoparticles conjug-
ates(ZnPANPC).
The reaction between alkyne-azide functionalities was performed by suspend-
ing 50 mg of alkyne functionalised nanoparticles (VIII) in water (1 ml) followed
by the addition of azido zinc porphyrin (XIII)(3.2 x 10-4 mmol). The catalyst
CuBr (0.05 mmol) was dissolved in DMSO (200 µl) and added to the reaction
mixture above. The volume of the reaction mixture was completed with deionised
water to a final volume of 2 ml with water, and the reaction was allowed to proceed
stirring for 18 hour at room temperature in total absence of light. Subsequently,
porphyrin nanoparticle conjugates were purified using desalting columns, the re-
action mixture was loaded into a PD10 (sephadex-25) column and eluted with 3
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ml of deionized water. The resultant nanoparticles were washed with ethanol (5
ml, 2 times) by centrifugation. The resultant dark green porphyrin conjugated
nanoparticles (XIX) were subsequently dried in vacuo (yield 43 mg, 86%).
2.2.4.3 Synthesis of porphyrin trimethyl ammonium nanoparticle con-
jugates. (ZnPATNPC)
Conjugation of 5-4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-[(4-
methylpyridynium)yl] porphyrinato zinc(II)trichloride (ZnPN3) via
alkyne/trimethyl ammonium functionalised polyacrylamide nano-
particles: (ZnPATNPC)
The conjugation of porphyrin with alkyne- trimethyl ammonium polyacrylam-
ide nanoparticles (ATNPs) was achieved by the application Cu-catalysed azide-
alkyne cycloaddition (CuAAC) method, also designated as “click Reaction”.
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Figure 2.15: Synthetic scheme to afford porphyrin-alkyne/trimethyl ammonium
nanoparticle conjugates (PATNPC): (IX) alkyne/trimethyl ammonium functionalised
polyacrylamide nanoparticles; (XIII) 5-4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-
[(4-methylpyridynium)yl]porphyrinato zinc(II)trichloride (ZnPN3); (XX) Porphyrin-
alkyne/trimethyl ammonium nanoparticle conjugates.
The reaction between alkyne-azide functionalities were performed by suspend-
ing 50 mg of ATNPs in water (1 ml) followed by the addition of Zn porphyrin (0.152
µmol Zn porphyrin) according to the scheme represented in Figure 2.15. The cata-
lyst CuBr (0.05 mmol) was dissolved in DMSO (200 µl)and added to the reaction
mixture above. The volume of the reaction mixture was completed with deionised
water to a final volume of 2 ml with water, and the reaction was allowed to pro-
ceed stirring for 18h at room temperature in total absence of light. Subsequently,
porphyrin nanoparticle conjugates were purified using desalting columns, the re-
action mixture was loaded into a PD10 (sephadex-25) column and eluted with 3
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ml of deionized water. The resultant nanoparticles were washed with ethanol (50
ml, 2 times) by centrifugation. The resultant dark green porphyrin conjugated
nanoparticles (XX) were subsequently dried in vacuo (yield 580 mg, 80%).
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2.2.5 Characterisation of nanoparticles
2.2.5.1 Dynamic Light Scattering (DLS): Size analysis of functional-
ised nanoparticles
The size characterization of non functionalised and surface modified nanoparticles
was performed by DLS using a Zeta sizer nano series instrument (Nano-ZS; Mal-
vern Intruments, Malvern UK), model ZEN 3600 equipped with an He-Ne internal
laser (633 nm; Max 5mW). Samples of nanoparticles were suspended in deionized
water (1 % w/v)), which had previously been filtered using a 0.02 µm filter (Sar-
torius Stedim Biotech, Anodisc 25), and aliquoted into a low volume glass cuvette
(ZEN2112; 12 µl). Measurements were taken with an angle of 173◦ backscatter
(NIBS) at 25◦C, each analysis was made up of eleven correlation analysis last-
ing ten seconds each. To estimate the repeatability of the measurements, three
aliquots of each sample was measured three times under the same conditions. Fur-
thermore, the reproducibility of the synthesis of nanoparticles was also evaluated,
for which three batches of nanoparticles were synthesized and size analysis was
performed as described above. The results were extracted from nano software and
the hydrodynamic radius was represented as a function of intensity distribution
and undersize curve.
2.2.5.2 Zeta Potential: Surface analysis of functionalised nanoparticles
Surface characterization of nanoparticles was performed by the measurement of
zeta potential using a Zeta sizer nano series instrument (Nano-ZS; Malvern In-
truments, Malvern UK). Suspensions of nanoparticles were prepared in phosphate
buffer pH 7.2 (0.1 % w/v) with an ionic strength of 5 mM and further injected
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into a clear disposable zeta cell (DTS1060C), each analysis was made up of 100
runs, three measurements with a delay of 10 seconds each. The determination
of zeta potential was achieved by Henry equation, described in Section 2.1.2.
Furthermore, Henry’s function (f(Ka)) was set for 1.5, known as Smoluchowski
approximation for aqueous conditions. The results were expressed as the mean of
three measurements.
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2.2.6 Human fetal Liver mesenchymal stem cell culture
Human fetal liver was collected into RPMI medium containing penicil-
lin/streptomycin by the MRC-Wellcome Trust Human Developmental Biology Re-
source, Newcastle-upon-Tyne, UK with appropriate maternal consents following
ethical approval by the Newcastle and North Tyneside Research Ethics Committee
in accordance with Human Tissue Authority regulatory guidelines. Samples from a
gestational age between 8 & 9 weeks, determined using published Carnegie staging
(Bullen and Wilson, 1997) were used in this study. Samples were received within
24 hours of collection. Upon receipt of the tissue, a single cell suspension was
prepared by physical disruption of the fetal liver, as previously described (Jones,
1999). Thereafter, the cell suspensions were transferred to RPMI containing 1 0%
dimethyl sulphoxide (Sigma Aldrich, Dorset, UK) and 20 % heat inactivated fetal
bovine serum (FBS - Sigma), in cryovials, then stored in liquid nitrogen (vapor
phase) at −186◦C .
2.2.6.1 Thawing of stored fetal liver cells
The isolation of hMSCs from the foetal liver microenvironment was achieved based
on the characteristic adherence of these cells to tissue culture plastic as described
by Friednestein [88]. Therefore, and immediately before use, a frozen cell sus-
pension was thawed by agitation in a 37◦C water bath. The cell suspension was
immediately transferred to a sterile universal container and 20 ml HBSS added
dropwise with constant agitation. The resultant suspension was centrifuged at
500 xg for 10 minutes, the supernatant discarded and the cells resuspended in me-
dium, as detailed below. After 48 hours, any non-adherent cells along with culture
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liquid were discarded, the adherent cells washed twice with HBSS and the medium
had been replaced.
2.2.6.2 In vitro cell culture of hMSCs
The cell culture of hMScs was based on a protocol developed by Coupland, et
al. to which were introduced some modifications [89]. Approximately 5 x 106
cells were grown in T25 culture flasks in 5 ml of complete medium. The chosen
medium was M199 as a source of vitamins, inorganic salts and amino acids [90].
The medium was further supplemented with 20 % heat inactivated FBS, as source
of a large number of growth factors and extracellular matrix molecules which
confer an enhanced cell attachment to plastic surfaces as well as proliferation. [91].
Subsequently, 1 % (v/v) of L-glutamine (10 µl/ml) was added as an essential
amino acid, intermediate in many metabolic pathways and alternative substrate
to glucose for energy. The medium preparation was completed by the addition
of antibiotics, 1 % (v/v) P/S (10 µl/ml) in order to confer bacterial protection.
All the supplements were previously sterilized through a 0.2 µm syringe filter
before being added to the medium. Special care was taken in the addition of the
supplements to the medium, all supplements were freshly added in order to avoid
degradation. The cells were maintained at 37◦C, 5 % CO2, 90% humidity and
medium was replaced every two days.
2.2.6.3 Harvesting of hMSCs
Cells were harvested at 70-90% confluence by enzymatic digestion. Confluent T25
flasks were subcultured at a ratio of 1:3. Prior to trypsinization, cells were washed
twice with HBSS, followed by the addition trypsin/EDTA (0.0025%/0.5%) in PBS
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and incubation for 3 min at 37◦C, 5% CO2, 90% humidity. Subsequently, the
action of trypsin was deactivated by FBS, follow by addition of complete medium
(as described above). The cell suspension was centrifuged for 10 min at 500 xg,
the supernatant was discarded and cells were resuspended in complete medium as
required.
2.2.6.4 Cryopreservation of hMSCs
For cryopreservation, hMSCs at 70-80% confluence were harvested by enzymatic
digestion, as described above. The resultant cells were resuspendend in medium
M199 supplemented with 10% of Hybri-MaxTM DMSO and 20% of heat inac-
tivated FBS. The cell suspension was aliquoted to 1- 1.5 ml cryovials which were
placed on a freezing container containing isopropyl alcohol (Mr Frosty) at−80◦C to
achieve 1◦C/hour cooling rate required for successful cryopreservation of cells. Sub-
sequently the cells were transferred to liquid nitrogen (vapour phase) at −186◦C.
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2.2.7 Cellular delivery of nanoparticles
For uptake studies, hMSCs were cultured in 8 well plates (LabTek Chamber
Slide w / Cover Glass Slide) and allowed to adhere for 24 hours. Subsequently
cells were incubated with 5 mg/ml of nanoparticles (sterilized using a 0.02 µm
syringe filter) for a period of 10 hours at 37◦C, 5 % CO2, 90 % humidity. The
excess of nanoparticles was removed by washing the cells twice with phenol red
and serum free medium. Mitochondrial staining was achieved by adding 5 µl
(0.188 nM) of mitotracker red to hMSCs, incubated with cells for a period of 20
minutes at 37◦ C, 5 % CO2, 90 % humidity. Excess of mitotracker red removal
was achieved by washing the cells twice with phenol red free medium. The cells
were then examined by fluorescence microscopy. Mitochondria was detected by
using the following conditions: λexc= 575 nm; λem= 632 nm. Nanoparticles were
visualized by green emission of FITC (λexc= 475 nm and λem= 530 nm). The
images reported in the Figures are representative of at least three independent
experiments.
2.2.8 Nanoplaticle uptake analysis
Nanoparticle internalization was evaluated by fluorescence intensity of FITC
dextran entrapped on the matrix of nanoparticles. hMSCs were cultured in 6 well
plates and allowed to adhere for 24 hours. Subsequently, cells were incubated
with 2.5; 5; 10; 20; 30; 40; 50 mg/ml of nanoparticles (sterilized using a 0.02 µm
syringe filter) for a period of 10 hours at 37◦C, 5 % CO2, 90 % humidity. The
excess of nanoparticles/porphyrin was removed by washing the cells twice with
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phenol red and serum free medium. Cells were immediately analysed by FCM.
The same procedure was applied to control cells.
2.3 Cellular viability analysis
To conduct cellular viability studies, hMSCs were cultured in 6 well plates and
allowed to adhere for 24 hours. Subsequently cells were incubated with 2.5; 5; 10;
20; 30; 40; 50 mg/ml of nanoparticles or 5; 10; 20; 30; 40; 50 µg/ml of ZnPN3,
(sterilized using a 0.02 µm syringe filter) for a period of 10 hours at 37◦C, 5 %
CO2, 90 % humidity. The excess of nanoparticles/porphyrin was removed by
washing the cells twice with phenol red and serum free medium. Mitochondrial
staining was achieved by adding 5 µl (0.188 nM) of mitotracker red to hMSCs,
incubated with cells for a period of 20 minutes at 37◦ C, 5 % CO2, 90 % humidity.
Excess of mitotracker red was removed achieved by washing the cells twice with
phenol red free medium. Cells were immediately analysed by FCM. The same
procedure was applied to control cells.
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2.3.1 Cellular effects of PATNPC activation
To determine the effects of irradiation hMSCs containing nanoparticles cultured
in 8 well plates (LabTek Chamber Slide w / Cover Glass Slide) and allowed to
adhere for 24 hours. Subsequently, the cells were incubated with 5 mg/ml of 5%
ZnPATNPC or 10 % ZnPATNPC or 20 % ZnPATNPC (sterilized using a 0.02
µm syringe filter) for a period of 10 hours at 37◦ C, 5 % CO2, 90 % humidity.
The excess of nanoparticles was removed by washing the cells with phenol red free
medium twice. Mitochondrial staining was achieved by adding 5 µl (0.188 nM) of
mitotracker red to hMSCs, incubated with cells for a period of 20 minutes at 37◦
C, 5 % CO2, 90 % humidity. Removal of mitotracker red excess was achieved by
washing the cells with phenol red free medium.
To evaluate the formation of ROS, specifically hydrogen peroxide, cells were in-
cubated with BPTFMC and the dye was allowed to be internalized by the cells
for a period of 1 hour at 37◦C, 5 % CO2, 90 % humidity. Removal of BPTFMC
excess was achieved by washing the cells twice with phenol red free medium. The
cells were then examined by fluorescence microscopy. Mitochondria were detected
by using the following conditions: λexc= 575 nm; λem= 632 nm. Nanoparticles
ZnPTNPC were visualized by green emission of FITC (λexc= 475 nm and λem=
530 nm). The detection of hydrogen peroxide was evaluated by the conversion of
BPTFMC (non-fluorescent) to HTFMC (fluorescent upon increasing quantities of
H2O2) λexc= 390 nm and λem= 435 nm.
Control experiments were based in the analysis of cells submitted to the exact same
treatments as described above (mitotracker red, BPTFMC), except the treatment
and incubation with nanoparticles. All control and sample images were acquired
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simultaneously under the same imaging conditions. The images reported in the
figures are representative of at least three independent experiments.
2.3.2 Controlled generation of ROS in hMSCs
To induce hMSCs to generate ROS on a controlled manner upon light irradiation
cells were treated 5 % ZnPATNPC or 5 % CuPATNPC (control). The hMSCs
were cultured in 8 well plates (LabTek Chamber Slide w / Cover Glass Slide) and
allowed to adhere for 24 hours. Subsequently, the cells were incubated with 5
mg/ml (sterilized using a 0.02 µm syringe filter) for a period of 10 hours at 37◦
C, 5 % CO2, 90 % humidity. Further, the excess of nanoparticles was removed
by washing the cells with phenol red medium twice. Mitochondrial staining was
achieved by adding 5 µl (0.188 nM) of mitotracker red to hMSCs, incubated with
cells for a period of 20 minutes at 37◦ C, 5 % CO2, 90 % humidity. Removal
of mitotracker red excess was achieved by washing the cells with phenol red free
medium. To evaluate the formation of ROS, specifically hydrogen peroxide, cells
were incubated with BPTFMC and the dye was allowed to be internalized by
cells for a period of 1 hour at 37◦ C, 5 % CO2, 90 % humidity. Removal of
BPTFMC excess was achieved by washing the cells with phenol red free medium.
The cells were then examined by fluorescence microscopy (Olympus 60x/NA 1.42,
Plan Apo N UIS2, 1U2B933). Mitochondria were visualized by red emission using
the following conditions: λexc= 575 nm; λem= 632 nm. Nanoparticles ZnPTNPC
were visualized by green emission of FITC (λexc= 475 nm and λem= 530 nm).
The detection of hydrogen peroxide was evaluated by the conversion of BPTFMC
(non-fluorescent) to HTFMC (increase in fluorescence upon increasing H2O2) λexc=
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390 nm and λem= 435 nm. Time-lapse images were collected at each 5 min for
a total period of 100 minutes. At each time point the following channels were
used: (1) blue channel to identify increase in intracellular quantity of hydrogen
peroxide (λexc=390 nm λem=435 nm); (2) Green channel to detect internalized
nanoparticles (λexc=475 nm λem=530 nm); (3) mitotracker red to evaluate and
visualize cellular viability (λexc= 575 nm; λem= 632 nm) and (4) bright field DIC
to detect morphological alterations in hMSCs. The irradiation of cells was achieved
at the same time that mitochondria were imaged with 575 nm wavelength with
LED (light emission diodide). The power of irradiation was determined by the
use of a power meter, 512 µW were registered for an exposed area of 8 mm2 with
a exposure time of 2 seconds. Control experiments were based in the analysis
of cells submitted to the exact same treatments as described above (mitotracker
red, BPTFMC), except that were treated with 5 % CuPATNPC. All control and
sample images were acquired simultaneously under the same imaging conditions.
The images reported in the figures are representative of at least three independent
experiments.
2.3.3 Titration of porphyrin with alkyne-trimethyl am-
monium polyacrylamide nanoplatforms (PATNP).
The conjugation of porphyrins (Zn porphyrin or Cu porphyrin) with alkyne- tri-
methyl ammonium polyacrylamide nanoparticles (ATNPs) was achieved by the
application Cu-catalysed azide-alkyne cycloaddition (CuAAC) method, also des-
ignated by “click Reaction”. The reaction between alkyne-azide functionalities was
performed by suspending 50 mg of ATNPs in water (1 ml) followed by the addition
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of porphyrin (Zn porphyrin or Cu porphyrin) according to the scheme represented
in Figure 2.16. The catalyst CuBr (0.05 mmol) was dissolved in DMSO (200 µl)
and added to the reaction mixture above. The volume of the reaction mixture
was completed with deionised water to a final volume of 2 ml with water, and
the reaction was allowed to proceed stirring for 18 h at room temperature in total
absence of light. Subsequently, porphyrin nanoparticle conjugates were purified
using desalting columns, the reaction mixture was loaded into a PD10 (sephadex-
25) column and eluted with 3 ml of deionized water. The resultant nanoparticles
were washed with ethanol (50 ml, 2 times) by centrifugation. The resultant dark
green porphyrin conjugated nanoparticles were subsequently dried in vacuo.
Figure 2.16: Synthetic scheme to afford titrated conjugation of porphyrins with alkyne-
trimethyl ammonium polyacrylamide nanoplatforms.
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2.3.4 Immunophenotypic characterisation of treated hM-
SCs
The evaluation of the phenotypic characteristics of hMSCs isolated from fetal liver
microenvironment was achieved by FCM. Suspensions of hMSCs were diluted to ≥
5 x 104 cells/ml with complete medium 20 % (vol/vol) FBS (as described above)
and subsequently centrifuged for 10 minutes at 500 xg. The supernatant was
discarded and 5 µl of the antibody was added. The same procedure was followed
multiple colour staining, 5 µl of each fluorescent tagged antibody was added to the
cell suspension. Following the addition of the antibodies, samples were incubated
for 30 minutes, at room temperature and kept in the dark. Subsequently, cells were
washed with 1 ml of complete medium 20 % (vol/vol) FBS centrifuged at 300 xg
for 5 minutes. The supernatant was discarded and cells were further resuspended
in 1 ml of medium M199. Cells were immediately analysed by FCM.
2.3.4.1 Immunophenotypic characterisation of hMSCs treated with
CuPATNPC or ZnPATNPC
The evaluation of the phenotypic characteristics of hMSCs treated with CuPAT-
NPC or ZnPATNPC was also carried out by FCM. Cells were initially treated
with 2.5 mg/ml of CuPATNPC or ZnPATNPC, (prepared as described in Section
2.2.4.2 without FITC-dextran entrapped) filtered through a 0.2 µm syringe filter
and further incubated for a period of 10 hours maintained at 37◦C, 5 % CO2, 90 %
humidity. Prior to trypsinisation, cells were washed twice with HBSS, to remove
any excess of nanoparticles. Further steps of trypsinization followed the same pro-
cedure described in Section 2.2.6.3. Further, suspensions of hMSCs were diluted
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to 5 x 105 cells/ml with complete medium 20 % (vol/vol) FBS and subsequently
centrifuged for 10 minutes at 500 xg. The supernatant was discarded and 5 µl
of each antibody was added. Following the addition of the antibodies, samples
were kept in the dark for 30 minutes at room temperature, after which time cells
were washed, with 1 ml of complete medium 20 % (vol/vol) FBS and centrifuged
at 300 xg for 5 minutes. The supernatant was discarded and cells were further
re-suspended in 1 ml of medium M199. Cells were immediately analysed by FCM.
The same procedure was applied to control cells (without addition of NPs).
2.3.4.2 Portable LED light system
For the development of a portable light system, an LED light source (Flood light
130 LED) was coated with two neutral density filters (0.3 ND) to control the optical
power of transmitted light. Subsequently, it was adapted (in the top of the density
filters) to fit an orange fluorescent acrylic layer, an absorptive filter to selectively
transmit light at a wavelength of approximately 575 nm, as represented in a)
Figure 7.7 . Furthermore, to confine the beam of light to the area of irradiation
it was adapted an opaque structure with black interior as shown in b) Figure 7.7.
Additionally, the optical power output was determined, by the use of a hand-held
power meter with integrated sensor and aperture of 8 mm (Laser check RoHS,
Coeherent), being achieved an output power of approximately 500 ± 5 % µW. The
LED output spectra was recorded with a UBS2000 fiber optic spectrometer (Ocean
Optics), the resultant wavelength versus intensity was graphically represented.
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Figure 2.17: Portable light system.
2.3.4.3 Immunophenotypic characterisation of irradiated hMSCs
treated with CuPATNPC or ZnPATNPC
To determine the effects of light irradiation on the surface marker profile of hMScs
containing ZnPATNPC 1.5 x 104 hMSCs were cultured in 6 well plates and allowed
to adhere for 24 hours at 37◦C, 5 % CO2, 90 % humidity. Subsequently, the cells
were incubated with 2.5 mg/ml of ZnPATNPC or CuPATNPC (sterilized using a
0.02 µm syringe filter) for a period of 10 hours at 37◦C, 5 % CO2, 90 % humidity.
Excess nanoparticles were removed by washing twice with HBSS. Four of 6 well
plates, were used to assess the effects on increasing doses of light. The first was
irradiated 5 times, the second was irradiated 10 times, the third for 15 times and
the last irradiated 20 times with PLS. Irradiations were performed for 2 sec at each
5 min , during the recovery cells were kept at 37◦C, 5 % CO2, 90 % humidity. At the
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end of 5, 10, 15 and 20 irradiations cells were washed with HBSS trypsinised and
subsequently centrifuged for 10 minutes at 500 xg. The supernatant was discarded
and 5 µl of each antibody was added. Following the addition of the antibodies,
samples were incubated for 30 minutes in the dark at room temperature, after
which the cells were washed, with 1 ml of complete medium 20 % (vol/vol) FBS
(as described above), by centrifugation 300 xg for 5 minutes. The supernatant
was discarded and cells were further resuspended in 1 ml of medium M199. The
same procedure was applied to control cells (without addition of NPs). Cells were
immediately analysed by FCM.
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2.3.5 Data analysis
Flow cytometry analysis and plot generation was performed by Walter & Elisa
analysis software; Eclectic and Lucid (WEASEL). Results are expressed as mean
plus or minus standard deviation (SD). For statistical analysis one-way analysis
of variance was performed, using Sigma-plot 11.0. P value <0.05 was considered
statistically significant.
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Chapter 3
Exploiting the surface chemistry
of polyacrylamide nanoparticles
3.1 From Reverse Microemulsions to Polyacryl-
amide Nanoparticles
The synthesis of polyacrylamide nanoparticles is a well documented process which
involves the formation of a reverse microemulsion (also called reverse micelles or
water-in-oil microemulsion) [43, 92–95]. The water droplets in the reverse mi-
croemulsion function as nanoreactors (templates), where, upon the addition of the
acrylamide-based water soluble monomers and initiators, the nanosized particles
are formed after polymerisation [43,93–96].
3.1.1 Reverse Microemulsions
Reverse microemulsions were first reported by Schulman & Hoar in 1943, defined as
optically transparent and thermodynamically stable systems, comprising aqueous
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droplets stabilized in a continuous polar fluid by an interfacial layer of surfactants
[97].
The surfactant acts as the driving force in the formation of reverse microemulsions.
Surfactants or amphiphiles are molecules characterised by two regions with distinct
properties, where a hydrophilic moiety (affinity for water), also called head, is
covalently linked to a hydrophobic moiety (affinity for oil), also called tail. The
surfactant head groups enclose an aqueous core which separates the water from
the non-polar solvent continuous phase. Consequently, the characteristic structure
of these molecules limits their total solubilization in both water and oil phases,
thus they tend to accumulate at the water-oil interface [98].
Figure 3.1: Schematic representation of water-in-oil microemulsions: Reverse Mi-
celles (1) consisting of a hydrophilic core compartmentalised by the hydrophilic head
of AOT (2) and with the alkyl tails directed to the hydrophobic continuous phase. A
co-surfactant (3) is added to introduce more fluidity and decrease the curvature of the
droplets.
In water/oil/surfactant systems, increasing concentrations of surfactant adsorp-
tion at the interface becomes favourable due to the strong hydrophilic interactions
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of the polar head with water. Therefore, as a result of the free energy of solvation
of the surfactant at the interface, exclusion of direct water-oil contact is observed.
Subsequently, these interactions, at a certain concentration (the CMC) (critical
micelle concentration), become saturated and the self-assembly of surfactant oc-
curs, with the formation of aggregates, also called micelles. This concentration
is known as critical micelle concentration, CMC. The complete adsorption of sur-
factant (micelle formation) at the interface leads to a substantial decrease of the
free energy of the system, in contrast to what happens when surfactant molecules
are dispersed in a continuous medium [98–101]. It is important to note that most
of the surfactants are not capable by themselves of lowering the interfacial ten-
sion sufficiently to confer stability to reverse micelles. Consequently, the addition
of a co-surfactant is often necessary. The co-surfactant is generally a nonionic
compound, which contributes for the further lowering of the interfacial tension, in-
troducing more fluidity and decreasing the curvature of the droplets. The decrease
of the curvature of the droplets will lead to the reduction of their size. The droplet
size in reverse micelles is directly related to the molar ratio of water-to-surfactant
(W).
W =
[H2O]
[Surfactant]
(3.1)
.
Changing (W) in reverse microemulsions can alter the water pool in inverse
micelles and, consequently, the size of the resultant micelles. At constant con-
centrations of surfactant, W increases with the increase of [H2O]. Therefore, the
water pool size is an adjustable parameter [98, 101].
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3.1.2 Polymerisation of acrylamide in reverse micelles.
It should be emphasized that reverse microemulsions are dynamic systems. Thus,
micelles collide via Brownian motion resulting in formation of short-lived clusters.
These clusters allow the transference of material between droplets [92, 102, 103].
The aqueous core will accommodate the water soluble acrylamide monomers such
as acrylamide and methylene bis-acrylamide. The effects of the water-soluble
monomers on the reverse micelles formation and size were previously investigated,
and it was found that they exert a co-surfactant effect [104]. The interaction of
monomers with the polar head of the surfactant leads to a further reduction on the
interfacial tension of the micelles. Consequently, the size of the reverse micelles
decreases [92, 98, 105].
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Figure 3.2: Vinyl addition polymerisation of acrylamide. Ammonium persulfate (4) in
the presence of TEMED generates sulphate free radicals (5), which in turn react at the
carbon-carbon double bond of acrylamide (6) resulting in activated acrylamide monomer
free radicals (7). Acrylamide radicals react with acrylamide monomers to form linear
polymer chains (8,9), bis-acrylamide containing two carbon-carbon double bonds (10)
reacts with 2 acrylamide radical monomers, allowing the formation of bridges between
the molecules of acrylamide (11).
The synthesis of the polyacrylamide matrix within in the aqueous droplets from
acrylamide monomers proceeds via a radical vinyl polymerization which consists
of stepwise reactions, as shown in Figure 3.2. In the first step, initiation, a redox
pair (reduction-oxidation), APS and TEMED, yields a pair of primary radicals
(4,5) [106, 107]. TEMED accelerates the rate of formation of free radicals from
persulfate and these in turn catalyze polymerization. Subsequently, the addition
of the primary radicals to acrylamide monomers will be part of the second step
propagation, where the reaction of activated monomers with inactivated monomers
occurs, promoting the propagation of a linear polymer chain (8). Furthermore,
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the presence of a cross linker N,N’ -methylenebis (acrylamide) (10) capable of re-
acting with two acrylamide monomers will induce the combination of linear chains
of polymer and the consequent formation of a porous network (10). The final
step is termination; at this stage the propagation of polymer chain ceases, leading
to the formation of polymer dead ends (11) and a porous matrix of polyacryl-
amide is formed in the aqueous droplets of the microemulsion [94, 106, 108]. As
in all reactions which involve free radicals as catalysts, the presence of any free
radical scavenger will lead to inhibition of the polymerisation reaction. Oxygen
is a key free radical scavenger. Thus, the successful synthesis of polyacrylamide
nanoparticles in reverse microemulsions is dependent on the appropriate elimin-
ation of all dissolved oxygen. Once synthesized, the recovery of the nanoscale
polyacrylamide particles from the inverse microemulsion is by rotary evaporation,
to remove the organic phase. Subsequently, addition of a polar solvent results in
the precipitation of the nanoparticles. The precipitation step allows collection of
the final nanospheres by removing the excess of surfactant [2, 89, 109].
Aims
The physiochemical properties of the nanoparticle core are known to be the
major factor for determining its specific application, likewise surface properties
are imperative. The assignment of specific functionalities at the surface of
nanoparticles, combined with their intrinsic characteristics (e.g. pore size, shape,
elasticity, swelling), confers control and specificity over the interactions with
biomolecules and cells. Therefore, surface functionalisation plays a crucial role in
the development of effective tools for diagnostic and therapeutic applications.
The present chapter aims to design and characterize functionalised polyacrylam-
84
ide nanoparticles. The introduction of different functionalities aimed to provide
reactive and stable chemical moieties for further conjugation, but also to assist
cellular uptake and specific sub-cellular localisation. To establish the reliability
of the synthetic procedure and the presence of the anticipated functionalities, the
resultant nanosystems were assessed by several techniques.
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3.2 Results and Discussion
The biological applications of nanoparticles rely on their physicochemical prop-
erties, such as size, shape, surface chemistry and surface charge, being under-
stood and controlled. For the present work, it was important to determine the
characteristics of the nanosystems developed. Zeta potential meaurements were
used to characterize the production of several positively charged nanosystems.
Particle size and size distributions were investigated by dynamic light scattering
(DLS) and differential centrifugation (CPS). The analysis of nanoparticle size is
difficult, despite the existence of several techniques, as all of them present tech-
nical/instrumental limitations due to the small nature of these systems (diameter
≤ 200 nm) [110–112]. Therefore, it was important to investigate nanoparticle size
by using complementary techniques.
3.2.1 Acrylamide monomers containing functional groups.
Acrylamide based monomers containing a chemical reactive moiety were used to
incorporate specific functionalities to polyacrylamide nanoparticles. The chem-
ical structure of the monomers used to introduce an amine, trimethyl ammonium
or alkyne functionalities are represented in Figure 3.3. The referred monomers
were incorporated and polymerized within the monomers mixture (acrylamide,
methylene bis-acrylamide) at the time of synthesis. The monomers used for the
introduction of an amino (Figure 3.3; (I)) and trimethyl ammonium functionalities
(Figure 3.3; (II)) were available commercially.
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Figure 3.3: Nanoparticles functionalised monomers. Mono functionalised
nanoparticles: (I)- N -(3-aminopropyl) methacrylamide hydrochloride. (II)- 3-
acrylamidopropyl trimethyl ammonium hydrochloride. (III)- N -propargyl acrylamide.
Dually-functionalised nanoparticles: (IV)- 3-acrylamidopropyl trimethyl ammonium hy-
drochloride; N -propargyl acrylamide.
With respect to the alkyne modification (Figure 3.3; (III)), the monomer
propargyl acrylamide was synthesized in our laboratory following the procedure
primarily described by Malkoch, et al. [113], later modified byWelser, et al. [87,114]
as represented in Figure 3.4.
Figure 3.4: Synthetic scheme to afford N - propargylacrylamide. (12)- acryloyl chlor-
ide; (13)- propargylamine; (III)- N -propargylacrylamide; (a)- diisopropylethylamine
(DIPEA); (b)- DCM.
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Figure 3.5: Mechanism of acrylation of amine-alkyne derivatives to afford N -
propargylacrylamide.
Briefly, as depicted in Figure 3.5, the mechanism involves the nucleophilic
attack of the carbon atom of acryloyl chloride by the lone pair on the nitrogen
atom of propargylamine, (14) forming the intermediate (15). Subsequently, an
elimination step leads to the reformation of the carbon-oxygen double bond with
exit of chloride ion (16). The hydrogen ion (17) was then eliminated by reaction
with chloride, to afford propargylacrylamide (18). The identity of the product
was confirmed by proton NMR, as shown in Figure 3.6. Analytical data was
in agreement with earlier publications (see Appendix A ) [87]. Therefore, the
successful synthesis of the acrylamide based monomer necessary to confer an alkyne
functionality to polyacrylamide nanoparticles was possible.
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Figure 3.6: 1H-NMR spectra of N -propargylacrylamide in CDCl3.
3.2.2 Characterization of size distribution of functionalised
nanoparticles.
The present work required the development of nanoparticles with several func-
tionalities for multiple proposes (e.g. conjugation, facilitated uptake, nanoparticle
stability). Therefore, nanoparticles were produced containing amino, alkyne or
alkyne/trimethyl ammonium functionalisations.
The size characterisation of surface modified polyacrylamide nanoparticles was
performed by dynamic light scattering (DLS). The results of dynamic light scat-
tering analysis were presented as function of the intensity distribution and un-
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dersize intensity. These graphical representations aimed to show the particle size
distribution on the sample analysed. However, the intensity distribution is known
to introduce small errors as a consequence of multiple scattering of fewer larger
particles. In order to report the most accurate hydrodynamic diameter, the Z-
average was used. This parameter is known to be the most stable value recorded
by dynamic light scattering for monodisperse and monomodal distributions. Z-
average results from the cumulants fit and is defined as the harmonic intensity
averaged particle diameter [110–112, 115]. A suspension of nanoparticles in water
was analysed straight after synthesis and monomodal distributions were observed
for both functionalised and non-functionalised nanosystems.
3.2.2.1 Polyacrylamide nanoparticles
Polyacrylamide nanoparticles have been used by several groups for different ap-
plications (e.g. ion sensing, vehicles for photosensitizer delivery) [37, 53, 55, 68,
116–119]. In general, it has been described that the cross linked polymerisation of
acrylamide carried out in reverse microemulsion leads to production of highly mon-
odispersed particles. Furthermore, the characterisation of these systems indicated
a dependence of water/AOT and monomer/crosslinker ratio producing nanopartic-
ulate systems with hydrodynamic diameter between 10 and 50 nm [102, 105, 120].
Similarly with the work previous developed, polyacrylamide nanoparticles were
synthesized via reverse microemulsion and characterised.
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Figure 3.7: Representative size distribution of polyacrylamide nanoparticles charac-
terised by Dynamic Light Scattering- DLS (t=0 day). The results were mean ± SD of
three independent measurements.
In Figure 3.7, the size distribution of polyacrylamide nanoparticles by DLS is
represented. A monomodal distribution with a size range 15-60 nm and a median
hydrodynamic radius of 33 nm was observed. These results indicated that it was
possible to reproduce the synthesis of polyacrylamide nanoparticles with physical
size and uniformity, consistent with literature [37, 43, 93,121].
3.2.2.2 Amino functionalised nanoparticles
Size characterisation of polyacrylamide nanoparticles containing an amino func-
tionality originated a monomodal distribution (Figure 3.8).
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Figure 3.8: Size characterisation of amino functionalised nanoparticles by DLS (t=0
day). The results were mean ± SD of three independent measurements.
The introduction of an amino functionalisation resulted in nanosystems with
increased median average of 49 nm compared to their non-functionalised counter-
parts of 33 nm (Figure 3.7). Furthermore, a wider size distribution was observed,
with a size range between 15 and 110 nm. The increased hydrodynamic diameter in
amino tailored nanoparticles was previously reported by several groups and attrib-
uted to an inherent aggregation pattern of amino functionalised polyacrylamide
nanosystems [2, 70, 87, 109, 122, 123]. Moore, et al. associated the aggregation
phenomenon to a slow aza-Michaelis addition between the N -(3-aminopropyl)
methacrylamide and the N,N’ -methylenebis (acrylamide) at the surface of adja-
cent particles [109]. Although nanoparticles were characterised immediately after
synthesis, it is possible that the presence of small aggregates resulted in larger size
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distribution of the samples. The agreement of the above results with previous re-
ported values suggests that it is possible to produce polyacrylamide nanoparticles
containing an amine functionality.
3.2.2.3 Alkyne functionalised nanoparticles
The impact of tailoring polyacrylamide nanoparticles with alkyne functionalit-
ies in particle size was evaluated and is shown in Figure 3.9. Similarly to
their non-functionalised counterparts, alkyne modified nanoparticles have shown
a monomodal distribution.
Figure 3.9: Size characterisation of alkyne functionalised nanoparticles by DLS (t=0
day). The results were mean ± SD of three independent measurements.
Small variations in distribution range (12-80 nm) and median hydrodynamic
size of 36 nm were verified for alkyne functionalised nanoplatforms. The results
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were similar to the ones reported previously by Welser, et al. [87], polyacrylamide
nanoparticles containing an alkyne functionality resulted in unimodal distributions
with 25 nm in hydrodynamic diameter. Small variations in particle size might be
a consequence of small alterations on the nanoparticle synthetic procedures.
3.2.2.4 Alkyne/trimethyl ammonium functionalised nanoparticles
Development of alkyne/trimethyl ammonium nanoparticles aimed for design of a
construct with a reactive functionalisation for further conjugation (alkyne) and to
confer a net positive charge (for facilitated cellular deliver and sub cellular local-
isation) to the system (trimethyl ammonium). Size characterisation for trimethyl
ammonium functionalised polyacrylamide nanoparticles was also evaluated. Tri-
methyl ammonium functionalisation was achieved by including different percent-
ages of the cationic monomer with acrylamide and N,N’ -methylenebis(acrylamide)
in the polymerisation reaction, which generated three systems containing increas-
ing percentages of the cationic monomer, 2.5 %; 5 % and 10 %, respectively. In this
section, the variation in size distribution as a consequence of increasing trimethyl
ammonium functionalisation was evaluated.
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Figure 3.10: Size characterisation of alkyne/trimethyl ammonium functionalised nan-
oparticles by DLS (t=0 day). (A)- 2.5 % TNPs; (B)- 5 % and (C)- 10 %. The results
were mean ± SD of three independent measurements.
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For particles containing 2.5 % of trimethyl ammonium monomer, a monomodal
distribution with a Z-average of 46 nm was obtained. Increasing the percentage
of trimethyl ammonium monomer (5 %) led to an slight increase in nanoparticle
diameter of 3 nm (49 nm). Further increase in trimethyl ammonium addition, to 10
%, led to higher Z-average of 50 nm. Despite the slight variations in Z-average as
consequence of increased trimethyl ammonium functionality, the size distributions
range was similar for the three systems, 25-120 nm. Sun, et al., reported on the size
of polyacrylamide nanoparticles containing trimethyl ammonium functionalities;
they observed a size increase with further addition of trimethyl ammonium [59].
The increase in size was associated with the positive charge at the surface of
polyacrylamide nanoparticles and an increased osmotic pressure as a consequence
of the dissociated counterions [124]. It was also postulated that the introduction of
a positively charged monomer lead to a change in water-oil microemulsion during
polymerization.
3.2.3 Surface charge characterization of functionalised
nanoparticles: Zeta Potential.
Characterisation of surface charge in functionalised polyacrylamide nanoparticles
was achieved by determination of electrophoretic mobility. Zeta potential was fur-
ther calculated by applying Henry equation (Chapter 2, Section 2.1.2). Zeta
potential measurements were performed at 25◦C, with Hepes buffer (1 mM) at
pH 7.0. Particle surface charge was found to be neutral for non-functionalised
as well as for alkyne tailored nanoparticles with zeta potential values of -3 mV,
as shown in Figure 3.11. The introduction of an amino group in the polymeric
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matrix of the nanoparticles generated an increase in zeta potential to +18 mV.
This was expected and was in agreement with previous reports [109, 125]. The
results indicated the successful insertion of an amino chemical modification which
confers a positive charge to polyacrylamide nanoparticles, as previously reported
by Moore and others [109, 125]. The introduction of increasing concentrations of
quaternary ammonium ion functionalities into polyacrylamide nanoparticles aimed
for the modulation of the net charge. Thus, as expected, the insertion of 2.5 % of
trimethyl ammonium monomer in the reaction mixture for the synthesis of pos-
itively charged nanoparticles, generated a surface charge of +13 mV. The further
increase to 5 % and 10 % of tetramethyl ammonium in the monomers mixture
was also accompanied by an increase in surface charge, to +18 mV and +28 mV,
respectively. Therefore, zeta potential results indicated that nanosystems carrying
increased levels of net charge were generated. The results were consistent with the
work previously developed by Sun, et al., who also investigated the development
of positively charged polyacrylamide nanoplatforms [59].
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Figure 3.11: Surface charge of functionalised polyacrylamide nanoparticles. The results
were mean ± SD of three independent measurements.
3.2.3.1 Comparison of nanoparticle sizes
The size distributions of the functionalised and non-functionalised nanoplatforms
were shown in Figures 3.7, 3.8, 3.9, 3.10. Figure 3.12 shows and compares the
average size diameters for the various nanoplatforms developed.
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Figure 3.12: Comparison of size variation in polyacrylamide functionalised nano-
particles by DLS. The results were mean ± SD of three measurements. Control (poly-
acrylamide NPs) vs. 2.5 %; 5 % and 10 % TNPs:** p< 0.001. Student’s-t-test.
The introduction of an alkyne moiety did not produce significant alterations
in size distributions when compared with non-functionalised systems (p> 0.05).
For the amino-functionalised nanoplatforms, an increased z-average was obtained,
even though that value was not significant (p> 0.05) when compared with its
non-functionalised counterparts. As mentioned above (Chapter 2), DLS intensity
distributions are prone to be mislead by the presence of a small amount of larger
particles. Thus, as stated above, the characteristic aggregation associated with
amino-functionalised NPs originated larger size distributions for these systems.
The increased z-average is hypothesized to result in small aggregation, which
would explain the larger size distributions and, consequently, overestimation of
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this value.
On the other hand, dual functionalised nanoplatforms (alkyne/TNPs) showed
statistically different hydrodynamic diameters when compared with the non-
functionalised particles (p< 0.001).
In order to further investigate the variations in nanoparticle size, measure-
ments using differential centrifugation sedimentation (CPS) were compared with
those obtained from DLS. Both methodologies resulted in monomodal distributions
for all analysed systems, previously reported as essential conditions for accurate
nanoparticle size determination by these instruments [126].
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3.2.3.2 Size distribution of nanoparticles: Dynamic light scattering
(DLS) vs. differential centrifugation (CPS).
Figure 3.13: Size characterisation of functionalised and non-functionalised polyacryl-
amide nanoparticles by dynamic light scattering (DLS) and differential centrifugation
(CPS) (t=0 day). The results were median ± SD of three independent measurements.
Control vs. 2.5 %; 5 % and 10 % TNPs:** p< 0.001; 2.5 % TNPs vs. 5 % TNPs: * p<
0.001; 2.5 % TNPs vs. 10 % TNPs: § p< 0.001; 5 % TNPs vs. 2.5 % TNPs: ⋄ p< 0.001;
5 % TNPs vs. 10 % TNPs: • p< 0.001; 10 % TNPs vs. 2.5 % TNPs: † p< 0.001; 10 %
TNPs vs. 5 % TNPs: ‡ p< 0.001. Student’s-t-test and One-Way ANOVA.
Figure 3.13 shows the hydrodynamic diameter of functionalised nanoparticles de-
termined by dynamic light scattering (DLS) and differential centrifugation sed-
imentation (CPS). Particle size analysis by CPS produced consistently lower
diameters for all nanoparticle systems when compared with DLS. This was in
agreement with observations reported by Elizalde, et al., for polymeric disper-
sions [126, 127]. Furthermore, it was possible to verify a consistent difference of
5 nm between the two methodologies for particle size for non-functionalised and
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alkyne NPs. For nanosystems containing positive charges a higher difference of 12
nm and 16 nm for 10 % ATNPs NPs was obtained. It is hypothesized that the vari-
ations produced by the two methodologies are due to differences in the approaches
used by the two techniques to determine the particle size (e.g. particle density). In
addition, the higher differences observed for positively charged nanoparticles could
be due to the swelling effect, as mentioned above (Section 3.2.2.4) and reported
by other groups [59]. The swelling effect appears mainly to be present in samples
analysed by DLS.
In sum, the results of particle size characterisation by the two different techniques
presented similar results. However, differential centrifugation sedimentation ap-
pears to produce higher similarity for the different functionalised systems than
DLS, especially for positively charged nanosystems. This difference could be asso-
ciated with the fact that DLS intensity distributions are highly affected by the pres-
ence of even small number of larger particles (therefore, prone to errors). Moreover,
CPS allowed a better resolution of smaller particles since it distinguished sizes dif-
fering by as little as 2 %. However, it is necessary to note that a good resolution
of small particle sizes requires high disk speeds, as the sedimentation velocity in-
creases with the square of particle size diameter (Chapter 2; Section 2.1.1.2).
Thus, to acquire a good resolution it would be necessary to involve several hours
per sample, which could become problematic due to the issue of background noise.
3.2.3.3 Nanoparticles stability over time: DLS characterisation.
Evaluation of the nanoparticle size over a long period of time was performed by
dynamic light scattering. The study was performed for nanoparticles which were
stored at −18◦C for a period of 10 months. Figure 3.14 shows the comparison
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between particle size measured at the time of synthesis and after 10 months of
storage at −18◦C. In general, the systems presented a monomodal distribution
before and after storage. However, a significant difference was seen for amine
functionalised NPs and 10 % ATNPs NPs.
Figure 3.14: Time-dependent size characterisation of polyacrylamide functionalised
nanoparticles by DLS. The results were mean ± SD of three measurements: amino NPs
(t= 0) vs. amino NPs (t= 10 months):* p< 0.05; 10 % TNPs (t=0) vs. 10 % TNPs
(t=10 months):* p< 0.05: Student’s-t-test.
The amino functionalised nanoparticles exhibited a significant increase in
particle size after storage. This was expected and, indeed, particle size increases
of amino modified NPs associated with aggregation have previously been reported
by others [2, 70, 87, 109, 122, 123]. Moreover, it is important to note that, after
storage amino functionalised NPs presented a monomodal distribution, but
only an increased polydispersion index (PDI=0.475) was observed. Positively
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charged and alkyne functionalised polyacrylamide nanoparticles at low TNPs
concentrations (2.5 % ATNPs, 5 % ATNPs) were found to be stable after 10
months of storage without significant variations in hydrodynamic diameter (p>
0.05). The 10 % ATNPs modified nanoparticles exhibited an increase 5 nm in
particle size, which was found to be statistically significant, though much less
obvious than the amino functionalised NPs (p< 0.05). It was found that the
functionalised nanosystems were stable after a long period of storage with a
maximum increase in hydrodynamic diameter of 5 nm.
104
3.3 Conclusions
For the development of nanoplatforms capable of inducing the generation of
ROS in cellular systems, free radical polymerization in reverse microemulsions
was used. Polyacrylamide matrix can be used to incorporate chemically reactive
functional groups by reacting monomers containing those groups in the free
radical polymerization. Chemical tailoring of nanoparticles is important to alter
the physicochemical characteristics of the resultant systems. This methodology
is frequently used to allow attachment of cargo molecules, but also to control
cellular uptake and sub-cellular localszation. In the present research, three types
of functionalised nanoplatforms were investigated.
Nanosystems containing amino or alkyne functionalities were investigated
to develop stable platforms to further conjugate an ROS generator moiety.
Successful tailoring of nanoparticles with amino or alkyne functional groups was
investigated by zeta potential analysis. Amino functionality had been previously
associated with positive net charge at the surface of the nanoplatforms, thus
was easily confirmed by zeta potential. On the other hand, alkyne chemical
modifications were more challenging to determine owing to the fact that this
functionality originates a slight negative charge, as observed for non-functionalised
nanoparticles. Dynamic light scattering and differential centrifugation were used
to investigate the diameter of the resultant nanosystems. Size analysis of the
resultant nanosystems presented very promising results; DLS data have shown
nanoplatforms with hydrodynamic diameters of 49 (amino groups) and 36 (alkyne
groups) nm, values compatible with biological applications (cellular uptake <100
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nm). Further studies on the functionalised nanosystems stability indicated that
amino tailoring was limiting for further studies, size increase over time indicated
that this approach shows aggregation over time. Mainly, it was found that
dispersion of these nanoparticles was only possible immediately after synthesis.
As for alkyne functionalised systems, great stability over time was found with no
size alterations even after 10 months storage. Alkyne functionalised nanoparticles
were promising approaches for conjugation.
The cellular uptake of polyacrylamide nanoparticles has previously been
reported as inefficient and, several approaches have been demonstrated (e.g.
gene gun, microinjection) to overcome this. Lately, physicochemical engineering
of the nanoparticle surface has been reported effective for facilitated uptake.
The presence of positive surface charge was previously reported to facilitate
uptake by conferring interaction between nanoparticles and biological membranes.
Trimethyl ammonium functional groups have been previously applied to confer
positive charge to polyacrylamide nanoparticles. This approach was developed
in this project to produce a dually functionalised nanosystem, a trimethyl
ammonium functionality to facilitate uptake and alkyne functionality for cargo
molecules conjugation. This methodology allowed the development of three types
of nanosystems and, size analysis confirmed the stability of these nanosystems
with diameters between 46 and 50 nm, even after 10 months of storage. As for net
surface charge, values between +13 and +20 (mV ) were achieved, representing
very promising approaches for the ongoing work.
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The major limitations of the present work was to verify the presence of alkyne
functionalities, future work will be developed to confirm the presence of such func-
tional group. In general, the present research allowed the development of stable
functionalised nanoplatforms with favorable physicochemical characteristics and
for the development of ROS generating nanosystems.
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Chapter 4
Development of Porphyrin
Polyacrylamide Nanoparticle
Systems.
4.1 Introduction
The advances in nanoparticle engineering have led to the creation of versatile
tools with multiple applications in biomedical therapeutic/diagnostic research, as
well as the study of biological processes and interactions. These advances were
based on transformations of the nanoparticle interface to accommodate surface
chemically reactive moieties that provide proper linkage of biomolecules under
physiological conditions [47, 128,129].
There are several important points to consider when designing a conjugation
reaction, the most important being that: the process of conjugation should not
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affect the activity of the molecule or interfere with nanoparticle functionality. A
more challenging requirement control, over the number of linkage sites available
for the molecules binding. The conjugation reaction should proceeds under mild
conditions and not be subject to competing reactions (e.g. hydrolysis) [129].
The development of conjugates that obey the characteristics cited above led to
the development of several coupling mechanisms. Figure 4.1 shows some examples
of the most common.
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Figure 4.1: Common coupling mechanisms used for conjugation.
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4.1.1 “Click chemistry”
In 2001 Torne and Meldal first introduced the concept of “click chemistry”, oth-
erwise known as the Huisgen 1,3-dipolar cycloaddition reaction of organic azides
and alkynes (CuAAC) [130]. Click reactions were defined as “... powerful, highly
reliable and selective reactions for the synthesis of new compounds...” [130]. In the
context of Huisgen 1,3-dipolar cycloaddition, the alkyne/azide is a metal-catalysed
variant between C-C triple and C-N triple bonds [130,131]. This reaction leads to
the formation of 1,2,3- triazoles. The attractiveness of Cu (I) catalysed reactions
is the fact that they are very robust, regioselective, of wide scope, insensitive
to solvent, can be performed at room temperatures, and produce, very high
yields [130–132]. It is also worth noting that the triazole formed is chemically
stable and inert to reactive conditions (e.g. oxidation, reduction, hydrolysis,
etc) [87, 130–136].
4.1.1.1 The mechanism of Alkyne-Azide CuAAC.
Briefly, the mechanism of alkyne/azide CuAAC, Figure 4.2, is initiated by the π
complexation of a CuI dimer to the alkyne, which lowers the pka of the terminal
alkyne (Fig. 4.2 (1)). According to Sonogashira coupling, CuI can be directly
inserted in alkynes [133,137].
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Figure 4.2: Click chemistry: accepted mechanisms for Cu(I) catalysed reaction between
azides and terminal alkynes. Adapted from [130]
.
A deprotonation of the terminal hydrogen leads to the formation of the Cu-
acetylide complex (Fig. 4.2 (2)). Thereafter, one of the ligands is displaced by N (1)
in the Cu-acetylide complex forming (3). Subsequently, the azide reacts with C(5)
through nucleophilic attack. On the other hand, proximity and electronic factors
favours the attack to C (4), forming a metallocycle (Fig. 4.2 (4)). Thereafter, due
to the contraction of the metallocycle, as consequence of a lone pair of electrons, N
(1) attacks C (5) with the release of the triazole (Fig. 4.2 (5)). The ligand denoted
by (L) can be represented by a variety of compounds, in the case of CuBr, the
ligand is bromide.
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4.1.1.2 Sources of Cu(I).
Several conditions have been established to achieve the active catalyst for
cycloaddition reactions. The most popular approach is the reduction of CuII
salts in situ to form CuI(e.g. CuSO4. 5H2O) mediated by a reducing agent
(e.g. sodium ascorbate). This methodology brings several advantages; low cost,
aqueous conditions, does not require an inert atmosphere. The main disadvantage
is that the reducing agent might convert CuII to Cu0; however, this can be
resolved by the use of an appropriate ratio of the reducing agent [130,131,133].
Another methodology is the use of CuI salts which does not require the use
of a reducing agent. However, it is important to protect the CuI from oxidation
when in contact with oxygen; thus, an inert atmosphere is normally required when
using this catalyst source. In addition, tetravalent ligands, such as (tris-(benzyl-
triazolylmethyl)amine) (TBTA) [21, 138], triethylamine hydrochloride [139], and
sulfonated bathopenantroline [140], were also found to confer protection of CuI
against oxidation and increase the reaction efficiency [130–133].
Aims
The purpose of the present chapter was the development and characterization
of stable nanoconjugates through the linkage between ROS generator moiety (por-
phyrins) and functionalised nanosystems as developed in Chapter 3. The efficient
attachment between NPs and porphyrins was studied by several methods; the focus
is to ensure only the linkage between the two portions and the absence of physical
adsorption. The present research also aimed to investigate the impact of conjuga-
tion on the characteristic profile of metal complexes of porphyrins. Furthermore,
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the physicochemical characteristics of the resultant porphyrin-nanosystems were
evaluated to ascertain compatibility with biological applications.
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4.2 Results and Discussion
One of the main challenges in the conjugation of nanoparticles with biomolecules is
the quantification of the number of ligands attached to the NP and where they are
attached. For this reason is difficult to achieve uniform distribution of molecules
conjugated at the surface of the nanoparticles. For the development of the present
project it was necessary to ensure that the amount of porphyrin coupled with
nanoparticles would be enough to promote a photosensitizing effect. Therefore,
several conjugation reactions were investigated and optimized to attain maximal
porphyrin conjugation whilst maintaining a stable system.
4.2.1 Spectroscopic characterisation of porphyrins
The fluorescent emission spectrum of porphyrins has been widely reported to be
sensitive to metallation, dimerization and hydrolysis [141,142]. In order to anticip-
ate any alterations resulting from the coupling reactions, spectroscopic character-
isation of porphyrins was performed. Figure 4.3 shows the absorption spectras of
five porphyrins that were used for conjugation with functionalised nanoparticles,
(for the sake of simplicity, the porphyrins used are labelled according to their metal
centre and functional group).
Metallated porphyrins, ZnPNCS (XII) and ZnPN3 (XIII), exhibit a maximum
(soret band) at 435 nm and two Q-bands of less intensity at 565 nm and 610 nm
(F), characteristic of zinc metalloporphyrins. Similarly, for ZnPMA (XIV), the
same pattern of absorption is observed; however, a red shift (4 nm) is seen for the
soret band. Copper metallated porphyrins present a maximum at 425 nm (Soret
band); however, in terms of Q-band, only one is distinguishable by its absorption
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spectra 555 nm. For the corresponding porphyrin free base (i.e. non metallated
(X)), the soret band at 420 nm and 4 maxima of lower energy transitions (Q
bands) are evident. The resultant spectra are a consequence of the highly conjug-
ated skeleton of porphyrins showing maximums of absorption (soret band) between
420- 439 nm resulting from ground state to the second excited state (S0 → S2)
transitions.
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-Figure 4.3: Absorption spectra of porphyrins in dH2O: (A)- 5-(4-
isothiocyanatophenyl)-10,15,20-(4-N-methylpyridiniumyl) porphyrin trichloride (X-
free base); (B)- 5-(4-azidophenyl)-10,15,20-tris-[(4-N-methylpyridinium)yl] por-
phyrinato copper(II)trichloride (XI- CuPN3); (C)- 5-(4-isothiocyanatophenyl)-10,15,20-
tris-[(4-N-methylpyridinium)yl] porphyrinato zinc(II)trichloride (XII- ZnPNCS);
(D)- 5-[4-[2-(azidoethoxy)ethyl]phenyl]-10,15,20-tris-[(4-methylpyridynium)yl] por-
phyrinato zinc(II)trichloride (XIII- ZnPN3); (E)- 5-4-(3-(3-methylthioureido)propyl
methacrylamide)phenyl)-10,15,20-tris-[(4-methylpyridynium)yl]]porphyrinato zinc(II)
trichloride (XIV- ZnPMA); (F)- detailed absorbance spectra for Q- bands regions (500-
650 nm) of ZnPN3; CuPN3 and ZnPNCS.
Subsequently, the lower intensity bands (Q-bands) result form weak transitions
to the first excited state, (S0 → S1) [143]. The different pattern between Q- bands
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of the free base (F) and metallated porphyrins were previously reported and result
from different vibrational components of the same electronic transition (x and y,
2 for each). However, for zinc metalloporphyrins, the presence of the metal ion
in the macrocycle cavity leads to a higher rigidity of the porphyrin ring structure
and, consequently, its symmetry. Therefore, the dipole transitions along x and y
are of now of identical energy, which results in an overlap reducing the number of
Q bands from four to two [143,144].
Figure 4.4: Emission spectra of porphyrins.
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4.2.2 Development of porphyrin polyacrylamide systems
via amino-isothiocyanate conjugation.
4.2.2.1 Optimisation of conjugation reaction conditions.
In chapter 3, the synthesis of amino functionalised nanoplatforms was described
and characterised. This procedure allowed the creation of a nanosystem which car-
ries an exposed amino group, firstly identified by its characteristic positive surface
net charge. Subsequent identification of these chemically reactive moieties in nan-
oparticles was confirmed by the use of fluorescence analysis. Fluorescamine (Fig-
ure 4.5 (1)) is a highly reactive heterocyclic dione which is characteristically non-
fluorescent; however, it becomes fluorescent when it reacts with primary amines.
Fluorescanime (4-phenylspiro-[furan-2(3H),1-phthalan]-3,3’-dione) has previously
been reported for the labelling of proteins, peptides, amino acids and primary
amines [145–147].
Figure 4.5: Mechanism of reaction fluorescamine with amino functionalised nano-
particles. (VI)- amino functionalised nanoparticles; (7)- fluorescamine; (8)- conjugates
with fluorescamine ligand (fluorescent form).
The addition of this reagent (Figure 4.5 (7)) to amino functionalised nano-
particles (VI) led to an activated form of fluorescamine as a consequence of its
reaction with the amino functionalisation present at the nanoparticles interface,
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thus conferring a methodology for the identification of these functional groups.
This was confirmed by measuring the fluorescence spectrum of activated fluores-
camine (λexc= 390 nm; λem= 465-475 nm).
Figure 4.6: Emission spectrum of amino and non- functionalised nanoparticles upon re-
action with fluorescamine. Non- functionalised NPs (V) were reacted with fluorescamine
(7) in aqueous conditions. In parallel, amino functionalised NPs (VI) were also incub-
ated with fuorescamine(7). The emission spectrum of amino and non-functionalised NPs
upon reaction with fluorescamine was collected. (A)- fluorescamine reacted with non-
functionalised NPs did not show any fluorescence (red plot); (B)- fluorescamine-amino
NPs showed fluorescence at 465 nm (blue plot). λexc= 390 nm; λem= 465-475 nm.
Figure 4.6 shows the schematic representation of the experiment performed to
identify the presence of amino functionalisations in polyacrylamide nanoparticles.
It is important to note that the evaluation of fluorescamine reactivity was made
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directly for both samples without any purification process prior to fluorescence
analysis. Therefore, as expected, the complete absence of fluorescence was ob-
served for non-functionalised nanoparticles (V) incubated with fluorescamine (7),
due to the lack of primary amino groups. Furthermore, for amino functional-
ised nanoparticles (VI) the presence of fluorescence was observed, which suggests
successful introduction of this functionality to the nanoparticles.
4.2.2.2 Spectroscopic characterisation of NP-porphyrin conjugates.
4.2.2.2.1 Capped porphyrin-nanoparticle conjugates (XVI- Zn-
PCNPC). Amino functionalised polyacrylamide nanoparticles were previously
reported to be prone to aggregation with a very short lifetime, ≤ 1 week. Moore,
et al. suggested that the reaction between N -(3-aminopropyl) methacrylamide
and unreacted N,N’ -methylene bisacrylamide was the mechanism responsible for
aggregation of amino functionalised nanosystems [109]. In the development of
porphyrin polyacrylamide systems via amino-isothiocyanate (ZnPNPC) conjuga-
tion, Josefsen, et al. reported diameters of 195 nm, suggesting aggregation; it was
reasoned that unreacted amino groups would lead to aggregation [2]. In order to
overcome this, a protocol was developed where the amino groups were inactivated
by reaction with acetic anhydride after porphyrin conjugation. Figure 4.8,
schematically shows the reaction of capping amino functionalised nanoparticles
with acetic anhydride [129,148].
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Figure 4.7: Reaction of porphyrin-amino nanoparticles with acetic anhydride. Acetic
anhydride (9) was reacted with porphyrin-amino nanoparticle conjugates (XV)
In order to investigate whether it was possible to block off amino groups at the
surface of polyacrylamide nanoparticles, the compound fluorescamine, was used,
as referred to in Section 4.2.2.1. To ensure the full capping of amino groups, an
excess of acetic anhydride was used. Figure 4.8 shows the fluorescence emission
spectra of capped polyacrylamide nanoparticles.
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Figure 4.8: Emission spectra of porphyrin-amino nanoparticles upon reaction with
fluorescamine.
It can be observed that fluorescamine fluorescence (λexc= 390 nm; λem=
465-475 nm) in NPs had amino functionality (green dotted line) whilst particles
without amino functionality ( PANPs, blank blue dotted line) did not show any
fluorescence. In addition, for capped amino NPs a low fluorescence was observed
(purple dotted line), suggesting that the cap of amino groups was not complete.
4.2.2.2.2 Porphyrin nanoparticles (XVII-ZnPNPs) Once it was estab-
lished that it was not possible to completely block reactive amino groups on nan-
oparticles, a porphyrin monomer with a reactive acrylamide was developed. This
approach involved the reaction of the monomer N -(3-aminopropyl)methacrylamide
with isothiocyanate porphyrins, as shown in Figure 4.9.
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Figure 4.9: Synthetic scheme to afford 5-4-(3-(3-methylthioureido)propyl
methacrylamide)phenyl)-10,15,20-tris-[(4-methylpyridynium)yl] porphyrinato zinc(II)
trichloride (APMAP).
For this approach, the monomer was directly incorporated into the matrix of
nanoparticles, thereby avoiding the presence of unreacted amino groups that fa-
cilitate aggregation. Therefore, an excess of ZnPNCS (XII) was reacted with
the monomer N -(3-aminopropyl)methacrylamide hydrochloride (I). The excess
of porphyrin aimed to exclude the presence of unreacted amino groups, which
also avoided time consuming purifications as it is a very straightforward reac-
tion without by-products. The reaction produced the porphyrin ZnPMA (XIV)
characterised in Section 4.2.1. Therefore, any unreacted porphyrin would be
collected after nanoparticles synthesis, along with the washing/purification step.
Figure 4.10 shows the absorption and emission spectra of porphyrin-nanoparticles
(XVII-ZnPNPs).
124
Figure 4.10: Absorption and emission spectra of ZnPNP (XVII).
It is possible to identify an absorption emission spectrum characteristic of free
base porphyrin when compared to that in Section 4.2.1. Although, it verified
changes in the absorption pattern, red shifted (4 nm) in relation to the soret-band
and blue shifted in relation to the Q-bands, these results could have arisen from
interactions of the porphyrin and the polyacrylamide matrix, such as entrapment
of the porphyrin in the polymeric matrix.
4.2.2.2.3 Porphyrin trimetylammonium nanoparticles (XVIII- ZnPT-
NPs) Following the above results, Section 4.2.2.2.2, and knowing the present
research aimed to exploit surface charge as a means for nanoparticle facilitated
cellular uptake and targeting, NPs with porphyrin (XIV- ZnPMA) and trimethyl
ammonium functionalities (II), were developed. The new nanosystem provided
the development of constructs with porphyrin and trimethyl ammonium ligands
covalent-linked to the polymeric matrix. Figure 4.11 shows the absorption and
emission spectra of porphyrin trimethyl ammonium nanoparticles (ZnPTNP).
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Figure 4.11: Absorption and emisson spectrums of ZnPTNPs (XVIII).
It is possible to identify an absorption and emission spectrum characteristic of
porphyrin when compared to that in Section 4.2.1 (XIV). Although, it verified
changes in the absorption pattern, red shifted in relation to the soret-band and
the Q-bands. Once again, the results suggest a possible interaction between the
porphyrinic ligand and the polyacrylamide matrix.
4.2.2.3 Size characterisation of porphyrin-NP conjugates.
Particle size of porphyrins-nanoparticle conjugates was investigated by dynamic
light scattering (DLS) . Figure 4.12 shows the hydrodynamic diameters of the
nanosystems developed.
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Figure 4.12: Hydrodynamic diameter of porphyrin nanosystems measured by dy-
namic light scattering. PAmNPC (Figure 4.7; XV)- porphyrin nanoparticle con-
jugates via amino functionalisation. ZnPCNPC (XVI)- porphyrin nanoparticle con-
jugates via amino functionalisation with unreacted amino groups capped. ZnPNP
(XVII)- porphyrin functionalised nanoparticles. ZnPTNP (XVIII)- porphyrin/ tri-
methyl ammonium functionalised nanoparticles. The hydrodynamic diameter presen-
ted is a result of is an average 3 independent batches ± SD. ZnPAmNPC vs. Zn-
PCNPC/ZnPNP/ZnPTNP: * P<0.05; ZnPCNPC vs. ZnPNP/ZnPTNP: § P<0.05 were
considered statistically different, all pairwise comparison One way ANOVA.
In general, monomodal distributions were observed for capped porphyrin
nanoparticles conjugated via amine functionalisation (ZnPCNPC) and for por-
phyrin (ZnPNP) and porphyrin/trimethylammoniun (ZnPTNP) functionalised
nanoparticles. In addition, for porphyrin nanoparticles conjugated via amino
functionalisation, a bimodal distribution was observed. The porphyrin nanosys-
tems attained by conjugation with amino functionalised have shown higher
hydrodynamic diameters of 152/20 ± 4.3 nm and 62 ± 2.3 nm for PAmNPC and
ZnPCNPC, respectively. Furthermore, the hydrodynamic diameter of PAmNPC
was significantly (p < 0.05) higher that ZnPCNPC, suggesting that amino capping
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prevented aggregation of ZnPCNPC. Previously, Josefsen, et al. characterised
the development of porphyrin-amino nanoparticles (PAmNPC) and found a
hydrodynamic diameter of 195 nm for PAmNPC, in agreement with the results
presented here [2, 70].
For porphyrin functionalised nanosystems, ZnPNP (38 ± 1.2 nm) and ZnPTNP
(40 ± 1.2 nm), independent of the number of functionalisations similar hydro-
dynamic diameters were observed. The results indicated that using porphyrin
monomers avoid aggregation.
Figure 4.13: Hydrodynamic diameter of porphyrin nanosystems after 10 months of
storage at -18◦ C. measured by dynamic light scattering. PAmNPC- porphyrin nan-
oparticle conjugates via amino functionalisation. ZnPCNPC- porphyrin nanoparticle
conjugates via amino functionalisation with unreacted amino groups capped. ZnPNP-
porphyrin functionalised nanoparticles. ZnPTNP- porphyrin trimethyl ammonium func-
tionalised nanoparticles. The hydrodynamic diameter presented is a result of an average
three independent batches ± SD. PAmNPC vs. ZnPCNPC: * P<0.05 were considered
statistically different, all pairwise comparison One way ANOVA.
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Further analysis of hydrodynamic diameter after 10 months of storage aimed
to evaluate the stability of the nanosystems developed. For PAmNPC, no
significant alterations in hydrodynamic diameter (size10 mo 176 ± 2 nm) were
found. Surprisingly, ZnPCNPC showed higher significant variations (p < 0.05)
than the one PAmNPC after 10 months of storage (ZnPCNPC size10 mo 191
± 5 nm). These results suggest that the incomplete capping of amino groups
is not enough to reduce the aggregation of ZnPCNPC. On the other hand,
porphyrin functionalised nanosystems, ZnPNP and ZnPTNP, showed high sta-
bility after 10 months storage with sizes of 39 ± 1 nm, and 47 ± 1 nm, respectively.
Taken together, the results of porphyrin nanoparticles attained via amino con-
jugation suggested that it was not possible overcome nanoparticle aggregation due
to amino functionalisation; however, PCNPC presented a lower diameter at the
time of synthesis. The use of porphyrin monomers attached to the polyacrylamide
matrix produced systems with considerable lower diameters than the porphyrin
conjugates and were highly stable after a long period of storage.
4.2.2.4 Surface characterisation of NP-conjugates.
The porphyrin nanoparticles aimed to attain characteristics that promote pass-
ive cellular uptake. In order to characterise the surface charge, zeta potential
of the resultant nanosystems was measured. It is important to note that por-
phyrins as tricataionic molecules contributed with three positive charges each. In
addition, unreacted amino functionalities and trimethyl ammonium functionalities
also conferred a net positive charge. The analysis of surface charge in the resultant
nanosystems is represented in Figure 4.14.
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Figure 4.14: Porphyrin nanosystems surface charge characterisation, zeta potential.
PAmNPC (Figure 4.7; XV)- porphyrin nanoparticle conjugates via amino function-
alisation. ZnPCNPC- porphyrin nanoparticle conjugates via amino functionalisation
with unreacted amino groups capped. ZnPNP- porphyrin functionalised nanoparticles.
ZnPTNP- porphyrin trimethyl ammonium functionalised nanoparticles. The zeta po-
tentials presented are a result of an average three independent batches ± SD.
For porphyrin- nanoparticle conjugates, PAmNPC (XV) and ZnPCNPC
(XVI), zeta potentials of +13 ± 1 mV and +6 ± 2 mV were observed. As
expected, the capping of unreacted amino functionalisations led to a decrease
in surface charge of ZnPCNPC (XVI). By contrast, ZnPNP (XVII) showed a
negative surface charge (-4 ± 1 mV ), which, indicates that the functionalization
of polyacrylamide NPs with porphyrins monomers results in the entrapment of
porphyrin molecules. As porphyrins are tricationic molecules, it was expected to
observe positive charge on those nanosystems if these ligands were to be exposed
at the surface of the NPs. Furthermore, the surface charge of ZnPNP (XVII)
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is consistent with non-functionalised polyacrylamide nanoparticles. As expected,
functionalization of polyacrylamide NPs with porphyrin and trimethyl ammonium
monomers ZnPTNP (XVIII) had led to an increase of surface charge to +13 ± 1
mV. Due to the newness of this system, it was not possible to achieve a comparison.
The results obtained suggest that it is possible to synthesize stable porphyrin
nanosystems through the use of porphyrin monomer (ZnPNP). In addition, con-
ferring a positive charge was also attained by the incorporation of a trimethyl-
ammoniun functionality (ZnPTNP). By contrast, conjugation of porphyrins via
amino functionalities (PAmNPC) was revealed to be inefficient due to aggrega-
tion. Capping of unreacted amino groups was not complete, therefore did not
allow the control of aggregation of PCNPC.
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4.2.3 Development of porphyrin polyacrylamide systems
via click chemistry methodologies.
In the previous section, the development of porphyrin-nanoporticles through amino
functionalisation led to aggregation. Subsequently, it was found that stable
nanosystems could be achieved by the use of porphyrin monomers. Although,
stable nanosystems were possible to achieve, the porphyrin was found to be en-
trapped in the polymeric matrix, therefore the photodynamic efficiency of por-
phyrins could have been compromised. Thus, porphyrin-nanoparticle conjugates
were developed through an alkyne functionality, the advantages of which were re-
ferred to in the introductory Section 4.1.1. The nanosystem described in this
section aimed to attain porphyrin conjugated at the surface of nanoparticles.
4.2.3.1 Optimisation of conjugation click reaction conditions.
As referred to in the introductory section of the present chapter, there are several
approaches described in the literature for efficient copper-catalysed triazole
formation. These approaches rely on a high concentration and constant presence
of copper (I) while the other reaction conditions can be adjusted according to the
final aim (e.g. temperature, solvent, etc). From these approaches, a number of
possible methodologies have been generated with CuI; CuBr and CuSO4 being the
most popular source of Cu(I) ions. The main difference between these copper salts
are that CuI and CuBr are Cu(I) sources that immediately forms Cu-acetylides
whereas CuSO4 is a copper (II) source which requires the presence of a reducing
agent to perform the conversion of copper (II) to copper (I) prior to formation of
Cu-acetylides. The advantage of using a copper (II) salt is the protection against
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oxidation from contact with oxygen. Prior to the establishment of a protocol
for copper(I)- Huisgen catalized 1,3, cycloaddition an initial evaluation of the
impact of the reagents on the hydrogel matrix and final yields was undertaken.
In the present study, all three sources (CuI, CuBr and CuSO4) were investigated
by incubation with functionalised nanoparticles in aqueous conditions. For the
removal of catalyst excess, upon reaction completion the resultant NPs were
purified by gel filtration sephadex (SEC columns, as shown in Figure 4.18). It
was found that using CuSO4 catalyst in the presence of sodium ascorbate as the
reducing agent led to an alteration in coloration of the blank polyacrylamide
nanoparticles (from white to yellowish), even after purification, the colouration
remained and the recovered yield was below 50 %. Although CuSO4 has been
a popular choice for copper-catalysed triazole formation, it was not possible to
justify this reagent based on its coloration and yield therefore it was abandoned
as a catalyst for further studies. The use of CuI and CuBr, however, induced
no alterations when introduced to non-functionalised nanoparticles and the final
yields of recovery were found to be, 72 % and 85 % respectively. The effects of
CuBr on the whole system in the study were tested and are reported in the final
characterisation of the resultant systems.
4.2.3.1.1 Click reaction of NPs with azidocoumarin. Previously, Welser,
et al. reported the development of alkyne functionalised nanoparticles, whose
characterisation by FT-IR at 3300 cm-1 (indication alkyne functionality) was found
to be difficult due to the strong absorbance of the polymer backbone [87, 114]. In
order to show the presence of alkyne groups in alkyne functionalised nanoparticles,
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fluorescence analysis was used. Similarly with amino functionalised nanoparticles
(Section 4.2.2.1), the introduction of alkyne functionalisation into polyacrylamide
nanoparticles was evaluated by an intrinsically non-fluorescent probe that becomes
fluorescent upon azide-alkyne reaction, with formation of 1,2,3 triazole product.
Sivakumar, et al. reported on the ability of 3-azidocoumarin to became fluorescent
upon reaction with alkyne moiety mediated by the catalyst copper (I) [85]. Hence,
the evaluation of the presence of alkyne functionalisations at the nanoparticle
interface was investigated by its reaction with 3- azidocoumarin through CuAAC
the reaction of which is represented in Figure 4.15. It is important to note that,
as the reaction was performed with a copper (I) catalyst, it was necessary to avoid
contamination with oxygen that would lead to oxidation; therefore all reactions
were performed with an excess of CuBr and in sealed vials.
Figure 4.15: Reaction that occurs from incubation of fluorescamine with alkyne
functionalised nanoparticles. (VIII) alkyne functionalised nanoparticles; (10) 3-
azidocumarin; (11) azidocoumarin-alkyne nanoparticle conjugates.
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In order to evaluate the efficiency of the CuAAC between 3-azidocoumarin-
alkyne nanoparticles, the emission spectra of the resultant conjugates were ana-
lysed, as shown in Figure 4.16.
Figure 4.16: Emission spectrum of alkyne and non-functionalised nanoparticles upon
reaction with 3- azidocoumarin. Non-functionalised NPs (V) were reacted with 3- azido-
coumarin (10) in aqueous conditions. In parallel, alkyne functionalised NPs (VIII)
were also incubated with 3- azidocoumarin (10). The emission spectrum of alkyne and
non-functionalised NPs upon reaction with 3- azidocoumarin was collected. (A)- fluor-
escamine reacted with non-functionalised NPs did not show any fluorescence (red plot);
(B)- 3-azidocoumarin-amino NPs showed fluorescence at 478 nm (blue plot) which could
also be observed under UV light (blue spot). λexc= 390 nm; λem= 478 nm.
The reaction mixtures correspondent to products (A) and (B) were analysed
without any purification. As expected, non-functionalised NPs did not react with
3-azidocoumarin, therefore no fluorescence was observed. The emission spectra
135
in Figure 4.16 reveals that the reaction product of (B) showed a fluorescence
maximum at 478 nm, confirming the presence of alkyne groups. In addition,
alkyne functionality was also confirmed by the exposure of both suspensions to
UV light only the conjugates exhibit a blue colouration (ii). These results clearly
demonstrate the presence of alkyne functionalisation and indicate the success of
the copper catalysed reactions.
4.2.3.1.2 Effect of copper (I) bromide in the absorption of metallated
porphyrins. Once the studies in the present work required the use of metallated
porphyrins, it was important to investigate the effect of copper (I) bromide on their
absorption spectra. This study aimed to verify whether the copper would became
entrapped in the cavity of the macrocycle. The impact of copper bromide on the
porphyrinic molecule was investigated by UV-vis spectroscopy. Entrapment of
copper ions in the macrocycle cavity results in a blue shift of the soret-band and
loss of the Q-band, thus Zinc porphyrin was incubated with CuBr (in the absence
of nanoparticles) and evaluated for a period of 20 hours. Figure 4.17 represents the
absorption spectra of ZnPN3 collected at different time points, were it is possible
to see the presence of three maxima of absorbance; one stronger correspondent to
the soret band at 435 nm and two others of weaker absorption correspondent to
the Q-bands at 565 and 610 nm, respectively. Therefore, by comparison with the
absorption spectra of ZnPN3 present in Figure 4.3 (page 117), no changes were
observed. The results obtained indicate that the protocol developed for azide-
alkyne linkage did not affect the structure of zinc porphyrins.
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Figure 4.17: Absorption spectra of ZnPN3 in presence of CuBr along 20 hours of
incubation.
Once the optimal reaction conditions for the covalent linkage between azide por-
phyrins and alkyne polyacrylamide nanoparticles were established, an experiment
was carried out to investigate whether any adsorption between the polyacrylamide
nanoparticles and the porphyrin was observed. To achieve this, non-functionalised
NPs were mixed with porphyrin, followed by the addition of CuBr.
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Figure 4.18: Fluorescence characterisation of alkyne modified nanoparticles and
its non-functionalised counterparts after CuAAC reaction with ZnPN3: (A)- non-
functionalised polyacrylamide nanoparticles after reacting with ZnPN3; (B)- cova-
lent attachment of ZnPN3 to alkyne modified polyacrylamide nanoparticles. i- non-
functionalised nanoparticle eluted from a SEC is shown by a translucid suspension of
NPs, while porphyrin remained in the top of the column; ii- suspension of porphyrin-
nanoparticles conjugates eluted from a SEC column is shown by the green colouration
of the resultant suspension.
Concurrently, an experiment was run where the porphyrins were mixed with
alkyne functionalised nanoparticles. The results are presented in Figure 4.18,
where it can be seen that the alkyne functionalised NPs VIII exhibit intense
colouration indicating efficient conjugation (B), shown by the eluted (ii) fraction
and fluorescence spectra (B). In contrast the non-functionalised NPs do not show
colouration (A; i), which was to be expected.
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4.2.3.2 Spectroscopic characterisation of NP-porphyrin conjugates.
Upon coupling of alkyne/trimethyl ammonium functionalised nanoparticles with
ZnPN3 it was necessary to evaluate the stability and characteristics of the resultant
systems. The effects of porphyrin nanoparticle conjugation were evaluated by
differences present in the absorption and emission spectrum of the conjugates.
Figure 4.19: Representative absorption and emission spectrum of porphyrin- al-
kyne/(2.5 %)trimethylammoniun nanoparticle conjugates (2.5 % ZnPTNPC). (A)
absorption and (B) emission spectra of porphyrin-alkyne nanoparticle conjugates;
(C)absorption and (D) emission spectra of porphyrin-alkyne/(5 %)trimethylammoniun
nanoparticle conjugates (5 % ZnPTNPC); (E) absorption and (F) emission spectrum of
porphyrin-alkyne/(10 %))trimethyl ammonium (10 % ZnPTNPC).
In Figure 4.19; the spectrum of the three types of porphyrin-trimethyl am-
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monium nanoparticle conjugates are shown. The investigation of ZnPN3 conjuga-
tion with alkyne/trymetylammonium nanoparticles (2.5 %; 5 % and 10 %) showed
a characteristic spectra of metalloporphyrins. The results suggest that the con-
jugation of porphyrins with trimethyl ammonium nanoparticles did not impact on
the characteristics of the porphyrins.
4.2.3.3 Size characterisation of NP-porphyrin conjugates.
Porphyrin-alkyne trimethyl ammonium nanoparticle conjugates were characterised
by dynamic light scattering. Figure 4.20 shows the hydrodynamic diameters of
the resultant conjugates.
Figure 4.20: Hydrodynamic diameter of porphyrin nanosystems measured by dynamic
light scattering. Porphyrin- alkyne/2.5 % trimethylammoniun nanoparticle conjugates
(2.5 % ZnPTNPC); porphyrin-alkyne/5 % trimethylammoniun nanoparticle conjugates
(5 % ZnPTNPC); porphyrin-alkyne/10 % trimethyl ammonium (10 % ZnPTNPC). The
hydrodynamic diameter presented is a result of is an average three independent batches
± SD. 10 % ZnPATNPC vs. 2.5 % ZnPATNPC/ 5 % ZnPATNPC: * P<0.05; were
considered statistically different, all pairwise comparison One way ANOVA.
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The results showed monomodal distributions for 2.5 % and 5 % ZnPATNPC
with hydrodynamic diameters of 42 ± 1 nm and 48 ± 1 nm, respectively. The dif-
ference in nanoparticle size for these conjugates was not too significant (p >0.05).
For 10 % ZnPATNPC, a bimodal distribution was observed with sizes of 30 ± 2
nm and 119 ± 2 nm. These results suggest that surface charge might be involved.
Others have previously reported on the size increase of trimethyl ammonium func-
tionalised polyacrylamide nanoparticles noting an increase in nanoparticle size as
the trimethyl ammonium functionality increased [59, 124, 149]. Sun, et al. found
that for 24 % of trimethyl ammonium functionality, 139 nm in hydrodynamic dia-
meter was achieved. This increase was suggested to be associated with a positive
charge linked to the polymer matrix, leading to hydrogel swelling as a consequence
of increased osmotic pressure [119].
Further analysis on the hydrodynamic diameter after 10 months of storage
at -18◦ C aimed to investigate the stability of the aforementioned nanosystems.
Figure 4.21 shows the hydrodynamic diameters.
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Figure 4.21: Hydrodynamic diameter of porphyrin nanosystems measured by dynamic
light scattering after 10 months storage. Porphyrin- alkyne/2.5 % trimethylammoniun
nanoparticle conjugates (2.5 % ZnPTNPC). Porphyrin- alkyne/5 % trimethylammoniun
nanoparticle conjugates (5 % ZnPTNPC). Porphyrin- alkyne/10 % trimethyl ammonium
(10 % ZnPTNPC). The hydrodynamic diameter presented a result of is an average
three independent batches ± SD. 5% ZnPATNPC (t= 0) vs. 5 % ZnPATNPC (t= 10
mo): * P<0.05; were considered statistically different, all pairwise comparison One way
ANOVA.
4.2.3.4 Surface characterisation of NP-conjugates.
Porphyrin alkyne/trimethyl ammonium nanoparticles surface charge were charac-
terised by zeta potential. In order to confer a positive surface coating on nan-
oparticles, trimethyl ammonium functionalisations and conjugation of tricationic
porphyrins were used. These manipulations aimed to produce a nanosystem with
characteristics for passive cellular uptake and specific sub cellular co-localisation.
Figure 4.22 shows the zeta potential of the nanosystems in study.
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Figure 4.22: Zeta potential characterisation of ZnPATNPC. Porphyrin- alkyne/2.5 %
trimethylammoniun nanoparticle conjugates (2.5 % ZnPTNPC). Porphyrin- alkyne/5 %
trimethylammoniun nanoparticle conjugates (5 % ZnPTNPC); porphyrin- alkyne/10 %
trimethyl ammonium (10 % ZnPTNPC). .
As expected, an increased trimethyl ammonium functionality led to a higher
surface charge. For 2.5 % and 5 % ZnPTNPC, surface charges of +15 ± 0.3 mV
and +17 ± 0.5 mV were observed. In addition, for 10 % ZnPTNPC, higher zeta
potential value was attained of 30 ± 4.7. These values showed a slight increase
in positive charge when compared with the trimethyl ammonium functionalised
nanosystems developed in Chapter 2.1, Section 3.2.3. It is hypothesized that the
differences obtained were a result of the positive charge carried by the porphyrin
conjugated at the surface of the nanoplatforms.
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4.3 Conclusions
The present chapter focused on the development of stable linkage between polyac-
rylamide nanoparticles and porphyrins for the construction of an ROS generator
nanosystem. Conjugation methodologies were exploited to achieve stable mon-
odisperse porphyrin-nanoparticle conjugates compatible with biological systems.
Firstly, the effect of linking porphyrins with amino functionalised nanosystems was
studied; as expected, these conjugates produced aggregates. This result showed
that not even reacting an excess of porphyrin was sufficient to overcome the ag-
gregation patterns of these NPs, as a result of unreacted amino groups. In order
to overcome these effects, a cap of uncreacted amino groups was investigated; a
remarkable lowering size was found. Unfortunately, DLS stability studies of these
porphyrin-NPs over time have shown formation of aggregates. Therefore, amino
functionalised nanoparticles were abandoned as an approach for porphyrin conjug-
ation.
A new strategy involved the covalent linkage of porphyrin monomers to the
polyacrylamide matrix of nanoparticles. This approach was found very attractive
and stable, surface charge analysis was consistent with non-functionalised NPs,
suggesting porphyrin entrapment in the polymeric matrix. The main limitations
of porphyrin entrapped NPs were the unknown photodynamic effects of porphyrin
entrapment and the unfavorable surface characteristics. These disadvantages led
to the design of two new constructs: the first originated to improve the biolo-
gical compatibility of porphyrin entrapped NPs conferred by introducing a posit-
ive surface charge by a trimethyl ammonium ligand. The resultant nanosystems
were shown to be very promising candidates for ROS generating nanoplatforms.
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In parallel, a second successful approach was explored by the surface linkage of
porphyrins moieties with alkyne/trimethyl ammonium dually functionalised NPs
through copper-catalysed triazole formation. This second construct allowed por-
phyrin surface exposure and conferred great stability over time.
Although many obstacles were found in the development of nanoparticle-
porphyrin conjugates, two promising constructs were attained: both contain
positive charges compatible with cellular uptake (conferred by trimethyl am-
monium functionalities), with a difference in porphyrin location (either entrapped
or at the surface).
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Chapter 5
Delivery of nanoparticles to
human Mesenchymal Stem Cells
5.1 Introduction
The potential of nanotechnology as a vehicle for improved therapeutic delivery,
imaging, biosensing, diagnosis and basic mechanistic studies in vivo and in vitro
is widely recognised. This mainly arises in consequence of the variability and
flexibility of these materials architecture to accommodate specific physicochemical
characteristics (e.g. shapes, sizes, surface charge, chemical reactive groups, etc)
for optimal biodistribution, cellular internalisation and intracellular trafficking.
As a consequence, several advances have been made in the characterisation and
establishment of mechanisms for nanoparticle uptake and their cellular fate.
However, and despite the extensive literature, it is not yet possible to draw
an optimal general pattern for nanoparticle uptake or intracellular localisation.
There has mainly been found an interdependency between uptake and nano-
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particle size, surface charge (among others physiochemical characteristics) and
cell-type [50,73, 150].
For cellular entry, the first obstacle nanoparticles face is the plasma membrane,
which creates a barrier between the intracellular (cytoplasm) and the extracellular
environment, and which dynamically acts on the regulation and coordination of
the entry and exit of small and large molecules [35]. Small molecule, can cross
the plasma membrane through membrane protein pumps or channels (e.g. ions,
sugars, aminoacids). Macromolecules are internalised through membrane-bound
mechanisms involving the invagination and pinch-off of the cell membrane for
internalisation in a process known as endocytosis. Based on the nature of
nanoparticles, it has been found that endocytic mechanisms arise as the most
important in nanoparticle uptake. The main endocytic mechanisms involved
in nanoparticle cellular uptake and their characteristics are briefly described below.
5.1.1 Endocytic mechanisms for cellular uptake of nano-
particles and size effect
The mechanism of endocytosis itself comprises several mechanisms which fall into
two main categories, phagocytosis, also known as “cell eating”, and pinocytosis,
also known as “cell drinking”. Phagocytosis mainly occurs in specialised mam-
malian cells (e.g macrophages, monocytes, neutrophils, endothelial cells, dendritic
cells) [151, 152]. On the other hand, pinocytosis occurs in almost all cells and is
further subdivided into four main mechanisms: macropinocytosis, clathrin- and
caveolae- mediated endocytosis and clathrin- and caveolae-independent endocyt-
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osis as schematically shown in Figure 5.1.
5.1.1.1 Phagocytosis
The uptake of nanoparticles through the phagocytic pathway occurs through three
steps: recognition of the nanoparticle by opsonisation, adhesion of the opsonised
particles to the macrophage and ingestion of the particles. The step of opsonisation
comprises the labelling of nanoparticles with opsonins (proteins), leading to a
visible form of the macrophages which further establishes specific receptor-ligand
binding at their surface. Once binding to the macrophage surface is established,
signalling cascade responses mediated by Rho family GTPases trigger the assembly
of actin with the formation of cell surface extensions (pseupodia; Figure 5.1; i) that
surround the particle, which is finally engulfed, originating the phagosome (Figure
5.1, A 1). In biological systems, the phagocytic process aims for clearance of
foreign material (e.g. bacteria, yeast, cellular debris, etc) and it is known that,
through phagocytosis nanoparticles in the range of 0.5 µm, up to 10 µm are taken
up [63, 153].
5.1.1.2 Pinocytosis
Macropynocytosis
In a similar manner to phagocytosis, macropinocytosis involves the formation
of membrane protrusions which collapse onto and fuse with the plasma membrane,
as schematically shown in Figure 5.1; (B, ii). These membrane protrusions are
formed through a similar mechanism to phagocytosis, in which the activation
of the RhO-family GTPases leads to the assembly of actin. Furthermore,
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the collapse of these membrane protrusions with the plasma membrane leads
to the formation of large vesicles called macropinosomes, Figure 5.1; (2) [152,154].
Clathrin-mediated endocytosis
Clathrin-mediated endocytosis (Figure 5.1; C iii) is the most intensively
studied endocytic mechanism and is present in all mammalian cells where it plays
a central role in the continuous uptake of essential nutrients (e.g. low-density
lipoprotein (LDL) and transferring, epidermal growth factor (EGF)). Endocytosis
proceeds through the recognition of nanoparticles by a membrane receptor
(adapter protein complexes) which recruits clathrin, a main cytosolic coat protein.
Polymerisation of clathrin units (triskelion polyhedral structure) helps to deform
the membrane into a coat pit, which leads to a vacuole formation holding the
nanoparticle [63, 152,154,155].
Clathrin-and caveolae- independent pathways
Cellular uptake can also be mediated by independent clathrin- and caveolin-
processes. These mechanisms involve cholesterol-rich microdomains present on
the plasma membrane, also known as lipid rafts of 40 up to 50 nm length.
The clathrin- and caveolin- mechanism’s independent pathways are still poorly
understood, largely because of the lack of inhibitors needed to study these
specific mechanisms presents a major challenge in the characterisation of these
pathways [75,152,154].
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Caveolae-mediated endocytosis
Caveolae-mediated endocytosis (Figure 5.1; E V) (caveolae from the Latin
little caves) is characterised by flask-shape invaginations displayed by the plasma
membranes in many types of eucariotic cells. It was previously demonstrated
that caveolae is localised to lipid rafts, which are areas of the membrane highly
concentrated in sphingolipids [152,156]. In addition, caveolae membranes are also
rich in caveolin-1 (muscle cell analogous caveolin-3) and caveolin-2. Caveolins
are proteins (21 kDa) anchored to the cell membranes through a hydrophobic
sequence on the cytosol side [152, 154, 157–159]. It is known that caveolin-1 is
responsible for the structural formation of the caveolae. However, the exact
funtion of, caveolin-2 exact mechanism remains unresolved.
To date, the exact mechanism of caveolae-mediated endocytosis is still unclear
and the link of cargo molecules and caveolae-receptors remains a matter of
study [157,159].
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Figure 5.1: Intracellular mechanisms of nanoparticle uptake.
5.1.1.3 Surface charge and cellular uptake
After nanoparticle size, the surface chemistry of nanoparticles is another area of
intense research. It has been found that the way nanoparticles interact with each
other, and also with the surrounding environment, determines their applications.
Surface charged nanosystems have been widely explored as a means to promote
cellular uptake and intracellular targeting. Cationic nanosystems have been
associated with enhanced cellular internalisation compared to anionic ones.
The rationale behind facilitated uptake for positively charged systems relies
on their electrostatic interaction with the negatively charged proteoglycans
present on the membrane [45, 51, 72, 160–162]. Between cellular transporters
approaches, the most popular are the short polycationic or amphiphilic peptides,
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cell penetrating peptides (CPPs) [89, 150, 160, 163]. However, many other
synthetic molecules have also been introduced, such as triphenyl phosphonium
and trimethyalmmonium [59,164].
Several studies have tried to clarify the mechanisms and interactions established
between positively charged systems and cells. Although it is not possible to draw
a general pattern of cellular internalisation for all the positively charged nano-
particles, which are extremely affected by other physico-chemical characteristics
(e.g. size, shape, nanoparticle composition, morphology, geometry) [51], it is
believed that endocytic mechanisms are the main operators of spherical cationic
nanosystems internalisation in mammalian cells.
Endocytic mechanisms include absorptive-type endocytosis, transcytosis, and en-
docytic processes which are clathrin- and caveolin independent [45,51,161,165,166].
Literature mainly suggests that internalisation of cationic nanosystems follows
clathrin- mediated mechanisms. However, it has also been reported that, upon
pharmacological inhibition of this pathway, nanoparticles follow alternative
mechanisms of internalisation, such macropinocytosis, which leads to an increased
concentration of nanoparticles inside the cell [160–162].
5.1.2 Nanoparticle engineering and sub-cellular fate
A major disadvantage in the development and effectiveness of cellular targeted
delivery of nanosystems is endo/lysosomal degradation. Therefore, several
methodologies have been developed to overcome endosomal sequestration. In
recent years, nanoparticle engineering has been applied to confer physico-chemical
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specificity and biological compatibility for more effective cargo delivery.
Surface charge was previously associated with facilitated kinetics of uptake;
however, it has also been associated with intracellular trafficking and endo-
somal escape. One mechanism of endosomal escape relates to the formation
of membrane pores. The interaction between amphiphilic cationic agents (e.g.
polyethyl-enimine (PEI) and the lipid bilayer of the endosome membrane results
in the formation of pores due to internal stress and/or membrane tension,
with release of the sequestered molecules [167–170]. This mechanism has been
previously exploited for several nanomaterials, such as, polyplex [171]; Gold
NPs [172] and Chitosan NPs [173].
Another mechanism for endosomal escape is the ”proton sponge effect”, which
involves the presence of agents with buffering capacity; examples of cationic
materials include poly(L-lysine), N[1-(2,3-dioleyloxy)propyl]-N,N,N -trimethyl
ammoniumchloride (DOTMA) and poly(amidoamide)dendimers [153, 167] among
many others [167]. The exact mechanism of endosomal escape remains elusive.
It is hypothesised, that the presence of unprotonated amines is involved, as they
can absorb protons pumped into the endosomes, leading to an increase of proton
being pumped into the endosome. In addition, an increase in Cl- and water
arises from the increased proton pumping. The osmotic swelling of endosomal
membrane emerges, with subsequent rupture and release of the contents to the
cytoplasm [153,167,174].
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A slightly different approach that promotes endosomal escape, is the pro-
cess of photochemical internalisation, which offers improved internalisation of
macromolecules to access the cytosol [163, 175–180]. The mechanism by which
this access is conceded, relies on the photodynamic activity of photosensitizer
molecules upon light activation of appropriate wavelength, as detailed in section
1.2. The ROS generated through photosensitizer activation is then responsible
for the destruction of the endosomal/lysosomal membrane, with the release of its
contents to the cytoplasm [175]. The cytotoxic activity of ROS is limited by their
short-lifetimes and range of action and is confined to endosomal compartments.
5.1.2.1 Cationic nanosystems and associated cyoxicity.
The main disadvantage of cationic nanosystems is the detrimental effects on the
cells. Cytotoxic effects induced by cationic nanosystems are primarily related
to its size, morphology and shape [51]. Nanoparticle positive surface charge
facilitates the association with the cellular membrane and the internalisation of
nanomaterials. However, highly charged nanosystems have been related with
cytotoxicity [45, 180, 181]. Excess of positive charge in the blood stream is known
to promote nanoparticle opsonisation aggregation. Furthermore, extracellularly,
the cytotoxic effects of these systems are a consequence of complement activation,
which leads to its clearing from circulation by the reticuloendothelial system
(RES) [45, 51, 153].Cationic nanosystems have been associated with toxicity and
immunogenicity which limits its clinical applications [153,167].
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Aims
This chapter aims to investigate the cellular uptake of trimethyl ammonium
functionalised nanoplatforms and porphyrinic/trimethyl ammonium nanosystems
developed in Chapters 3 and 4. In addition, it was also intended to evaluate the
internalization profile and sub-cellular co-localisation of these nanosystems. The
impact of these nanoplatforms was also studied for cellular toxicity in hMSCs. In
order to achieve this, fluorescent microscopy and flow cytometry analysis were
used.
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5.2 Results and Discussion
For the present work, a system capable of inducing controlled toxic responses in
hMSCs mediated by ROS generation was required. Mitochondrion is known as
the major source of ROS, which are involved in the fundamental signalling process
and are also mediators of pathological oxidative damage [3, 182–185]. In order
to develop a tool to trigger the controlled production of ROS in hMSCs, it was
reasoned that the mitochondrion would be a preferential target for nanoparticle
systems. Mitochondrion targeting strategies often involve the use of cationic
systems, exploiting the intrinsically negatively charged mitochondrial inner
membrane [122, 186–188]. Although, in theory, cationic systems accumulate pref-
erentially at mitochondria, some cationic systems have previously been reported to
remain entrapped in endosomes/lysosomes [89,189]. It was anticipated that, even
though endosomal/lysosomal would be a possible outcome for the intracellular
fate of porphyrinic nanoplatforms developed, photochemical internalisation could
be applied in order to facilitate its release to the cytosol. As referred to in
Section 5.1.2, light activation (specific wavelength) of nanoplatforms containing
photosensitizers led to 1O2 production, reported as a mechanism for rupture of
the endocytic/lysosomal membranes and nanoplatform’s cytoplasmic release. It
is note-worthy that lack of cellular toxicity was associated with this mechanism of
internalisation as consequence of nanoplatform endocytic/lysosomal entrapment
and the 1O2 short-range phototoxic effect [190–194].
The delivery of polyacrylamide nanoparticles developed in Chapters 3 and 4,
to hMSCs was investigated by flow cytometry and fluorescent microscopy using
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the fluorescent signal of porphyrin or FITC-dextran. Poprhyrin emission (red
λem 630 nm) resulted from covalent linkage of these molecules to functionalised
polyacrylamide nanoparticles. The fluorescence of FITC-dextran(green λem
520 nm) was present due to entrapment of these molecules in the matrix of
polyacrylamide nanoparticles at the time of synthesis. The process and feasibility
of the physical entrapment of FITC-dextran has been previously reported by
many studies [37, 55, 58, 89, 109]. It was generally reported that the covalent
linkage between the fluorophore, fluorescein isothiocyanate and an inert large
molecule such as dextran (10 000 Mw) would confer protection against fluorophore
leaching out of the polymeric matrix [37, 55]. Moreover, entrapped FITC-dextran
in polymeric matrices has been previously associated with high stability and the
capability to sense pH variations, and has been described as a potential tool for
intracellular pH sensing [58].
5.2.1 Cellular uptake of positively charged polyacrylamide
nanosystems
5.2.1.1 Internalisation of positively charged nanoplatforms.
Although nanoparticle engineering seems to be a feasible approach to confer spe-
cific chemical characteristics to nanoparticles, allowing it to be efficiently internal-
ised and redirected to specific sub-cellular compartments, some disadvantages still
exist.
In order to investigate the internalisation of positively charged nanosystems,
polyacrylamide nanoparticles were synthetically manipulated to incorporate
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different percentages of trimethyl ammonium functionalities. The trimethyl
ammonium modified polyacrylamide nanosystems under study presented zeta
potentials between +13 mV and +25 mV and were incubated with hMSCs for a
15 hour time period. The internalisation of the positively charged nanosystems
was then visualised through fluorescent microscopy. Due to the small size of the
nanosystems studied and the resolution limit of the microscope, visualisation
of individual nanoparticles was not possible and images show an ensemble of
nanoparticles. For all the experiments, images were collected in z-stack mode
and only by reaching the centre of the cell was possible to visualise nanoparticle
fluorescence (green λem 520 nm), unless stated otherwise.
Figure 5.2: Representative live-cell imaging of hMSCs treated with 5 mg/ml of 2.5
% TNPs. A- Differential interference contrast image of hMSCs; B- 2.5 % TNPs (FITC
λem= 520 nm); C- Overlay of Differential interference contrast and 2.5 % TNPs. Ima-
ging performed with widefield Olympus Deltavision elite deconvolution fluorescent mi-
croscope, Olympus U-plan S- Apo 60x/NA 1.42. Scale= 17 µm.
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Figure 5.2, shows a representative image of hMSCs treated with 2.5 %
TNPs. As can be observed, nanoparticles were passively uptaken by hMSCs;
see (Fig. 5.2 (C)) Nanoparticles appear as punctated and granular structures dis-
tributed through the cytoplasm. Moreover, it was also possible to observe the
absence of particles associated with the cellular membrane. This was verified by
the absence of green emission at the top and bottom of the cell (Z-stack, data not
shown).
Figure 5.3: Representative live-cell imaging of hMSCs treated with 5 mg/ml of 5 %
TNPs. A- Differential interference contrast image of hMSCs; B- 5 % TNPs (FITC λem=
520 nm); C- Overlay of differential interference contrast and 5 % TNPs. Imaging per-
formed with widefield Olympus Deltavision elite deconvolution fluorescent microscope,
Olympus U-plan S- Apo 60x/NA 1.42. Scale= 15 µm.
Similarly, 5 % TNPs NPs also shows the presence of punctated/granular struc-
tures distributed throughout the cytoplasm. Figure 5.3 (C) shows the overlay of
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phase contrast and green emitted light, where it is possible to observe the distri-
bution of nanoparticles in the area surrounding the nucleus.
Figure 5.4: Representative live-cell imaging of hMSCs treated with 5 mg/ml of 10
% TNPs functionalised nanoparticles. A- Differential interference contrast image of
hMSCs; B- 10 % TNPs nanoparticles (FITC λem= 520 nm); C- Overlay of differential
interference contrast and 10 % TNPs NPs. Imaging performed with widefield Olympus
Deltavision elite deconvolution fluorescent microscope, Olympus U-plan S- Apo 60x/NA
1.42. Scale= 17 µm.
In addition, the treatment of hMSCs with 10% TNPs NPs also revealed the
presence of punctate/granular structures emitting green light; see Figure 5.4
(B);(C). However, contrary to the 2.5 % and 5 % of positively charged systems
described earlier, 10 % TNPs NPs showed the presence of green emitted light from
the top to the bottom of the cell in the areas indicated by white arrows; see Fig-
ure 5.4 (C). The results suggest the presence of nanoparticles adherent to the
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cell membrane. It is important to note that cells under analysis were extensively
rinsed with phenol red free medium prior to analysis. Furthermore, the same evid-
ence was present in several cells within the same sample and also in independent
experiments.
The cellular uptake for positively charged nanosystems suggested the success-
ful internalisation of all three systems, as expected. The results obtained are
in accordance with those previously reported by Sun, et al. for trimethyl am-
monium functionalised nanoparticles and many other studies for other positively
charged nanosystems [51, 59, 160, 161, 195]. Furthermore, in accordance with the
work developed by Jiang, et al., nanoparticles with a surface charge >+25 mV
showed a small percentage of nanoparticulates associated with the cellular mem-
brane [73,196].
5.2.1.2 Sub-cellular co-localisation of internalised positively charged
nanosystems.
The internalisation of cationic systems was evaluated by high resolution widefield
fluorescent microscopy. In Figure 5.5, the intracellular co-localisation of 2.5 %
TMA NPs, either with mitochondria or endo/lysosomes in hMSCs, was evaluated.
The overlaid images between mitochondrion and FITC labelled 2.5 % TNPs, (see
Figure 5.2 (E)), shows partial points of co-localisation between nanoparticles
and mitochondria. At those regions where mitochondria and nanoparticles coin-
cide, a yellow fluorescence was obtained, as can be observed in regions R1 and
R2. Similarly, co-localisation with endo/lysosomal vesicles was detected by the
overlay between blue endo/lysosomal staining and the FITC labelled NPs ori-
ginating a light blue fluorescence for co-localised points. Therefore, as seen in
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Figure 5.2 (F), for regions R3 and R4 minimal co-localisation of nanoparticles
with endo/lysosomes was observed from each other.
Figure 5.5: Representative analysis of intracellular co-localisation of 2.5 % TNPs
(5mg/ml) with mitochondria and endo/lysosomal vesicles by widefield Olympus Delta-
vision elite deconvolution fluorescent microscopy. (A)- Differential interference contrast
of hMSCs. (B)- hMSCs mitochondrial staining with mitotracker red; λexc=594 nm,
λem=610 nm. (C)- endosomal/lysosomal staining with lysotracker blue; λexc=399 nm,
λem=457 nm. (D)- FITC fluorescence 2. 5 % TNPs; λexc=488 nm, λem=526 nm. (E)-
mitochondrial and FITC overlaid images; R1 and R2- zoom of regions R1 and R2 in
E to show co-localisation of nanoparticles with mitochondria. (F)- endo/lysosomal and
FITC overlaid images showing sub-cellular localisation of 2.5 % TNPs; R3 and R4-
zoom of regions R3 and R4 in F to show co-localisation of nanoparticles with endo-
somes/lysosomes. Olympus U-plan S- Apo 60x/NA 1.42. Scale= 17 µm.
The analysis of 5 % TNPs internalised co-localisation with mitochondria or
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endosomes/lysosomes showed a similar trend to 2.5 % TNPs, and is shown in
Figure 5.3(E), (F). As can be observed in regions R1 and R2, partial points of co-
localisation were identified by the yellow fluorescence (nanoparticle concentrated
at the mitochondrion). Furthermore, lyso/endosomal co-localisation was minimal
for 5 % TNPs as shown in regions R3 and R4 where blue and green fluorescence
was found isolated .
163
Figure 5.6: Representative analysis of intracellular co-localisation of 5 % TNPs
(5mg/ml) with mitochondria and endosomal/lysosomal vesicles by widefield Olympus
Deltavision elite deconvolution fluorescent microscopy. (A)- Differential interference
contrast of hMSCs. (B)- hMSCs mitochondrial staining with mitotracker red; λexc=575
nm, λem=632 nm. (C)- endosomal/lysosomal staining with lysotracker blue; λexc=390
nm, λem=435 nm. (D)- FITC fluorescent 5 % TNPs; λexc=475 nm, λem=523 nm. (E)-
mitochondrial and FITC overlaid images; R1 and R2- zoom of regions R1 and R2 in E
to show co-localisation of nanoparticles with mitochondria. (F)- endosomal/lysosomal
and FITC overlaid images; R3 and R4- zoom of regions R3 and R4 in F to show co-
localisation of nanoparticles with endo/lysosomes. Olympus U-plan S- Apo 60x/NA
1.42. Scale= 15 µm.
Contrary to the 2.5 % and 5 % cationic nanosystems described above, the ana-
lysis of 10 % TNPs co-localisation with mitochondrial and endosomal/lysosomal
organelles showed a low co-localisation with mitochondria. Higher co-localisation
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was observed with stained endosomes/lysosomes.
Furthermore, mitochondrial staining for 10% TNPs was generally dimmer than
that observed for the systems 2.5 % and 5 % TNPs. It is important to note that
mitochondrial staining with mitotracker red was previously reported to be sensitive
to variation in mitochondrial membrane potential [197]. Thus, a decrease in mito-
chondrial staining was previously associated with a decrease in membrane potential
and, consequently, is also an indicator of diminished cellular viability [197, 198].
Therefore, the lower viability found for hMSCs incubated with 10 % TNPs, was
consistent with the viability studies described in Section 5.2.1.3. Cytotoxicity
associated with cationic systems is mainly correlated with the interaction of these
systems and the phospholipidic membrane. However, it has also been reported that
these systems can also exert cytotoxic actions, even if entrapped in lysosomes. This
is mainly due to the swelling and disruption of these organelles as the consequence
of a buffering of H+, with release of hydrolytic enzymes that subsequently degrade
intracellular macromolecules [51].
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Figure 5.7: Representative analysis of intracellular co-localisation of 10 % TNPs (5
mg/ml) with mitochondria and endo/lysosomal vesicles by widefield Olympus Deltav-
ision elite deconvolution fluorescent microscopy. (A)- Differential interference contrast
of hMSCs. (B)- hMSCs mitochondrial staining with mitotracker red; λexc=575 nm,
λem=632 nm. (C)- endosomal/lysosomal staining with lysotracker blue; λexc=390 nm,
λem=435 nm. (D)- FITC fluorescent 10 % TNPs; λexc=475 nm, λem=523 nm. (E)-
mitochondrial and FITC overlaid images; R1 and R2- zoom of regions R1 and R2 in E
to show co-localisation of nanoparticles with mitochondria. (F)- endosomal/lysosomal
and FITC overlaid images; R3 and R4- zoom of regions R3 and R4 in F to show
co-localisation of nanoparticles with endosomes/lysosomes. Olympus U-plan S- Apo
60x/NA 1.42. Scale= 15 µm.
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5.2.1.3 Impact of positively charged nanoparticles on hMSCs: Viabil-
ity versus particle uptake.
In order to achieve a better understanding of the cellular uptake of the different
positively charged systems, flow cytometry (FCM) was used as a complementary
technique to fluorescence imaging. The enhanced uptake of positively charged
systems has been associated with toxic effects in treated cells; this technique was
also used to evaluate the level of toxicity associated with the nanosystems being
studied [188].
Figure 5.8: Representative bi-variate plot of cell survival/apoptosis analysis by flow
cytometry [199].
The assessment of nanoparticle uptake by flow cytometric analysis is well estab-
lished [89,199–202]. Flow cytometric analysis of cellular uptake and the toxicity of
the positively charged nanosystems was performed according to the scheme shown
in Figure 5.8. Bi variate scatter plots of healthy hMSCs were used to isolate
(gate) live cell populations and to provide a comparison model to other popu-
lations (treated cells). Forward scatter provides information about the cell size,
which should be positive for viable cells. Side scatter provides evidence about
the complexity/granularity of the cell. Apoptotic cells present a decrease in size
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(cell shrinking) and increased granularity (formation of apoptotic bodies- nuclear
spheral follicles) [78, 79, 199]. Forward and side scatter bi-variate plots were used
to isolate (gate) the region of cell survival.
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Figure 5.9: Analysis of cellular uptake of positively charged nanoparticles by flow
cytometry. hMSCs were treated overnight (≈15 hours) with several doses (2.5, 5, 10,
20, 30, 40, 50 mg/ml)of TNPs (2.5 %, 5 % and 10 %). (A)- FCM histogram of events vs
SS for 10 % TNPs. (B)- Dose-dependent comparison of events vs FITC for 10 % TNPs.
(C)- FCM histogram of events vs. SS for 5 % TNPs. (D)- Dose-dependent comparison
of events vs. FITC for 5 % TNPs. (E)- FCM histogram of events vs. SS for 2.5 % TNPs.
(F)- Dose-dependent comparison of events vs. FITC for 2.5 % TNPs. (G)- Graphical
representation of dose-dependent comparison of FITC normalised median fluorescence
intensity. Medians were calculated from two independent experiments conducted in
triplicate. Error bars represent mean ± SD (n=6). 10 % vs. 5 and 2.5 % TNPs: * p<
0.05; 40 mg/ml 5 % vs. 2.5 % TNPs: ** p< 0.05; 50 mg/ml 2.5 % vs 5 % TNPs: § p<
0.05; 50 mg/ml 5 % vs 10 % TNPs:† p< 0.05; 50 mg/ml 10 % vs 2.5 % TNPs:‡ p< 0.05
were considered statistically different, One Way ANOVA.
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Figure 5.9 shows the internalisation of positively charged nanoparticles in
hMSCs in a dose-dependent manner. From side scatter histograms, it was pos-
sible to observe discrete granularity variations in hMSCs with the increase in dose
and charge of nanoparticles (A), (C) and (E). Forward scatter histograms were
found to be constant with the different nanoparticle dosages (data not shown).
The results indicate the successful internalisation of catonic nanosystems in hM-
SCs. Similarly, Coupland, et al. investigated the uptake of TAT- functionalised
polyacrylamide nanoparticles in hMSCs by flow cytometry. They found that in-
ternalised NPs contributed to slight variations in cell granularity (increased) due
to nanoparticle internalisation (increase in cellular complexity) [89,203]. Further-
more, they also obtained an invariable pattern in the forward side histograms
for treated and non-treated cells, indicators of unaltered morphology and viab-
ility [89, 199]. Additionally, the analysis of FITC fluorescence intensity resulted
in increased fluorescence (uptake) for 10 % >5 % and >2.5 % TNPs,respectively.
The results suggest that higher nanoparticle uptake is associated with increased
positive charge on the nanoparticles.
Graphical analysis of the FITC fluorescence intensity versus nanoparticle concen-
tration (see Figure 5.9 (G)), showed non-significant variations in uptake for 2.5
% and 5 % TNPs in the range of concentrations from 2.5 mg/ml to 30 mg/ml.
For concentrations above 30 mg/ml, significant increase of nanoparticle uptake for
cells treated with 5 % TNPs was found. More significant variations were found
for cells treated with 10 % TNPs NPs on a concentration range of 5 mg/ml to 50
mg/ml. However, it was reasoned that variations in the 10 % TNPs uptake were
partially affected by the presence of these systems interacting with the cellular
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membrane, as demonstrated by microscopic analysis (Section 5.2.1.2). Unfortu-
nately, flow cytometric analysis did not allow differentiation between nanoparticles
internalised and associated with the cellular membrane, as flow cytometry provides
information on the total fluorescence of each cell.
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Figure 5.10: Analysis of cellular viability in hMScs treated overnight with 2.5 %, 5
% and 10 % TNPs by flow cytometry. hMScs were treated overnight with several doses
(5, 10, 20, 30, 40, 50 µg/ml) of TNPs. Representative bi-variate plots: (A)- untreated
cells; (B)- cells treated with 50 µg/ml; (C)- cells treated with 30 µg/ml; (D)- cells
treated with 5 µg/ml, show alterations in population density for treated and un treated
cells. Graph (E) shows the impact of 2.5 %, 5 % and 10% TNPs in hMSCs viability,
demonstrating that 10 % TNPs have high impact on hMSCs survival. Percentage of
viability was calculated from two independent experiments conducted in triplicate. Error
bars represent mean ± SD (n=6). Statistical analysis, control vs. [NPs]: * p< 0.05,
all pairwise comparisons:** p< 0.05 were considered statistically different, One Way
ANOVA.
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Cationic nanoparticle systems are often associated with a high level of
toxicity [71,74,204,205]. In order to evaluate the toxicity associated with cationic
nanosystems flow, cytometric analysis of treated live hMSCs was performed and
compared with healthy cells (non-treated). Cellular viability was assessed by the
comparison between bi-variate scatter plots in healthy and treated cells. Figure
5.10 shows the resultant scatter plots, where healthy cells were gated Figure 5.10
(A) provide a reference for comparison with treated cells. As can be observed in
the scatter plots of treated hMSCs, the number of cells in the gated area (viable
cells) are small at higher concentrations of cationic nanoparticles (B), meaning
that the survival rate is low. The low rate of survival is visualised by the increase
in number of cells with low forward scatter and high granularity. Furthermore,
the decreasing of nanoparticle dosage leads to an increase in hMSCs survival, as
can be observed by the increased number of cells in the gated area (C,D).
The same trend was achieved for all three cationic nanosystems; however, for
2.5 % TNPs the cellular viability remained high throughout all the dosing
concentrations. Figure 5.10 (E) shows cell viability as a function of nanoparticle
dosing concentration. Significant impact in hMSCs viability was found for 10 %
TNPs in the range of 2.5 mg/ml to 50 mg/ml compared to control cells (p <0.05).
Furthermore, cells treated with 5 % TNPs also showed significant deleterious
effects in hMSCs survival at highest concentrations (50 mg/ml and 40 mg/ml) (p
<0.05).
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Figure 5.11: Analysis of necrotic/late apoptotic events in hMSCs treated with cationic
nanosystems by flow cytometry. hMSCs were treated overnight (≈15 hours) with several
doses (2.5, 5, 10, 20, 30, 40 ,50 mg/ml)of TNPs (2.5 %, 5 % and 10 %) . (A)- FCM
contour plot of PI vs. FS for untreated hMSCs. (B)- FCM contour plot of PI vs. FS for
hMSCs treated with 50 mg/ml of 10 % TNPs. (C)- FCM contour plot of PI vs FS for
hMSCs treated with 30 mg/ml of 10 % TNPs. (G)- Graphical representation of percent-
age of total necrotic cells versus nanoparticle concentration. Medians were calculated
from two independent experiments conducted in triplicate. Error bars represent mean
± SD (n=6). 20 mg/ml 10 % vs. 2.5 % TNPs: ‡ p< 0.05; 30 mg/ml 2.5 % vs. 5 %
TNPs vs. 10 % TNPs: § p< 0.05; 40 mg/ml 2.5 % vs 5 % vs. 10 % TNPs:† p< 0.05; 40
mg/ml 10 % TNPs vs. 50 mg/ml 10 % TNPs: ** p< 0.05; 50 mg/ml 2.5 % vs. 5 % vs.
10 % TNPs:⋄ p< 0.05; 40 mg/ml 5 % TNPs vs. 50 mg/ml 5 % TNPs:* p< 0.05; were
considered statistically different, One Way ANOVA.
In order to further investigate the impact of cationic nanosystems on cellular
viability, hMSCs were incubated with several dosages of cationic nanoparticles
and stained with propidium iodide (PI), which leads to a highly fluorescent signal
in necrotic or late apoptotic cells. Propidium iodide is a DNA intercalating dye;
it intercalates with the major groove of double-stranded DNA. This agent is
not able to cross intact cellular membranes, and only permeates compromised
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membranes of dying or dead cells [78, 79, 199,206].
Figure 5.11 (A; B; C) shows the PI versus forward scatter bi-variate contour
plots of treated and untreated hMSCs. As can be seen, staining with PI is absent
in untreated cells (A). For cells treated either with 50 mg/ml (B) or 30 mg/ml
(C) of cationic nanoparticles, the portion of the population which stains positive
for PI is more evident in cells treated with 50 mg/ml (red gated populations).
The percentage of necrotic cells versus nanoparticle concentration for the three
cationic systems studied is shown in Figure 5.11 (D), which reveals a significantly
higher percentage of necrosis for hMSCs treated with 10 % TNPs (p <0.05).
Additionally, 5 % TNPs NPs present a significantly high number of necrotic
events for nanoparticle concentrations from 20 mg/ml up to 50 mg/ml.
The results shown in Figures 5.10 and 5.11 are in good agreement with the
literature, where cationic systems were often found to have a negative impact
on the viability of several types of cells [71, 74, 188, 204, 205]. Previous studies
on the effect of cationic systems on cellular viability have shown that polyelec-
trolytes (e.g. poly-(lysine)) exhibit toxicity in vitro due to interactions with
the phospholipids in the cell membrane which results in its disruption [74,188,205].
The delivery of cationic polymeric nanosystems shows that, in general, charge
confers enhanced internalisation while also conferring mitochondrial sub-cellular
targeting. However, the results also suggest that for NPs with higher surface
charge, pronounced cytotoxic actions and lower capability of specific sub-cellular
targeting is observed. From these experiments it can be speculated that the
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design of cationic systems needs to consider a tight balance between surface
charge, sub-cellular targeting and cell viability.
It is note-worthy that, for 2.5% TNPs in the range of concentrations from 2.5
mg/ml up to 50 mg/ml, there was no significant impact on cell viability and that
these NPs were internalised and localised to the mitochondria within hMSCs
co-localisation. Similarly, 5 % TNPs were good candidates for enhanced uptake
and mitochondrial targeting; although in a more restricted range of concentrations
(up to 30 mg/ml). Contrary, 10 % TNPs showed high levels of toxicity. Moreover,
major co-localisation with endo/lysosomes was also found for these systems, but
also NPs/membrane interactions.
5.2.2 Cellular uptake of porphyrin nanosystems
Once the influence of positive NP charge on delivery and cellular viability of
hMSCs was characterised, attention was directed at investigating the delivery of
porphyrin-nanoparticle systems hMSCs.
As shown in the previous chapter (Chapter 4), porphyrin emission is collected at
a 630 nm wavelength. Therefore, it was not possible to assess cellular viability
using propidium iodide (λem 617 nm) due to the overlap in the emitted light
fluorescence. Therefore, cellular viability was investigated by staining hMSCs
with mitotracker green.
Similar to mitotracker red and due to its lipophilic cationic nature, mitotracker
green accumulates in mitochondria by electrostatic interaction with the negatively
charged inner mitochondrial membrane. This interaction leads to the fluorescent
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form of the dye. Normally, mitotracker dyes are known to respond to variations
in the mitochondrial membrane potential. Unlike mitotracker red, however,
mitotracker green has previously been reported to be unaffected by variations in
mitochondrial membrane potential [198].
Figure 5.12: Representative image of hMSCs viability assessment by flow cytometric
analysis of positive selection for mitotracker green.
Although mitotracker green is not a suitable dye to assess cellular viability in
real time, it is capable of efficiently reporting relative changes in green fluorescence
upon treatment. Figure 5.12 shows a representative bi-variate plot for viability
assessment of hMSCs by mitotracker green. The positive selection for mitotracker
green, blue gated area, was isolated for non-treated cells. Thus, a reference model
was created to compare with treated populations.
5.2.2.1 Effects and internalisation of free porphyrin.
Porphyrins as photosensitizers are known to produce toxic effects in cells once
activated by light; indeed, this is the basis of PDT. In order to anticipate possible
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toxic effects as a consequence of imaging conditions, cell survival was first evaluated
under bright field DIC light for a period of 16 hours.
Figure 5.13: Representative timelapse live cell imaging of hMSCs treated ith 5 µg/ml
of porphyrin. Differential interference contrast images were collected every 30 min for
a total period of 16 hours. Imaging was performed with widefield Olympus Deltavision
elite deconvolution fluorescent microscope, Olympus U-plan Apo 40x/ NA.0.95
Figure 5.13 shows the monitoring of morphology of hMSCs incubated with
porphyrins; an initial point with cells was chosen and cells were imaged every 30
min. It is possible to observe that cells remained healthy for the full 16 hours
of imaging; additionally, cell growth can be observed after two hours of imaging.
The results were consistent throughout the entire culture and also in independent
experiments. Therefore, they indicate that cellular viability remains unaffected
throughout the time of imaging when incubated with the porphyrin dye.
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Figure 5.14: Representative analysis of intracellular co-localisation of porphyrin dye
with mitochondria and endosomal/lysosomal organelles by widefield Olympus Delta-
vision elite deconvolution fluorescent microscopy. (A)- Differential interference con-
trast of hMSCs. (B)- Porphyrin emission; λexc=575 nm, λem=630 nm. (C)- endo-
somal/lysosomal staining with lysotracker blue; λexc=399 nm, λem=457 nm. (D)- hM-
SCs mitochondrial staining with mitotracker green; λexc=488 nm, λem=526 nm. (E)-
Differential interference contrast and porphyrin overlaid images showing that porphyrin
is distributed throughout the cytoplasm ; R1 and R2- zoom of regions R1 and R2 in
E to show the distribution of porphyrin in the cell. (F)- mitochrondrial and porphyrin
images showing no interaction of porphyrins with mitochondrias R3 and R4- zoom of
regions R3 and R4 in F to show co-localisation of porphyrin with mitochondrium (G)-
endosomal/lysosomal and porphyrin overlaid images showing low sub-cellular localisa-
tion of porphyrins in endosomes/lysosomes; R5 and R6- zoom of regions R5 and R6 in
G to show co-localisation of porphyrin with endosomes/lysosomes. Olympus U-plan S-
Apo 60x/NA 1.42. Scale= 15 µm.
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The sub-cellular co-localisation of porphyrin dye was then evaluated in order
to create a comparison model to subsequently understand the intracellular fate
of porphyrin-polyacrylamide nanosystems. Similarly as for cationic nanosystems,
the determination of porphyrin intracellular fate was evaluated by fluorescent
microscopy.
Figure 5.14 shows the intracellular co-localisation of porphyrins. The internal-
isation of porphyrin was investigated by its red fluorescent light emission (λem
630 nm). As for cationic nanosystems (Section 5.2.2.1), the intracellular fate of
porphyrin dye was studied in regard to two main compartments, the mithocondria
and endo/lysosomes. Using mitotracker green for mitochondrial staining and
lysotracker blue for endo/lysosomal staining, as can be seen in Figure 5.14 (B)
and (E), it is possible to observe the intracellular distribution of porphyrin dye
throughout the cytoplasm and outside of the nucleus. Moreover, no porphyrin
dye was found to interact with the extracellular membrane. In addition, the
analysis of porphyrin/ mitochondria interaction, (F), revealed that the porphyrin
dye was not found co-localised with mitochondria. The analysis of porphyrin dye
co-localisation with endo/lysosomes, (see Figure 5.14 (G)); R5, R6 also reveals
low co-localisation patterns with these vesicles.
The results shown in Figure 5.14 contradict the general literature for cationic
porphyrins, which states that the delocalised positive charge on porphyrins facilit-
ates their interaction (all porphyrins have three positive charges) with the charged
lipids on the extracellular membrane and facilitates diffusion and interaction with
the negatively charged inner mitochondrial membrane [187, 207–209]. Pavani,
et al. reported on the efficiency of several porphyrins to target mitochondria
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through their charge-facilitating mitochondrial co-localisation [187]. Their study
showed that porphyrins targeting mitochondria are not only dependent on the
overall charge of the porphyrin, but also on the metal centre. They found that
metallated cationic porphyrins would present lower interaction with mitochondria
than the free base. In addition, it was suggested that incorporation of a zinc
metal on the cavity of the macrocycle increases the hydrophilicity of porphyrins,
diminishing their ability to interact with the hydrophobic membranes [187, 210].
Although it was found that the zinc insertion decreased the porphyrin mi-
tochondrial interaction, it was also found that zinc increased intracellular
interaction with membranes. In addition, it was stated that the photodynamic
efficiency of zinc porphyrins was independent of the photosensitizer intracellular
co-localisation [187].
Additionally, to investigate the toxicity of porphyrins in hMSCs in the absence
of light activation (dark toxicity), cells were incubated with porphyrin dye for 15
hours and analysed by flow cytometry (Figure 5.15).
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Figure 5.15: Analysis of cellular viability in hMScs treated with porphyrins by flow
cytometry. hMScs were treated overnight with several doses (5, 10, 20, 30, 40, 50 µg/ml)
of pophyrin. Representative bi-variate plots: (A)- untreated cells; (B)- cells treated
with 50 µg/ml; (C)- cells treated with 30 µg/ml; (D)- cells treated with 5 µg/ml,
show no alteration in population density for treated and untreated cells. Graph (E)
shows the impact of porphyrin in cellular viability; no alterations were found in viability.
Percentage of viability was calculated from two independent experiments conducted in
triplicate. Error bars represent mean ± SD (n=6). Statistical analysis, p> 0.05 not
statistically different, One Way ANOVA.
The bi-variate plots in Figure 5.15, show no alterations in population density
(gated area A) for treated (B), (C) or (D) and non-treated (A)hMSCs. Addi-
tionally, the analysis of percentage of cellular viability did not show significant
alterations in hMSCs.
The results obtained suggested that the porphyrins in study do not present signi-
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ficant dark toxicity.
Figure 5.16: Analysis of cellular uptake of porphyrin in hMScs treated by flow cyto-
metry. hMScs were treated overnight with several doses (5, 10, 20, 30, 40, 50 µg/ml)
of pophyrin. Representative histogram of porphyrin uptake: (A)- Side scatter analysis
showing increase in cellular complexity with the increase of poprhyrin concentration.
(B)- Porphyrin fluorescence intensity increases with the concentration of porphyrin.
(C)- Representative bi-variate plot analysis of cell populations positive for porphyrin.
(D)- Graph of porphyrin median fluorescence intensity with the concentration of por-
phyrin, It can be observed that the fluorescence intensity increases with the dosage of
porphyrin. Error bars represent mean ± SD (n=6). Statistical analysis,* p< 0.05 were
considered statistically different, One Way ANOVA.
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The porphyrin uptake studies reveal that porphyrins are passively uptaken by
hMSCs. As shown in Figure 5.15 (A), the increased internalisation of porphyrins
leads to an increase in cellular complexity/granularity in a dose-dependent
manner, as seen by the variation in side scatter intensities for treated and non-
treated cells. Furthermore, as shown in B, the variation in dosage of porphyrin
leads to different patterns of uptake. As the dosage of porphyrin increases, a
significant increase, in uptake was verified, as shown by the graph in Figure 5.15
(D). Similarly, Peng et al. have shown an increased uptake of cationic porphyrins
by HeLa cells [211]. Therefore, the results obtained suggest that porphyrins are
efficiently internalised.
Taken together, the results indicate that the porphyrins in study were
internalised in cells. Additionally, when investigating their cellular fate, a
cytoplasmic concentration (Figure 5.14) was found. However, it was not possible
to determine their specific sub-cellular fate, as co-localisation with mitochondria
or endo/lysosomes was not observed.
5.2.2.2 Effects and internalisation of porphyrin-nanoparticle conjug-
ates (ZnPATNPCs).
In order to investigate the delivery of porphyrin-nanoparticle conjugates to hM-
SCs, cell survival under a bright field light was firstly analysed. Below are shown
the time-lapse images for a total of 16 hours (acquired every 30 min) of hMSCs
treated with porphyrin-nanoparticles conjugates. Figure 5.17 shows that hMScs
were able to survive for the full period of imaging without any deleterious effects.
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The results indicate that is possible to proceed to real time imaging of hMSCs
under experimental conditions. Furthermore, it was also possible to verify that no
activation of porphyrins was achieved.
Figure 5.17: Representative timelapse live cell imaging of hMSCs treated with 5 mg/ml
of ZnPATNPCs. Differential interference contrast images were collected every 30 min
for a total period of 16 hours. Imaging performed with widefield Olympus Deltavision
elite deconvolution fluorescent microscope, Olympus U-plan Apo 40x/ NA.0.95
The intracellular fate of ZnPATNPCs in hMSCs by fluorescence microscopy
was then investigated. The internalisation of ZnPATNPCs was investigated by
the red emitted light fluorescence of porphyrins (λexc=575 nm, λem=630 nm).
185
Figure 5.18: Representative analysis of intracellular co-localisation of ZnPATNPCs
with mitochondria and endo/lysosomal vesicles by widefield Olympus Deltavision elite
deconvolution fluorescent microscopy. (A)- Differential interference contrast of hMSCs.
(B)- hMSCs mitochondrial staining with mitotracker green; λexc=488 nm, λem=526
nm. (C)- Porphyrin emission (ZnPATNPCs); λexc=575 nm, λem=630 nm. (D)- en-
dos/lysosomal staining with lysotracker blue; λexc=399 nm, λem=457 nm. (E)- Differ-
ential interference contrast and ZnPATNPCs overlaid images showing that ZnPATNPCs
are distributed throughout the cytoplasm. (F)- mitochrondrial and porphyrin images
showing partial concentration of porphyrins in mitochondrias R1 and R2- zoom of re-
gions R1 and R2 in F to show co-localisation of porphyrin with mitochondrium (G)-
endosomal/lysosomal and porphyrin overlaid images showing low sub-cellular localisa-
tion of ZnPATNPCs in endo/lysosomes; R3 and R4)- zoom of regions R3 and R4 in
G to show co-localisation of porphyrin with endo/lysosomes. Olympus U-plan S- Apo
60x/NA 1.42. Scale= 17 µm.
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Figure 5.18 shows the analysis of co-localisation of ZnPATNPCs in hMSCs.
The overlay of differential interference contrast (A) and porphyrin emission (C)
images shows the distribution of nanoparticles in the cytoplasm and outside
the nucleus. In addition, mitochondrial co-localisation studies, (F) R1 and
R2, indicate that porphyrins present a partial co-localisation pattern with
mitochondria. These results are different to those found for free porphyrin, where
mitochondrial co-localisation was not attained. On the other hand, and also
contrary to the results above (free porphyrin delivery) partial co-localisation
was also found with endo/lysosomal vesicles. Endosomal/lysomal co-localisation
of porphyrin-nanoparticles was previously suggested by Kuruppuarachi, et al.
however their study did not present any co-localisation studies to support the
statement.
The intracellular fate of ZnPATNPC in hMSCs indicates that the covalent linkage
of porphyrins to polymeric nanosystems changes the overall characteristics of
the system. The free porphyrin delivery suggests that the presence of zinc in
the cavity of the macrocycle tends to introduce a more hydrophilic character to
porphyrins as also reported by Pavani, et al., thus leading to lower concentration
of these porphyrins in the mitochondrium [187]. The linkage of porphyrin to
polyacrylamide vehicles seems to reverse that effect. Thus, and due to the limited
number of studies in this matter, it was not possible to directly assume the use
of polymeric vehicles would change the overall properties of zinc porphyrins.
However, it is important to note (F) that no total co-localisation of ZnPATNPCs
with mitochondria was achieved.
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Taken together, the results above suggest that ZnPATNPCs were success-
fully passively internalised in hMSCs. Internalisation fate seems to be mainly
directed to mitochondria, but not completely, as some co-localisation to endo-
somes/lysosomes was also observed. Although the present work did not aim to
establish the exact mechanism of nanoparticle uptake, the results suggest the
existence of more than one mechanism for ZnPATNPCs uptake. The first confers
cytoplasmic access and a second would lead to vesicles entrapment.
As with free porphyrin and cationic nanosystems, the cellular toxicity resulting
from nanoparticle delivery was investigated.
In Figure 5.17, the analysis of cellular viability through bi-variates plots comparing
treated and non-treated hMSC populations clearly show alterations in cellular
viability. In bi-variate plot (B), it is possible to observe a considerable increase in
cell granularity/complexity and decrease in size, suggesting death; as previously
reported by others [78, 79, 199].
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Figure 5.19: Analysis of cellular viability in hMScs treated with ZnPATNPCs by
flow cytometry. hMScs were treated overnight with several doses (5, 10, 20, 30, 40,
50 mg/ml) of pophyrin-nanoparticle conjugates. Representative bi-variate plots: (A)-
untreated cells; (B)- cells treated with 50 mg/ml; (C)- cells treated with 30 mg/ml;
(D)- cells treated with 5 mg/ml, show alterations in population density (gated area) for
treated and untreated cells in a dose-dependent manner. Graph (E) shows the impact
of porphyrin-nanoparticle conjugates in cellular viability; it was observed that concen-
trations of nanoparticles of 50 mg/ml cause detrimental effects in hMSCs. Percentage
of viability was calculated from two independent experiments conducted in triplicate.
Error bars represent mean ± SD (n=6). Statistical analysis, control vs. NPs 50mg/ml:*
p< 0.05 were considered statistically different, One Way ANOVA.
Additionally, cell survival increases with the decrease in nanoparticle concen-
tration. The comparison between treated and non-treated cells shows that only 50
mg/ml of ZnPATNPC present a significant deleterious effect on cellular viability
(p< 0.05) with a reduction in viability observed at concentrations above 30 mg/ml.
The cellular uptake of ZnPATNPC in hMSCs was then analysed. Figure
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5.19 presents the results associated with nanoparticle uptake. In (A) the
histogram of side scatter analysis is shown, from which it was possible to attain
subtle alterations in cells granularity/complexity in nanoparticle concentration
dependence. The results suggest the increased nanoparticle uptake leads to an
increase cellular complexity. Previously, Coupland, et al. had also reported that
internalisation of polymeric nanoparticles in hMSCs resulted in an increased
granularity pattern [89,203].
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Figure 5.20: Analysis of cellular uptake of ZnPATNPCs in hMScs by flow cytometry.
hMScs were treated overnight with several doses (5, 10, 20, 30, 40, 50 mg/ml) of Zn-
PATNPCs. Representative histogram of nanoparticle uptake: (A)- Side scatter analysis
showing increase in cellular complexity with the increase of ZnPATNPC concentration.
(B)- Porphyrin fluorescence intensity increases with the concentration of ZnPATNPC.
(C)- Representative bi-variate plot analysis of cell populations is positive for ZnPAT-
NPC. (D)- Graph of porphyrin median fluorescence intensity with the concentration
of ZnPATNPC, It can be observed that the fluorescence intensity increases with the
dosage of porphyrin. Error bars represent mean ± SD (n=6). Statistical analysis, group
comparison pairwise:* p< 0.05 were considered statistically different, One Way ANOVA.
In addition, the hypothesis of increase in granularity as a consequence of in-
creased nanoparticle uptake can be also confirmed by the histogram of porphyrin
fluorescence intensity. In (B) it is possible to observe that for higher NPs concen-
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trations leads to increased porphyrin fluorescence intensity.
The graph in Figure 5.19 (D) shows the variation in median fluorescence intensity
with nanoparticle concentration. The results show significant increase in porphyrin
median fluorescence, significant for each increase in nanoparticle concentration.
5.2.2.3 Effects and internalisation of porphyrin nanosystems. (ZnPT-
NPs
ZnPTNPs were investigated for cell morphology under microscopic conditions.
hMSCs treated with ZnPTNPs were shown to be unaffected by the imaging con-
ditions for a period up to 16 hours, as can be observed from Figure 5.21.
Figure 5.21: Representative timelapse live cell imaging of hMSCs treated with 5 mg/ml
of ZnPTNPs. Differential interference contrast images were collected every 30 min for
a total period of 16 hours. Imaging performed with widefield Olympus Deltavision elite
deconvolution fluorescent microscope, Olympus U-plan Apo 40x/ NA.0.95
The intracellular fate of ZnPTNPs in hMSCs was then investigated. As with
the nanosystems described in Section 5.2.2.2, the investigation of the sub-cellular
fate of ZnPTNPs was performed by fluorescent microscopy. Figure 5.22, shows
the co-localisation studies performed. The internalisation of ZnPTNPs was
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followed by the detection of red emitted fluorescence (C) (λem). The merged
differential contrast between interference image and the porphyrin emitted
fluorescence showed that porphyrin was internalised in the cytoplasm of hMSCs
(see Figure 5.22 (A);(C) and (E)) and outside the nucleus. To investigate the
specific co-localisation of ZnPTNPs, the images of stained mitochondria and
porphyrin were merged with the yellow fluorescence indicative of concentration
of ZnPTNPs in the mitochondria (F). As can be observed in (F), and is more
detailed in R1 and R2, partially ZnPTNPs co-localised with mitochondria.
Studies of endosomal/lysosomal ZnPTNPs entrapment was performed by the
overlay of porphyrin emission (C) and lysosonal/endosomal staining (D); the
pink fluorescence was an indicator of lysosomal entrapment. The merged image,
5.22 (G), shows the presence of lysosomal entrapment (see zoom images R3
and R4); however, it is still possible to observe the presence of red fluorescence
not co-localised with lysosomes. As for ZnPATNPCs, the results of ZnPTNPs
intracellular fate also suggest the presence of more than one mechanism of
nanoparticle internalisation.
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Figure 5.22: Representative analysis of intracellular co-localisation of ZnPTNPs with
mitochondion and endo/lysosomal vesicles by widefield Olympus Deltavision elite decon-
volution fluorescent microscopy. (A)- Differential interference contrast of hMSCs. (B)-
Porphyrin emission; λexc=575 nm, λem=630 nm. (C)- endosomal/lysosomal staining
with lysotracker blue; λexc=399 nm, λem=457 nm. (D)- hMSCs mitochondrial staining
with mitotracker green; λexc=488 nm, λem=526 nm. (E)- Differential interference con-
trast and porphyrin overlaid images showing that porphyrin is distributed throughout
the cytoplasm. (F)- mitochrondrial and porphyrin images showing small concentra-
tion of porphyrins in mitochondrias R1 and R2- zoom of regions R3 and R4 in F to
show co-localisation of porphyrin with mitochondrium. (G)- endosomal/lysosomal and
porphyrin overlaid images showing low sub-cellular localisation of porphyrins in endo-
somes/lysosomes; R3 and R4)- zoom of regions R3 and R4 in G to access co-localisation
of porphyrin with endosomes/lysosomes. Olympus U-plan S- Apo 60x/NA 1.42. Scale=
12 µm.
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Analysis of hMSCs survival after incubation with increased concentrations
of nanoparticles is shown in bi-variate plots in Figure 5.23. Variations in cell
population density between treated (B),(C) and (D) and non-treated (A) hMSCs
was observed. It was noticed that hMSCs treated with 50 mg/ml nanoparticles
presented higher impact of cell viability. This can be seen, from a population (left
side of the bi-variate plot) presenting low forward scatter (small cell size) and
high side scatter (increase in cell complexity/granularity), which is an indicator of
cellular death. That population disappears as the concentration decreases while
cells treated with nanoparticles concentrations of 30 mg/ml present a significant
decrease in dead cells and a more similar pattern to non-treated cells.
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Figure 5.23: Analysis of cellular viability in hMScs treated with porphyrin entrapped
trimethyl ammonium nanoparticles by flow cytometry. hMScs were treated overnigth
with several doses (5,10, 20, 30, 40, 50 mg/ml) of ZnPTNPs. Representative bi-variate
plots: (A)- non-treated cells; (B)- cells treated with 50 mg/ml; (C)- cells treated with
30 mg/ml; (D)- cells treated with 5 mg/ml show small alterations in population dens-
ity (gated area) for treated and untreated cells in a dose-dependent manner. Graph
(E) shows the impact of porphyrin-nanoparticle conjugates in cellular viability, it was
observed that concentrations of nanoparticles of 50 mg/ml caused detrimental effects
in hMSCs. Percentage of viability was calculated from two independent experiments
conducted in triplicate. Error bars represent mean ± SD (n=6). Statistical analysis, all
group comparison pairwise:* p< 0.05 were considered statistically different, One Way
ANOVA.
Figure 5.23 (E) plots the percentage of cellular viability against the concen-
tration of nanoparticles. The results support the observations iterated from the
bi-variate plots; a significant difference in cellular viability was found for cell pop-
ulations incubated with 50 mg/ml of ZnPTNPs (p< 0.05).
The results show that, as for ZnPATNPCs, high concentrations (50 mg/ml) of
nanoparticles leads to deleterious effects in cell viability. It was found that for
the same concentration of nanoparticles (50 mg/ml), ZnPATNPCs (18 % cellu-
lar viability) present higher rates of cell death than for ZnPTNPs (35 % cellular
viability), suggesting that ZnPATNPCs are more toxic for hMSCs.
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Figure 5.24: Analysis of cellular uptake of porphyrin entrapped trimethyl ammonium
nanoparticles in hMScs by flow cytometry. hMScs were treated overnight with several
doses (5, 10, 20, 30, 40, 50 mg/ml) of ZnPTNPs. Representative histogram of nano-
particle uptake: (A)- Side scatter analysis showing increase in cellular complexity with
the increase of ZnPTNPs concentration. (B)- Porphyrin fluorescence intensity increases
with the concentration of ZnPTNPS. (C)- Representative bi-variate plot analysis of cell
populations positive for ZnPTNPs. (D)- Graph of porphyrin median fluorescence intens-
ity with the concentration of PTNPs. It can be observed that the fluorescence intensity
increases with the dosage of porphyrin. Error bars represent mean ± SD (n=6). Stat-
istical analysis, all group comparison pairwise:* p< 0.05 were considered statistically
different, One Way ANOVA.
When investigating the cellular uptake of ZnPTNPs, variations in the side
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scatter histogram were not found, meaning that no alterations in cell complex-
ity/granularity were found as a consequence of nanoparticle uptake ( see Figure
5.24(A)), which differs greatly from the previous nanosystems. Furthermore,
from analysis of the histogram of porphyrin fluorescence intensity variations, it
was found that the porphyrin intensity presented lower and less variations when
compared with ZnPATNPCs. The same evidence can be observed in Graph (D)
where smaller variations, although significant, were found for all the concen-
trations. Surprisingly, the lowest concentration (5 mg/ml) also presents higher
porphyrin fluorescence intensity when compared with all other concentrations;
the same evidences were found in independent experiments. These results might
be a consequence of the porphyrin entrapment on the polymeric matrix, which
could lead to partial quenching of the porphyrin fluorescence, justifying the lower
variations in fluorescence intensity when compared with the systems above.
The results show that ZnPTNPs are efficiently delivered to hMSCs and its
sub-cellular fate is mainly mitochondria while a small portion is also entrapped
in endo/lysosomes. As with the previous findings for ZnPTNPs uptake by flow
cytometry, fluorescence microscopy found a decreased fluorescence emission of por-
phyrins when compared with ZnPATNPCs. Those findings again suggest that
porphyrin entrapment into the polymeric matrix might lead to some level of fluor-
escence quenching.
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5.3 Conclusions
The present work showed the successful uptake of positively charged and por-
phyrinic nanoparticles in hMSCs, using live cell fluorescence imaging and flow
cytometry analysis.
Positively charged nanoplatforms clearly showed an uptake on a charge dependent
manner. Nanoplatforms with low levels of surface charge were seen as the most
promising route for the facilitated uptake and mitochondrial co-localisation of
polymeric nanoparticles in hMSCs. This study showed that it is possible to engin-
eer nanoparticles surface with trimethyl ammonium and create specific conditions
for facilitated delivery and targeting without compromising the viability of the
cellular system. Although not being possible to draw a mechanism of cellular
uptake, the presence of positive charge seems to be involved with endosomal
escape and mitochondrial co-localisation.
In general, this project was most concerned with the development of a
non-invasive nanotool that could in turn accumulate at the mitochondria,
this system was achieved by multifunctional nanoplatforms containing trimeyl
ammonium/porphyrin functionalities. Although, porphyrins (free state) were not
accumulated to endosomes/lysosomes or mitochondria. Porphyrinic nanoplat-
florms, encapsulated or conjugated, were successfully delivered and preferentially
accumulated in mitochondria. The above indicates that most likely the mitochon-
drial accumulation occurs as a result of trimethyl ammonium functionalization.
The uptake of these nanosystems did not show impact in hMSCs viability up
to 40 mg/ml. The main limitation was to promote a complete accumulation of
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nanoplatforms at mitochondria. Further studies on the mechanisms of internaliz-
ation would provide a better understanding on how to manipulate nanoplatforms
surface to attain full mitochondrial association.
These results were very encouraging towards the development of a non-invasive
nanotool to investigate the real time effects of ROS in hMSCs.
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Chapter 6
Porphyrinic nanoplatforms for
the controlled generation of ROS
in stimulated human
Mesenchymal Stem Cells
6.1 Introduction
Oxidative stress has been correlated with several conditions such as, inflammation,
cancer, Parkinsons and, Alzheimers among others neurodegenerative diseases. Ox-
idative stress arises from the incapacity of antioxidant systems for ROS removal.
Accumulation of ROS leads to toxicity due to their high reactivity towards DNA,
proteins and lipids. Despite the widespread postulation of ROS mechanisms, little
is actually known about the immediate response in living cells to the generation of
these highly reactive compounds. The study of the precise mechanisms responsible
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for ROS pathology is challenging due to ROS high reactivity, short lifetime and
difficult detection. Therefore, the development of specific tools and methodolo-
gies that could enable a deeper knowledge of its action and mechanisms would be
important for the prevention and therapeutics of ROS related diseases.
6.1.1 Porphyrins: production of reactive oxygen species
Photosensitizers are molecules that absorb energy from light, at specific
wavelengths, and transfer this energy to molecular oxygen, leading to produc-
tion of ROS [16, 28, 212, 213]. Photosensitizers can exert its toxicity through two
main mechanisms. Reactions type I, occur through electron/hydrogen transfer
from the photosensitizer, which results in the production of ions, or by the re-
moval of electron/hydrogen from the substrate molecules [1, 16, 214, 215]. Further
reaction of these radicals with oxygen leads to ROS production (hydrogen perox-
ide, superoxide radical and hydroxyl radicals). Reactions type II, involve energy
transfer from the photosensitizer to molecular oxygen, with formation of singlet
oxygen. The mechanism involved in ROS production depends mainly on the type
of photosensitizer [1,16,214,215]. Photodynamic reactions induce oxidative stress
via type I and type II reactions, which operate simultaneously. The prevalence
ratio of these two mechanisms in cellular systems is conditioned by the photo-
sensitizer location, target molecule and efficiency of energy transfer to molecular
oxygen, consequently oxygen concentration also plays an essential role [215–217].
However, evidences exists that type II reactions are the most important in photo-
dynamic therapy.
The amount of ROS produced through the mechanisms above, will lead to oxid-
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ative stress and consequently cell death (apoptosis, necrosis or autophagy). As a
result of ROS short lifetime and therefore low diffusion, the sub cellular structures
damaged by these mechanisms are restricted to an area surrounding the locale of
its generation and the location of the photosensitizer [30, 218–220].
6.1.2 Zinc and copper porphyrins as photosensitizers
Photophysical properties of porphyrins can be greatly impaired according to the
nature of the central metal ion [221]. Metalation of porphyrins is known to primar-
ily contribute to the strength of the porphyrinic ring through the stabilisation of
its symmetry. However, metalation has additional effects on the porphyrin, which
is mainly depending on the ligand structure, the type of axial ligation, the elec-
tronegativity of the metal and also the spin state of the central metal ion. The
major difference between metalloporphyrins relies on their classification; they can
be classified as open-shell or closed-shell in relation to the centre ion metal, which
mainly influences their luminescence patterns. In the closed shell group, diamag-
netic metal ions can be found as Cd(II); Mg(II); Zn (II), which are characterised
by its strong fluorescence. On the other hand, open-shell paramagnetic metallo-
porphyrins present centers such as Cu(II); Fe(II); Mn(II) whose fluorescence is not
observed [222].
In the group of closed-shell metalloporphyrins, zinc porphyrin shows up as an
important model of photosensitizers. The zinc insertion on the porphyrin ring
seems to provide stabilization of the porphyrinic ring, improving its action as a
photosensitizer. Furthermore, the zinc metal centre was also reported as improv-
ing the interactions of the photosensitizer with membranes, thus improving the
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photosensitizing activity by the oxidation of membrane lipids, which leads to the
activation of chain oxidative reactions and decomposition into free radicals [187] .
On the other hand, in paramagnetic copper porphyrins, the existence of an
unpaired electron in the upper orbital of the central metal ion, which interacts with
the porphyrin π system, induces the formation of tri-multiplet states [223–226].
Therefore, a spin allowed transition for relaxation is enabled by the fact that the
tri-multiplet state at higher energy has formally the same spin multiplicity as the
ground state molecule, leading to quenching of the triplet excited state [222–226].
Aims
The present chapter aims to establish the development of a nanotool for the
controlled endogenous generation of ROS in light stimulated hMSCs. It was aimed
to investigate the photodynamic effects in hMSCs of activated porphyrinic nano-
platforms, as developed in Chapter 4. High levels of oxidative stress induced
by singlet oxygen generation are known to be lethal for cells (e.g. PDT). There-
fore, multifunctional porphyrinic nanosystems were investigated and redesigned
in order to reach controlled generation of ROS by cumulative exposure to light
(of appropriated wavelength). It was also intended to evaluate in real time the
impact of increasing oxidative stress in treated hMSCs submitted to cumulative
light dosages. Thus, real time impact of ROS in cellular viability and hydrogen
peroxide response was evaluated by fluorescent time-lapse microscopy.
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6.2 Results and Discussion
The present chapter introduces the development of a nanoscale tool for single
cell studies of ROS effects in hMSCs. Therefore, porphyrinic nanoplatforms were
delivered to hMSCs. The principle of this system was to use porphyrinic moeties
linked to polymeric matrices to induce the endogenous production of ROS in a
controlled manner. The porphyrinic moiety acts as an ROS generator, upon light
exposure of appropriate wavelength. The effects of ROS on hMSCs were then
investigated using the porphyrin nanoplatforms developed in Chapter 4 (Fig. 6.1)
and whose delivery to hMSCs was demonstrated in Chapter 5.
Figure 6.1: Schematic representation of the porphyrinic nanoplatforms in study.
ZnPATNPC- zinc porphyrin nanoparticle conjugates and ZnPTNP- zinc porphyrin en-
trapped nanoparticle conjugates.
For the porphyrinic nanoplatforms in study, the exact amount of photosensit-
izer conjugated at the surface or entrapped is unknown. The functionalization of
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nanoparticles is hampered by the random nature of the free radical polymerisation
of polyarylamide, making it impossible to establish the number of functionalities
introduced in the synthesis of the nanoparticles or the concentration of porphyrin.
Thus, in the development of both nanoplatforms (ZnPTNPC and ZnPTNP), a
maximum of porphyrin was reacted, achieved by adding an excess of porphyrin.
The presence of porphyrin fluorescence on the supernatants during the purification
step confirmed that an excess of photosensitizer molecules was used. In order to in-
troduce similar amounts of photosensitizer in both nanosystems, the same number
of moles were reacted with ATNPs (ZnPATNPC) and polymerised in ZnPTNPs.
However, it is worth noting that this methodology only aimed to approximate the
amount of photosensitizer and differences were expected in both nanosystems,
due to the interactions and reactivity of photosensitizers and reaction components.
6.2.1 Porphyrin-NPs:ROS generation in hMSCs
6.2.1.1 Detection of ROS
To study the oxidative response in hMSCs, as a consequence of photosensitizer
activation, a fluorescent reporter molecule toward ROS was used. The major
limitations in the detection of ROS are associated with their short lifetime and
high reactivity (in the order of ns); most of the commercially available probes do
not respond specifically to one type of ROS and/or are affected by other nonspecific
chemical interactions [227,228].
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Figure 6.2: Detection of H2O2 through its reaction with 4-trifluoromethyl coumarin
pinacol boronate (BPTFMC) with the release of pinacolborane (trigger) leading to the
release of the fluorophore active form, 7- hydroxy-4-(trifluoromethyl) coumarin (HT-
FMC).
The present study chose a fluorescent reporter towards H2O2 developed by Al-
haj Zen,(as part of his PhD project, Nottingham University, 2013). The molecule
BPTFMC is a modified coumarin based fluorophore whose fluorescence is masked
by the presence of a boronate group, as represented in Figure 6.2. In the pres-
ence of H2O2, the trigger is cleaved, affording the fluorescent reporter molecule
HTFMC.
6.2.1.2 Imaging hMSCs: Multichannel fluorescence stitching
To study the effects of porphyrin activation on hMSCs, the wavelength of its ac-
tivation was determined. Porphyrins spectra presented several absorption points
which could be used. However, it was anticipated that lower wavelengths (<550
nm) would lead to inefficient photosensitization due to competitive absorption with
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other molecules which lead to reduced photosensitization [16,28]. In order to avoid
compromising the photosensitizer activity and ROS modulation, a wavelength of
diminished absorption, 575 nm, was chosen. Characteristically, the action of pho-
tosensitizers is limited to the area of irradiation, this being one of the main ad-
vantages of photosensitizers in therapeutic applications (avoiding side effects in
non-diseased cells). This localised activity has been reported to be a consequence
of the high reactivity of ROS and low diffusion patterns [1, 16, 18, 25, 30, 229]. In
order to evaluate the cytotoxic effects of activated porphyrinic nanoplatforms, a
multichannel fluorescence imaging was performed. Due to the damage of pho-
tosensitizers being restricted to the irradiated area, the imaging was performed
in irradiated and surrounding areas. As schematically represented in Figure 6.3,
the LED light source for photosensitizer activation was achieved by transmitted
LED light at 575 nm from an Olympus inverted microscope. The experimental
design was aimed to allow a real time observation of the effects of photosensitizer
activation.
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Figure 6.3: Schematic representation of live cell experimental design for studying pho-
tosensitizer activation. Untreated cells were irradiated with LED light from a widefield
Olympus delta vision elite deconvolution fluorescent microscope, Olympus U-lan S- Apo
60x/NA 1.42. hMSCs stained with mitotracker green λexc=488 nm ; λem=511 nm. (A):
experimental design of cell irradiation. (B): multichannel mosaic image acquisition to
observe effects of porphyrin activation on the surrounding cell population. (C): mosaic
of collected images, irradiation point at image 13 (red dotted line- central image) of
25 acquired images. (D): combination of mosaic images into a single panel, stitching
performed by software softWoRx.
For this experiment, and due to photosensitizer activation, it was necessary
to establish a fluorescence method to visualize the cellular effects of ROS (e.g.
cell viability). In addition, considering the photosensitizer activation wavelength
(575 nm), it was necessary to consider a viability fluorochrome that would not
absorb light at any of the porphyrin excitation points (430 nm; 575 nm; 610 nm).
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Therefore, hMSCs were stained with a cationic membrane-permeant fluorochrome
which accumulates preferentially in the mitochondrial matrix by differential po-
tential (staining mitochondria). In this experiment, mitochondrial alterations due
to ROS toxic effects were visualized by the use of mitotracker green (MTG).
6.2.1.3 Effect of porphyrin-NPs on cells when irradiated with light
Porphyrin activation was achieved by exposure of treated hMSCs, (whith either
ZnPATNPC or ZnPTNP), to a single light dosage of 512 µW/2 sec at 575 nm
wavelength, as shown in Figure 6.4.
For non-treated hMSCs (control; top panel) toxic effects by light exposure
were not observed, suggesting that the chosen wavelength did not affect hMSCs.
Absence of HTFMC fluorescence also indicates the absence of H2O2 generation
when cells were exposed to this level of light. In addition, it was also possible
to observe that the fluorochrome HTFMC was unresponsive to the intracellular
environment of hMSCs.
For hMSCs incubated with ZnPATNPC, alterations in cellular morphology were
observed, represented by white arrows in the DIC image (middle panel; D).
Likewise, a ”blast zone” is visible at the centre of the image in the proximity of
irradiation, indicated by the absence of MTG staining. The blurred fluorescence
of mitotracker green suggests the loss of mitochondrial integrity, as previously
reported by Pendergrass, et al. [198]. In addition, an increase in fluorescent
emission of HTFMC (blue fluorescence; F), a consequence of BPTFMC activation,
is indicative of H2O2 production.
Similarly with the control cells, hMSCs incubated with ZnPTNPs did not show
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alterations either in cellular morphology or viability (bottom panel; G/H),
indicating that entrapment of photosensitizers in the polymeric matrix depresses
photosensitizer activity. As for HTFMC fluorescence, different levels of response
(bottom panel; right) were observed. Low fluorescence intensity of HTFMC
suggests low production of H2O2, thus small photodynamic effect at the irradi-
ation point was found. Mitotracker green also shows the staining of individual
mitochondria, which indicates integrity of the organelle [198].
At this stage it was not possible to use a fluorescent dye responsive to variations
in mitochondrial membrane potential, which would have given a better idea of
cell viability, (MMP) due to the absorption and emission points of porphyrin and
spectral overlap with most MMP sensitive dyes (i.e. mitotracker red).
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Figure 6.4: Multichannel 2D mosaic imaging. hMSCs were stained with mitotracker
green, incubated with BPTFMC, single irradiated and visualized by a widefield Olympus
delta vision elite deconvolution fluorescent microscope, Olympus U-lan S- Apo 60x/NA
1.42. hMSCs were incubated overnight with porphyrinic nanoplatforms (ZnPATNPC
or ZNPTNPs, incubated with BPTFMC λexc= 390 nm and λem= 435 nm for its act-
ive form HTFMC and stained with mitotracker green λexc= 488 nm ; λem= 511 nm.
Scale=51µm. Stitched mosaic image generated from 25 microscopic fields. Point of
irradiation represented by the dotted red line. Control cells (top panel) do not show
alterations in the pattern of cell morphology (A) or mitotracker green staining (B) it
also shows the absence of BPTFMC activation by ROS, H2O2, thus the absence of blue
fluorescence (C). On the other hand, cells incubated with ZnPATNPC (middle panel)
indicate high cellular damage upon single light stimulation visualised by phase contrast
(D), loss of mitochondrial delimited staining (E) and conversion of BPTFMC into the
active form HTFMC with the consequent appearance of blue fluorescence (F). hMSCs
incubated with ZnPTNPs (bottom panel) on phase contrast image show little response
to single light dosage (G), which can be further confirmed by mitotracker green staining
(H), non specific and little response to BPTFMC activation is present (I).
The previous results, as expected, suggest that the amount of photosensitizer
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conjugated to polyacrylamide nanoparticles leads to immediate cellular damage at
the irradiation point and surrounding areas, which is hypothesized to be a con-
sequence of a burst of ROS. Subsequently, it was also possible to anticipate that
ZnPATNPC would be a better system to modulate ROS generation in hMSCs,
given that ZnPTNPs have not demonstrated a homogeneous response of HTFMC.
These results contradict the previous reports of Gao, et al. [69,230], which stated
that encapsulation of photosensitizers does not alter their photosensitizing activ-
ity. However, random cellular damage and low photosensitizing activity was also
present in their results [69, 230]. Other studies reported the non-interference of
polyacrylamide matrix in the singlet oxygen production [62, 230]. It is hypothes-
ized that porphyrins covalently linked to the polyacrylamide matrix might not
produce a homogeneous distribution of porphyrin throughout the nanoplatforms,
leading to a lower photodynamic activity.
6.2.2 ZnPATNPC for the controlled generation of ROS in
hMSCs.
Based on the previous results (Section 6.2.1), ZnPATNPC was selected as the
model system to be used in the modulation of ROS generation in hMSCs. It was
anticipated that to achieve that system it would be necessary to adjust light dosage
or the amount of photosensitizer conjugated at the surface of nanoplatforms. The
adjustment of light dosage was not considered to be a valid approach given that,
for live cell studies, the exposure conditions were already minimal. Therefore, the
adjustment of the photosensitizer at the surface of the nanoparticles was selected,
as the best approach to control the amount of ROS generated by stimulated
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hMSCs. At this point, in order to achieve a nanoplatform capable of inducing
intracellular ROS generation in a controlled manner, it was firstly necessary
to develop porphyrinic-nanoplatforms unresponsive to single light dosage upon
photosensitizer activation. The rationale behind this approach was to decrease
the amount o photosensitizer to a level that confers little production of singlet
oxygen, upon single light dosage. Subsequently, an increase in the intracellular
amounts of ROS would be achieved by the administration of increasing light
dosages.
6.2.2.1 ZnPATNPC: Modulation of conjugated porphyrin
The present section concerns the development of porphyrinic nanoplatforms un-
responsive to single light dosage. As previously discussed in Section 6.2 the
photosensitizer concentration conjugated with ATNPs was difficult to attain due
to the random nature of free radical polymerisation and functionalisation of these
nanosystems. Therefore, for the development of a new nanosystem, ATNPs were
titrated with photosensitizer. The original porphyrinic nanoplatform previously
investigated (Section 6.2) was used as a reference and labelled as 100% ZnPAT-
NPC.
For the design of a new porphyrinic nanoplatform, it was considered necessary to
maintain the physico-chemical characteristics of the previous systems. Therefore,
it was reasoned that the trimethyl ammonium functionality (2.5 %) would confer a
positive net charge necessary to maintain passive cellular uptake and mitochondrial
co-localisation. In addition, decreased amounts of porphyrin would be conjugated
to the NPs.
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6.2.2.1.1 Size and surface charge characterisation of ZnPATNPC. For
the adjustment of particle surface charge for titrated porphyrin, the knowledge
achieved in the third and fifth chapters was used. It was found that for mito-
chondrial co-localisation would need a total net charge between + 12 mV and
20 mV. Therefore, alkyne/trimethyl ammonium NPs (ATNPs) were developed
with net surface charge of approximately + 13 mV. Further increase in surface
charge would be conferred by the conjugation of the tricationic porphyrin, which
contributes with three positive charges each.
Figure 6.5 shows the surface charge (A) and size characterisation (B) of NPs
titrated with porphyrin. Surface charge results show ATNPs present a zeta
potential of approximately + 13 mV. Further conjugation with an excess of Zn
porphyrin (100 % ZnPATNPC) leads to an increase in surface charge to + 23 mV.
This system had been previously shown to generate a burst of ROS in hMSCs
upon a single light irradiation. For nanosystems containing 75 % to 25 % of Zn
porphyrin coating, zeta potentials of approximately +20 mV were observed. As
expected, lower zeta potential values for nanosystems titrated with 10 and 5 % of
Zn porphyrin (+15 mV) was achieved.
Taken together, the results showed it to be possible to generate nanosystems
with surface charges in the range of + 12 mV up to + 20 mV which were found
to confer mitochondrial co-localisation. In addition, surface charge variations in
the new porphyrin nanoplatform developed suggest the successful titration of
porphyrin with ATNPs.
216
Hydrodynamic diameter of titrated porphyrin nanoplatforms indicated that all
the systems presented size compatible with cellular uptake, below 100 nm. Figure
6.5 (B) shows the hydrodynamic diameters of porphyrin titrated nanoparticles.
For nanosystems containing a dual functionalisation (B2; 45 nm) compared with
their non-functionalised counterparts (B1; 37 nm), significant variation in size was
observed.
The size analysis for porphyrin conjugated nanosystems observed an increased
hydrodynamic diameter compared to their functionalised counterparts. For the
different titrated porphyrin conjugates, low variations in size were identified, a
hydrodynamic diameter of around 80 nm.
With regards to zeta potential, variations in surface charge of the titrated por-
phyrin conjugates were observed as expected. Higher surface charge was obtained
for alkyne trimethyl ammonium nanoparticles reacted with an excess of porphyrin
(100 % ZnPATNPCs) whilst decrease in porphyrin conjugated at the surface led
to proportional reductions for the remaining porphyrin titrated conjugates.
It is hypothesized that the increase in size upon porphyrin conjugation might be
associated with the variations in surface charge. The same evidences was previ-
ously reported by Rubinstein, et al. and others [59, 124] for cationic polymeric
nanosystems. One of the suggestions from these observation related to positive
charge covalently bonded to the hydrogel matrix (trimethyl ammonium functional-
isation) increasing the osmotic pressure in consequence of dissociated counterions,
leading to hydrogel swelling.
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Figure 6.5: Characterisation of functionalised nanoplatforms comparison with their
porphyrin conjugated counterparts. A. shows the zeta potential results. B. hydro-
dynamic diameter of the resultant systems (1) control PANPs, (2) dually functionalised
(ATNPs); (100%) ZnPATNPCs, (75- 5 %) PATNPCs.
6.2.2.1.2 Fluorescence characterisation of ZnPATNPC Variations in
photosensitizer conjugated with ATNPs in titrated nanosystems was evaluated by
fluorescence characterisation. Figure 6.6 shows the emission spectras of the con-
jugates resultant from the titration of porphyrin with ATNPs. The first emission
spectra of 100% Zn PATNPC refers to the system which had been shown above
to induce immediate toxic effects (Section 6.2.1.3). The derived systems, from
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75 % to 5%, correspond to polyacrylamide nanoplatforms with titrated amounts
of porphyrin at the surface. The results obtained clearly show that decreasing
the proportion of photosensitizer reacted with ATNPs led to a decrease in the
fluorescence intensity. The results obtained suggest that it was possible to develop
porphyrin-nanoplatforms containing different amounts of photosensitizer conjug-
ated.
Figure 6.6: Fluorescence emission spectra of titrated porphyrins at the surface of
polyacrylamide nanoparticles.
6.2.2.2 Cellular effects of porphyrin modulated nanosystems.
The real time effect of photosensitizer activation in treated hMSCs was evaluated
by fluorescent microscopy. Thus, hMSCs treated with the new porphyrin-
nanoparticle conjugates (75 %- 5 % ZnPATNPC) were exposed to a single light
dosage and the effects were evaluated. For cells treated with ZnPATNPC,
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photosensitizers ranging from 75 % up to 20 % have shown high impact on cell
viability. Furthermore, similar to 100 % ZnPATNPC, a ” blast zone ” was also
observed in hMSCs incubated with 75 %- 20 % ZnPATNPC. Figure 6.7, shows
the effects of photosensitizer activation in hMSCs treated with 20 % ZnPATNPC
(K-M); alterations in cell morphology were observed.
In consequence of the decreased amount of porphyrin conjugated to 20 % to
5 % ZnPATNPC, a fluorescent signal of porphyrins was not observed when
excited at 575 nm, thus it was possible to stain hMSCs with an MMP sensitive
fluorochrome. As previously demonstrated by Pendergrass, et al., mitotracker
red (CMXRos), which responds to relative changes in MMP, was chosen for the
subsequent experiments.
Figure 6.7 presents the effects in hMSCs of nanoplatforms containing 20 %, 10
% and 5 % of porphyrin conjugation exposed to single light dosage of 512 µW/2
sec at 575 nm wavelength. As can be observed, at these levels of photosensitizing
effect it was not necessary to proceed to multichannel mosaic imaging to achieve
cellular viability (Imaging Olympus U-plan S-Apo 40x/ NA 0.90). It was possible
to visualize that hMSCs treated with 20 % ZnPTNPC still presented a high
level of H2O2 production upon light stimulation (L), with decreased cellular
viability at irradiation point (M). Higher cellular viability was obtained for 10 %
ZnPTNPC with augmented mitotracker red fluorescence(I) and lower fluorescence
of HTFMC. For hMSCs incubated with 5 % ZnPATNPC (F), HTFMC remained
unresponsive (E) and increased cellular viability was observed.
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Figure 6.7: Effects of titrated porphyrin nanoplatforms in hMSCs upon single light
dosage exposure. Cells were irradiated with LED light from a widefield Olympus delta
vision elite deconvolution fluorescent microscope, Olympus U-plan S- Apo 60x/NA 1.42
and imaged with the same system and an Olympus U-plan S- Apo 20x/NA 0.85 . hMSCs
were incubated with BPTFMC λexc= 390 nm and λem= 435 nm for its active form
HTFMC stained with mitotracker red λexc=575 nm ; λem=599 nm to evaluate cellular
viability dependent on mitochondrial membrane potential.
6.2.2.3 Effect of 5 % ZnPATNPC on cells when irradiated by light:
Controlled generation of ROS.
The latest results suggest that it is possible to attain a porphyrinic nanoplatform
unresponsive to single light dosages by reducing the percentage of porphyrin con-
jugation to 5 %. Bearing this is mind, it was investigated how far hMSCs could
be light stimulated and maintain cellular viability.
hMSCs treated with 5 % ZnPATNPC were submitted to cumulative light dosages
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at 575 nm (512 µW/2 sec each dosage) and analysed by time-lapse fluorescent mi-
croscopy. To evaluate ROS effects, it was important to follow variations in cellular
viability, which was performed by mitochondrial staining with a MMP sensitive
dye, mitotracker red CMXRos. It is important to note that, prior to mitochon-
drial staining, it was investigated whether any fluorescent signal of porphyrin was
present when excited at 575 nm wavelength (data not shown) to avoid unspecific
staining of mitochondria which would lead to misinterpretation of results.
Therefore, hMSCs incubated with porphyrinic nanoplatforms were stimulated by
LED irradiation, 575 nm wavelength at 5 minutes each for a total period of 100
minutes. During this period the real time increase in oxidative stress was invest-
igated.
The intention of the present study was to demonstrate that photosensitizing effects
were a consequence of the photosensitizer activity of zinc porphyrins; in order to
demonstrate this a control porphyrin (copper porphyrin) was used. As elucidated
in Section 6.1.2, copper metallated porphyrins present a quenched fluorescence
due to the interaction between the porphyrin π system and the unpaired electron
from the orbital of the central metal ion [222–226]. Furthermore, the quenching of
fluorescence also relates to inefficiency on the intersystem crossing of the singlet
electronic state to originate the longer lived triplet excited state. Thus, copper
porphyrin does not present photosensitizing activity upon light exposure. The
use of a CuPATNPC allows the toxic effect to be specifically associated with the
photosensitizing activity of ZnPATNPC.
The toxic activity of ZnPATNPC in stimulated hMSCs was then investigated in
parallel with hMSCs treated with CuPATNPC. Figure 6.8 shows the effects of
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cumulative live cell irradiation at 575 nm, 512 µW/2 sec. The left panel shows
the response of hMSCs treated with CuPATNPC upon light stimulation. As ex-
pected, it is possible to observe that cellular morphology is maintained through
all irradiation times. Likewise, cellular viability was established by the presence of
mitochondrial staining of individual mitochondria (mitotracker red staining). Fur-
thermore, as previously anticipated, hMSCs incubated with CuPTNPC did do not
show increase in ROS production through the period of irradiation, as shown by
unresponsive HTFMC, which is indicative of the absence of H2O2 production. On
the other hand, hMSCs incubated with ZnPTNPC showed unresponsive HTFMC
in the first 30 minutes of light treatment, with a slight increase at 30 minutes of
irradiation (cumulative administration of six light dosages); however, no changes
were present in phase contrast imaging or mitochondrial staining. At 60 minutes
of irradiation (cumulative administration of 12 light dosages), a visible increase in
oxidative stress was noticed, due to H2O2 production (HTFMC activation).
The impact of increased oxidative stress was also visible in mitochondrial stain-
ing, where a decrease in mitotracker red intensity and alterations in the pattern of
staining was observed, suggesting a decreased MMP. Also, oxidative stress signals
were visible by alterations in cellular morphology (Figure 6.8, indicated by white
arrows). Further increase in oxidative stress was present upon 100 minutes (cu-
mulative administration of 20 light dosages) of light treatment, which verified an
augmented fluorescence in HTFMC and, consequently, a decrease in MMP (MTR)
and cellular viability (phase contrast white arrows). Taken together, the previous
results indicate that it is possible to induce hMSCs to produce endogenously ROS
in a controlled manner.
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Figure 6.8: Live cell imaging of endogenous H2O2 production upon irradiation of hMSCs treated with either CuPATNPC or ZnPATNPC. LED
irradiation of hMSCs at each 5 min for a total of 100 min. hMSCs were previously treated (overnight incubation) with CuPTNPC containing
FITC-dextran entrapped (left panel) or ZnPATNPC containing FITC-dextran entrapped (right panel). It is possible to observe, by phase contrast
imaging, spindle shaped fibroblastic-like MSCs (left and right panels, first columns). The intracellular presence of CuPATNPC or ZnPATNPC
can be visualized in green, due to FITC emission at λem= 523 nm (left and right panels, middle columns). Activation of HTFMC to BPTFMC
was mediated by the presence of endogenous H2O2, λem = 435 nm and can be observed only after 60 and 100 min of light treatment, exclusively
in hMSCs treated with ZnPATNPC (left and right panels, third columns).Images obtained with a widefield Olympus delta vision deconvolution
fluorescent microscope; Olympus U-plan S-Apo 60x/ NA 1.42. Scale= 12 µm.
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6.3 Conclusions
The research developed in the present chapter provides information on the
photosensitizing effects of activated porphyrinic nanoplatforms in hMSCs. From
the porphyrinic nanosystems in the study, ZnPATNPC and ZnPTNP, it was
concluded that entrapment of porphyrins in the polyacrylamide matrix depresses
the photosensitizing activity. Thus, conjugations of porphyrin at the surface of
polyacrylamide nanoparticles have been shown produce a ”blast” of ROS and
induce oxidative stress at lethal levels in treated hMSCs upon light exposure.
The conjugation of zinc porphyrins at the surface of nanoparticles produced
efficaciously singlet oxygen.
In conclusion, nanoplatforms containing porphyrins entrapped were not a suitable
methodology to control the photodynamic activity of porphyrins in cells. Further
investigations of the photophysical properties of entrapped and free porphyrins
are needed (e.g. spectroscopy, lifetime and quantum yields measurements) to
bring better understanding of the interactions responsible for this event.
One of the main limitations of the present research was being unable to establish
an association between porphyrin concentration and photosensitizer effect. The
random nature of the free radical polymerization does not allow quantifying the
number of functionalities introduced and, in consequence, the concentration of
porphyrin.
ZnPATNPC produced a burst of ROS in hMSCs which, in part, was a promising
result; however, the aim was to create a tool that would elicit, in situ, a progressive
increase in ROS generation. Thus, the knowledge acquired from previous research
(Chapters 3; 4; 5), allowed engineering porphyrinic nanoplatforms to confer
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biological compatibility and controlled ROS production by modulating the coating
of nanoplatforms with porphyrin.
The treatment of hMSCs with 5 % ZnPATNPC has been shown to successfully
produce in situ small bursts of ROS by cumulative light dosages allowing to
follow, in real time, an increase in oxidative stress culminating in cell death.
A means to prove production of ROS in a controlled manner following porphyrin
activation by exposure to light dosages of specific wavelengths was achieved and
included the use of a hydrogen peroxide sensitive dye which is accumulated in
mitochondria. It was also necessary to evaluate cellular responses to an increase
in oxidative stress, established by the use of a commercial dye (mitotracker red)
that provides information on cellular viability. Mitotracker red dyes stain active
mitochondria by exploiting their inner mitochondrial membrane potential, thus
loss in cellular viability due to the deleterious effects of ROS produced (H2O2)
was successfully followed.
By establishing that the viability of hMSCs treated with copper porphyrin
nanoplatforms exposed to light of appropriate wavelength was unaltered, it
was possible to conclude that the photosensitizing effect was restricted to the
photo-activity of zinc porphyrin nanoplatforms.
In summary, the knowledge acquired from these nanosystems led to the successful
development of a nanotool for the endogenous generation of ROS in a controlled
manner. Such a system offers the possibility of investigating real time responses to
ROS effects. Furthermore, it also provides the study of single cell and metabolic
pathways in great detail by the use of a non-invasive system. Thus, it can greatly
contribute to the development of basic science in the field of ROS and uncover
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potential therapeutic targets in related diseases.
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Chapter 7
Impact of ROS in the
differentiation state of
Mesenchymal Stem Cells
7.1 Mesenchymal Stem Cells
Stem cells are defined as biologically undeveloped cells with the capacity for pro-
liferation, self-renewal and a high potential to generate one or more types of differ-
entiated progeny [231–234]. According to their development potential, stem cells
can be characterised as totipotential (differentiate into all embryonic and extraem-
bryonic cells types), pluripotential (able to give rise to all embryonic cell types),
multipotential (able to give rise to a great number of cellular lineages), oligopoten-
tial (originates a more limited number of cellular lineages) and unipotential (only
able to originate one specific cellular lineage) [231,234].
The notion of Stromal Cells, later called Mesenchymal Stem Cells (MSCs),
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was first introduced by Alexander Friedenstein, et al. [88]. In 1970, they fol-
lowed a culture of mouse bone marrow cells in plastic dishes, supplemented with
foetal calf serum; Friedenstein observed the presence of a nonhematopoietic pop-
ulation (0.01% to 0.001%) of plastic adherent nucleated cells along with the non-
adherent hematopoietic cells. A few years later, Friedenstein introduced a second
breakthrough by exposing the idea of clonogenic stromal cells, showing that non-
hematopoietic single adherent cells were capable of developing into fibroblast-like
colonies, originating the term colony-forming unit fibroblasts (CFU-F) [235]. This
same evidence was later reported in human bone marrow by Castro Malaspina,
et al. [236]. Friedenstein’s subsequent investigations provided evidence of osteo-
genic potential by the self-renewal capability of stem cells through regeneration of
heterotopic bone tissue [235,237,238]. Further studies uncovered many other char-
acteristics of this progeny; Schofield introduced the hypothesis of a stem cell niche
within the bone marrow, suggesting that hematopoietic stem cells were regulated
by an association with the bone marrow microenvironment [239–241].
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Figure 7.1: Representative multilineage differentiation potential of MSCs. MSCs self-
renewal and differentiation into mesenchymal tissues, such as bone, cartilage, muscle,
stroma and adipose. It also shows the plasticity of MSCs to differentiate into tissues such
as heart, liver, skin and nervous tissue. Adapted from Caplan and Bruder, 2001 [242].
7.1.1 Immunophenotypic Characterisation of hMSCs
7.1.1.1 Cell Surface Molecules
The identification and characterisation of cell surface molecules follows a protocol
designated as CD protocol, where CD stands for cluster of differentiation. The CD
nomenclature was originally developed in 1984 by a group of immunologists at an
International Workshop on Human Leukocyte Differentiation Antigens (HLDA)
aiming to standardise and develop an understanding of surface molecules in leuk-
ocyte (white blood cells). These CD molecules are either membrane receptors or
ligands responsible for transducing activation signals to the inside of the cell, and
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therefore regulating activation mechanisms. Consequently, the presence of these
molecules defines the function and specialisation of each cell. The potential of
these antibodies to identify different types of cells at different stages was quickly
understood and the CD nomenclature was subsequently extended to other types
of cells, such as stem cells [243,244] .
As shown in Diagram 7.2, the different monoclonal antibodies are labelled
with different fluorochromes, which allows for their individual identification. The
interaction between the labelled paratope (part of the antibody that recognizes
the epitope) and the epitopes (part of surface receptor that is recognized by the
immune system) imparts a fluorescent signal to the cell. Specifically, for the mono-
clonal antibodies represented in Figure 7.2, single cells present fluorescent signals
in the green (CD29) and yellow (CD105) regions of the visible spectra, due to
paratope-epitope interaction. Absence of interactions between CD45 and CD 34
with the surface of MSCs leads to the absence of fluorescent emission in the orange
and red, regions of the visible spectra, respectively, for single cell analysis.
7.1.1.2 Cell surface molecules characteristic of MSCs
As described above, MSCs were initially characterized by homogenous adherence
to plastic (as a way to purify and isolate these non hematopoietic populations),
spindle-shaped fibroblastic morphology and their tri-lineage differentiation poten-
tial into osteoblasts, chondroblasts and adipocytes. However, with increased know-
ledge about these cell types, allied to their presence in bone marrow ( as well as
many other tissues), it has led to difficulties in their identification. Firstly, a vari-
ation of differentiation potential and morphology arising from in vivo to in vitro
conditions was observed. Additionally, alterations were identified according to the
231
Figure 7.2: Schematic diagram of monoclonal antibody interaction with the surface receptors in Mesenchymal Stem Cells (MSCs). The antibodies
represented, are specific for the multicolour analysis of the present work. Therefore, the interaction of CD29 and CD105 antibodies with the surface
receptor in MSCs and the absence of interaction of CD 45 and CD 34, are represented. It also describes the main biological properties of [245–248].
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tissue from where the cells were collected in an age dependent manner. These
factors have led to enormous difficulty in developing a universal phenotypic char-
acterisation of MSCs. Therefore, in 2006, The International Society for Cellular
Therapy (ISCT), published a proposal for a minimum criteria panel of cell surface
markers for the identification of MSCs. Thus, MSCs should be positive (≥ 95%)for
CD105, CD73, CD90 and negative (≤ 2%) for CD45, CD34. CD14 or CD 11b,
CD79α or CD19 and HLA DR (Major Histocompatibility Complex class II cell
surface receptor) [249]. Since then, it has been verified that hMSCs express a
wide variety of other cell surface markers in addition to the ones defined by the
ISCT. In 2011, Mafi, et al. presented a summary of the most common cell sur-
face markers for MSCs isolated from different tissues. Thus, it was identified that
CD105, CD29, CD90, CD44, CD73, CD13, CD146, CD106, CD54 and CD166 were
the most frequently reported as positive and CD34, CD14, CD45, CD11b,Cd49d,
CD106, CD10 and CD 31 as the most frequently absent [250].
The present study concerns itself with, a selection of the surface markers most
commonly expressed by MSCs isolated from foetal liver, CD29 and CD105 as pos-
itive markers and CD34 and CD45, which are only expressed for the hematopoietic
lineage (absent for MSCs).
7.1.1.3 Role of ROS on the undifferentiated state of hMSCs
Much attention has been given to MSCs, mainly because of their potential to con-
tribute to tissue repair in vivo and thus, their applications in tissue engineering
and regenerative medicine. To date, ROS have been primarily associated and in-
vestigated for their damaging effects. Chapter 1, noted the role of reactive oxygen
species in stress and disease, however, the recent potential of these species to act
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as intracellular signalling intermediates sheds new lights on uncovering the mech-
anisms involved in these processes. Therefore, in stem cell biology it has become
important to investigate the role of ROS in stem cell renewal. It is well documented
that stem cells normally reside in niches which are defined by a low level of ROS,
which is important to maintain their self-renewal potential and stemness [251].
However, the levels at which ROS exert a homeostatic or a detrimental role on the
balance between stem cell renewal and differentiation is still unknown. The aim of
the present chapter is to contribute to recognising the impact of ROS on MSCs.
Aims
The aim of this chapter is the application of the previous nanotool (Chapter 6
and developed methodology to investigate the impact of ROS in the undifferenti-
ated state of hMSCs. Initially, primary hMSCs isolated from a foetal liver microen-
vironment were investigated for the expression of characteristic surface markers of
undifferentiated MSCs, as well as for hematopoietic markers. The effect of in-
creasing doses of light on hMSCs treated with the photosensitizer-nanoplatform
conjugated on the profile of antibodies surface markers was then investigated. The
incidence of apoptosis and necrosis in stimulated hMSCs was also evaluated .
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7.2 Results and Discussion
The goal of the present study was to investigate the impact of ROS on the undif-
ferentiated state of hMSCs.
7.2.1 Morphology of hMSCs
hMSCs were used as a cellular model due to their therapeutic potential associated
with regenerative medicine. The isolation of MSCs from foetal liver microenvir-
onment was carried out according to the widely accepted methodology of plastic
adherence [235]. Initially, the morphology of adherent cells was investigated and
documented by widefield real time (RT) fluorescent and differential interference
contrast (DIC) microscopy. As can be observed in Figure 7.3, expanded cells
presented a fibroblast-like appearance with a homogeneous spindle shape. The
same morphological features were consistently observed after all passages, 1-10.
The results of this study were consistent with observations previously reported by
many groups for expanded MSCs [232,235,252–254].
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Figure 7.3: Representative phase contrast image of adherent cells isolated from fetal
liver microenvironment, resembling spindle shaped fibroblastic-like MSCs. Olympus U-
Plan S-Apo 20X/NA 0.85. Scale= 35 µm.
7.2.2 Characterisation of hMSCs:
The impact of ROS on undifferentiated hMSCs was assessed by flow cytometry
(FCM). The characteristics of adherent cells, isolated from the foetal microenvir-
onment, were analysed for specific surface antigen expression. The exact surface
antigen expression for the characterisation of hMSCs is still a matter of debate,
despite many reported profiles. Using the criteria published by ISCT based
on the work reported by many groups [232, 249, 250, 252, 255, 256], profile for
hMScs characterisation has been postulated, which includes positive expression
for CD29 and CD105, and the absence of hematopoietic markers CD34 and
CD45 [232,253,257,258]. This was the chosen criteria for this work.
236
Figure 7.4: Characterisation of adherent cells isolated from foetal liver microenvir-
onment (passage 3). a) Unstained live gate: elimination of sources of interference by
exclusion of debris, sub-cellular particles and early apoptotic events(R2) and selection
of viable events (R1); b) Live gate of stained hMSCs. R1 gated middle panels, controls
of spectral overlap; c) CD105(PE) vs. isotype control CD29 (FITC); d) FMO ( -CD105)
CD29 (FITC) vs. CD105 (PE); e) FMO (-CD45) CD34 (PC5) vs. CD45 (ECD); f)
FMO (-CD34) CD45 (ECD) vs. CDC (PC5). FITC- fluorescein isothiocyanate (λex=
488 nm; λ em= 520 nm). PE- phycoerythrin (λex= 488 nm; λ em= 565 nm). ECD-
PhycoerythrinTexas Red-X (λex= 488 nm; λ em= 620 nm). PC5-phycoerythrin-cyanine5
(λex= 488 nm; λ em= 665 nm).
The evaluation of the phenotypic characteristics of hMSCs was performed on a
minimum of 25000 cells. Cells were stained for the simultaneous detection of sev-
eral markers; CD29 (FITC- fluorescein isothiocyanate); CD105 (PE- phycoeryth-
rin); CD45 (ECD-PhycoerythrinTexas Red-X) and CD34 (PC5-phycoerythrin-
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cyanine5).
Prior to characterisation by FCM, care was taken to avoid potential sources of
artifacts. Thus, healthy populations were selected on the basis of contour plots,
representing forward versus side scattered light measurements, through the cre-
ation of logical gates, as represented in Figure 7.4 a) and b) (R1, R2). Side and
forward scattered light of cell debris and dying cells are low due to the smaller
shape and lower amount of organelles present in these populations, a) and b) R2
Figure 7.4. It is important to note that the elimination of these populations is es-
sential in phenotypic characterisation since they might present an altered marker
expression or establish unspecific bonding with antibodies, either contributing for
false positive or false negative readings.
Additionally, spectral overlap between the fluorochromes in use and background
fluorescence was also considered. For these reasons, a compensation protocol was
created. The term compensation is used in flow cytometry to refer to a process
where the spectral overlap between different fluorochromes is mathematically re-
moved. The creation of an appropriate compensation protocol avoids detection
of false positive or false negative results and is thus essential for proper analysis.
The principle chosen for compensation was based on the creation of hMSCs single
staining controls for each antibody. Controls were also created where all the anti-
bodies under study were present minus one, called fluorescence-minus-one (FMO),
as represented in Figure 7.4. The application of this methodology was based
on work previously developed by Coupland [195]. Figure 7.4 c) shows the FMO
control for CD 29(FITC), which is an isotype control. An isotype control is an
antibody that has no specific interaction with any component in the cell, therefore
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it allows the elimination of non-specific binding. Controls of fluorescence overlap
for CD105-PE, CD45-ECD and CD34-PC5 were based on FMO, the resultant bi-
variate dot plots are presented in Figure 7.4 d), e)and f). It was not intended
in this work to not detailed compensation principles; however, for further inform-
ation regarding fluorescence compensation please refer to the work developed by
Baumgarth and Roederer, Roederer Maecker and Trotter [84, 259,260].
Figure 7.5: Representative immunophenotypic profile of hMSCs isolated from foetal
liver microenvironment, P3 to P10. Flow cytometry bi-variate dot plots (R1 gated)
show positive expression of a) CD29 and CD105 and absence b) for both CD45 and
CD34. Histogram plots (R1 gated) showing the overlay between controls (doted lines)
and test samples (coloured lines) show that adherent cells stain positive for mesenchymal
markers c) CD29 and d) CD105, and stain negative for hematopoietic markers, e) CD45
and f)CD34.
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Finally, Figure 7.5 represents the characterisation of hMSCs in bi-variate dot
plots of CD29 against CD105 and CD34 versus CD45. As shown on the right
panel, hMSCs were strongly positive for both, CD29- FITC and CD105-PE an-
tibody conjugates as previously reported human for foetal liver MSCs by several
authors [232, 252]. On the other hand, as expected, the expression of hematopoi-
etic progenitor markers CD34-PC5 and CD45-ECD antibody conjugates was not
observed. The combined results of the controls (Figure 7.4), after compensation,
and from the multiple colour staining (Figure 7.5), indicate the successful isolation
of hMSCs from the foetal liver microenvironment.
7.2.3 Effect of nanoparticle delivery on the surface marker
expression in hMSCs:
After successfully characterising adherent cells isolated from the foetal liver mi-
croenvironment as hMSCs, the effect of nanoparticle delivery on the surface profile
of hMSCs was evaluated.
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Figure 7.6: Effect of nanoparticle internalisation on the immunophenotypic profile of
hMSCs, representative from P3 to P10. Flow cytometry bi-variate plots (R1 gated) FSS
vs. SSC of MSCs incubated with nanoparticles do not show any alterations due to
nanoparticle delivery, a) and, b). Analysis of the bi variate plots of surface markers,
shows positive expression of CD29 and CD105 ≥ 99% and very little expression for both
CD45 and CD34≤ 1% for cells without nanoparticle incubation (column a); the same
pattern was verified for cells treated with CuPATNPC (column b).
Surface marker’s characterisation in hMSCs was carried out by FMC analysis
using four colour staining. To evaluate the impact of porphyrinic nanoplatforms
on the surface profile of hMSCs, CuPATNPC were used. The rationale behind
this experiment was to firstly investigate the impact of the nanoparticle itself
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on the surface markers expression of hMSCs. In addition, knowing that copper
porphyrins present a quenching of the triplet state when activated by light of ap-
propriate wavelengths, alterations on the surface markers profile due to porphyrin
photodynamic effects could then be excluded. CuPATNPC without FITC-dextran
entrapped were incubated overnight with hMSCs. The impact of porphyrinic
nanoplatforms in hMSCs is shown in Figure 7.6 and it can be ascertained that
internalisation of nanoparticles does not affect the surface maker’s expression in
hMSCs. Comparison between control cells (absence of nanoparticles) and treated
cells (CuPATNPC) showed very similar percentages of expression. Thus, expres-
sion of CD29 and CD105 were equally positive for 99.8% of the population, as
opposed to CD45 and CD34 where expression was less than 1% of the population.
The results presented were consistent with work previously reported by Coupland
et al., where it was shown that the delivery of polyacrylamide nanoparticles to hM-
SCs did not alter the expression of CD29 and CD105 while the absence of CD34
and CD45 expression was also observed [89].
7.2.4 Impact of ROS on surface marker expression in hM-
SCs:
Once it was verified that the internalisation of NPs did not affect the differenti-
ation profile of hMSCs, a study was carried out to evaluate whether the generation
of ROS would alter its phenotype. To investigate the effects of oxidative stress
on hMSCs, the approach previously developed with light activated ZnPATNPC
(Chapter 6; Section 6.2.2.3) for controlled generation of ROS was applied. In
order to achieve this, it was necessary to first develop a light system for cell
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irradiation that mimicked the one previously performed microscopically.
7.2.4.1 Light system for the irradiation of hMSCs
The development of a portable light system for porphyrin activation would then
have to confer the same light intensity and wavelength when applied over the same
exposure time. Thus, a system with a characteristic wavelength for porphyrin
activation at 575 nm with an irradiation power of approximately 500 µW was
constituted, as shown in Figure 7.7.
Figure 7.7: Portable light system for photosensitizer activation. a) Portable LED
coated with 2 neutral density filters plus a fluorescent acrylic layer; b) Portable LED
adapted to an opaque structure with black interior to restrict the area of irradiation; c)
Last step of the system for cell irradiation; d) Graphical representation of the wavelength
vs. intensity irradiation output, peak at 575 nm.
Confirmation of the effectiveness of the developed portable light system to
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activate the porphyrinic nanoplatforms was investigated. In the same manner,
microscopy was used to follow the effects in treated cells with ROS increase. Cells
were firstly exposed to light by the use of the portable light system and then
imaged by differential contrast imaging. The excitation wavelength of 488 nm
(corresponding to FITC excitation) to confirm the presence of internalised nan-
oparticles was applied. Furthermore, wavelengths of 405 nm (corresponding to
HTFMC excitation) were employed for the detection of HTFMC activation by
intracellular production of H2O2. In Figure 7.8, the effects of hMSCs irradiation
using the portable light system are shown. Similar to the results previously ob-
tained by microscopic irradiation (Chapter 6; Section 6.2.2.3), oxidative stress
followed by H2O2 production was noticed with the use of the portable light system.
As expected, cells treated with CuPATNPC were not affected by cumulative light
irradiation during a 100 minutes period (20 irradiations), as can be observed by
the unresponsive HTFMC (Figure 7.8, third column). However, cells treated with
ZnPATNPC and irradiated with the portable light system showed evidence of ROS
production after 30 minutes of irradiation (six light dosages), which became more
pronounced with cumulative light dosages of 12 and 20 irradiations, respectively.
These results indicate that hMSCs were capable of handling and scavenging the
amount of ROS generated by the first six light dosages; however, further insults led
to its accumulation and detrimental effects. Taken together, these results verified
the effectiveness of portable light system irradiation to stimulate ROS production
by ZnPATNPC internalized in hMSCs.
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Figure 7.8: Live cell imaging of endogenous H2O2 production upon irradiation of hMSCs treated with either CuPATNPC or ZnPATNPC. PLS
was used for the irradiation of hMSCs at 5 min intervals for a total of 100 min. hMSCs were previously treated (overnight incubation) with
CuPATNPC containing FITC-dextran entrapped (left panel) or ZnPATNPC containing FITC-dextran entrapped (right panel). It is possible to
observe, by phase contrast imaging, spindle shaped fibroblastic-like MSCs (left and right panels, first columns). The intracellular presence of
CuPATNPC or ZnPATNPC can be visualised in green, due to FITC emission at λem= 523 nm (left and right panels, middle columns). Activation
of HTFMC to BPTFMC was mediated by the presence of endogenous H2O2, λem = 435 nm and can be observed only after 60 and 100 min of light
treatment, exclusively in hMSCs treated with ZnPATNPC (left and right panels, third columns).Images obtained with a widefield Olympus delta
vision deconvolution fluorescent microscope; Olympus U-plan S-Apo 60x/ NA 1.42. Scale= 12 µm.
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7.2.4.2 Surface profile of hMSCs upon light treatment
In order to study the impact of ROS on hMSCs identity, cells were exposed to
numerous dosages of light (portable light system) and changes in expression of
CD29- FITC, CD105- PE, CD45-ECD and CD34-PC5, antibody conjugates were
monitorised by flow cytometry.
To isolate any possible effects on the identity of hMSCs as a result of ROS
stimulation, the experiment was performed in parallel with two controls. One
control consisted of hMSCs free of nanoparticle treatment (negative control) and
the other consisted of hMSCs treated with CuPATNPC (positive control). The
bi-variate dot plots represented in Figure 7.9 show the surface molecule profiles
for CD29- FITC versus CD105- PE and; CD45-ECD versus CD34-PC5 antibody
conjugates following the administration of 5, 10, 15 and 20 light dosages. The
results obtained suggested that 5 or 10 light irradiations did not impact on the
expression of the selected surface markers. In addition, the dot plots of CD29
against CD105 showed a high level of expression of these two surface markers of
approximately 99%. The expression of hematopoietic progenitor markers, CD45
and CD34, was completely absent. Upon 15 light dosages, a decrease of almost
4% in the expression of CD105 was detected. The same evidence was observed
after the administration of 20 light dosages with a decrease of CD105 expression
of approximately 6%. Variations of expression of CD 105 at 15 and 20 irradiations
was isolated to hMSCs incubated with ZnPATNPC and was not observed in any
of the controls.
The heterogeneity of CD 105 expression following the exposure of hMSCs oxidative
stress (15-20 light dosages) could have been indicative of stem cell differentiation
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stages. However, it is necessary to consider that hMSCs morphology was signific-
antly impaired upon 15 and 20 light dosages exposure. Thus, variations in CD
105 expression could also be associated with an alteration in cellular membrane
integrity leading to less affinity of the antibody to the membrane receptor.
Currently, there are not many investigations of the direct impact of ROS on
the surface profile of hMSCs. However, a few reports indicate that augmented
oxidative stress is related to signalling and initiation of cellular differenti-
ation [196,261–263] while ROS have also been associated with in vitro senescence
growth arrest of MSCs [39]. It is important to note that these studies involved
the exogenous addition of hydrogen peroxide to mimic an oxidative environment.
The subtle variations in hMSCs CD 105 marker expression have previously been
associated with adipogenic differentiation by Tormos, et al. and also Kanda, et
al. [261,264].
To further investigate the variation of CD105 expression in hMSCs, an evaluation
of the incidence of apoptosis and necrosis upon 5, 10, 15 and 20 exposures to light
was performed in parallel. This experiment aimed to investigate if an increase
in apoptosis/necrosis was consistent with the decrease of CD105 expression.
Specifically, during apoptosis the loss of phospholipidic membrane asymmetry
occurs, which can result in decreased affinity of antibodies for the surface
markers. Figure 7.10 shows two controls: a positive control, cells incubated with
CuPATNPC, and a negative control, non-treated cells. For both controls an
incidence of apoptosis of about 20 % was verified. This level of apoptosis was
considered to result from experimental procedure as the hMSCs were submitted
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Figure 7.9: Immunophenotypic characterisation of hMSCs upon different light dosages. In the absence of nanoparticles cells were negative for
hematopoietic markers CD34 and CD45 and positive for markers of undifferentiated MSCs CD29 and CD105 (left panel). The same pattern was
observed for 5, 10, 15 and 20 light dosages. Similarly, hMSCs incubated with control CuPATNPC, at different light dosages, responded positively
for CD29 and CD105 markers and negatively for CD34 and CD45 (middle panel). The analysis of hMScs incubated with ZnPATNPC showed an
undifferentiated profile after 5 and 10 light dosages; however, at 15 and 20 min a decrease in CD105 expression of 3.8 % and 5.7%, respectively
(right panel) is observed.
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to light exposure every 5 min with consequent variation of their environmental
conditions, during a total period of 100 minutes. Furthermore, a subsequent
staining with monoclonal antibodies presented a second disturbance to the cells,
thereby representing another variation on its optimal growth conditions.
The analysis of hMSCs incubated with ZnPATNPC and consequently stimulated
to produce ROS (upon light exposure) presented an augmented incidence of
apoptosis with the increase of exposure to light. It was verified that, upon five
irradiations, cells presented an incidence of apoptosis of approximately 29 %,
which was similar to the results obtained after 10 irradiations (30 %). However,
cells exposed to 15 and 20 irradiations presented higher values of 37 % and 44
%, respectively. Statistical analysis indicated that the variations observed on the
incidence of apoptosis with exposure to light were statistically significant P<
0.001 (comparison between test samples at 5, 10, 15, and 20 irradiations).
When investigating the incidence of necrosis, no changes were observed (Fig-
ure 7.11). The percentage incidence of necrosis was inferior to 4%. These results
do not preclude the existence of necrosis.
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Figure 7.10: Flow cytometric analysis of the incidence of apoptosis in hMSCs stimu-
lated to produce ROS upon light exposure. Live cells were stained with annexin V to
determine the incidence of apoptosis; it is possible to observe an augmented incidence
of apoptosis in cells incubated with ZnPATNPC. Means were calculated from two inde-
pendent experiments conducted in triplicate. Error bars represent mean ± SD (n=6).
ZnPATNPC 20 dosages vs. ZnPATNPC 5,10,15: *** p < 0.001, One Way ANOVA;
control vs. ZnPATNPC: * p < 0.05, One Way ANOVA; CuPATNPC vs. ZnPATNPC:
* p < 0.05, One Way ANOVA.textitP values textless 0.05 were considered statistically
different.
DNA labelling with propidium iodide (PI) requires the permeabilisation of the
cellular membrane and interaction of the dye with DNA, which is only possible
in late apoptotic/necrotic cells. At this stage, the integrity of the membrane is
compromised allowing endogenous access of the dye. Furthermore, fragmentation
of DNA is characteristic of necrotic/death cells with the subsequent loss of PI
staining, which could justify such low percentage of necrosis.
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Figure 7.11: Flow cytometric analysis of the incidence of necrosis in hMSCs stimulated
to produce ROS upon light exposure. Live cells were stained with PI to determine the
incidence of necrosis; it is possible to observe there were no major variations of the
levels of necrosis with values below to 5%. Results are representative two experiments
conducted in triplicate (n=6).
The low level of propidium iodide fluorescence might also indicate that the
levels of apoptosis refer to earlier apoptotic events. Apoptosis investigation by
Annexin V staining happens because the phospholipidic membrane of the apop-
totic cells remains asymmetric with the exposure of phosphatidyl serine, which
binds to annexin V [79]. A late apoptotic stage would require the permeabilisation
of membrane which would allow access for popridium iodide to interact with
DNA, and thus the observation of fluorescence at λem = 608 nm.
Overall, these results suggest that an increased light dosage leads to an aug-
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mented level of incidence of apoptosis. Furthermore, the incidence of apoptosis
might also explain the subtle decrease of the expression of CD105; alterations of
the asymmetry of the phospholipidic membrane on apoptotic cells could lead to
slightly lower affinity of the antibody with the endoglin surface receptor.
In order to closely investigate whether the increased amount of endogenous
ROS induced changes in the profile of hMSCs, the surface marker expression was
studied after two passages of light treated cells. To achieve this, hMSCs were
firstly treated with 20 light dosages and then cultured under normal conditions.
The morphology of hMSCs along the two subculture stages were investigated,
no changes were observed . Cells were stained for CD29- FITC, CD105- PE,
CD45-ECD and CD34-PC5 antibody conjugates after two subculture stages and
studied by using FCM. Furthermore, there was also no indication of diminished
proliferation.
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Figure 7.12: Immunophenotypic characterisation of hMSCs upon exposure to 20 light
dosages followed by subculture (two passages). Left and middle panel show the expres-
sion profile for the negative and positive controls, respectively. It is observed that both
controls present positive expression for CD29 and CD105 (top panels) and were equally
negative for CD45 and CD34 (bottom panel). The test sample in the right panel shows
a similar expression with both positive and negative control.
Bi-variate dot plots were analysed and are presented in Figure 7.12, showing
the surface molecule profiles for CD29- FITC versus CD105- PE and CD45-ECD
versus CD34-PC5 antibody conjugates. After two passages it was found that non-
treated hMSCs and, hMSCs treated with CuPATNPC and ZnPATNPC presented
the exact same profile. As initially observed in this chapter, hMSCs had shown
positive expression of CD29 and CD105 (≥ 99%) and reduced expression for both
CD45 and CD34 (≤ 1%). Therefore, the results suggested that a burst of ROS
was not responsible for differentiation or senescence patterns in these MSCs. In
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addition, the heterogenity previously observed for CD 105 following 15 and 20 light
dosages is suggested to be a consequence of the loss of membrane asymmetry and
thus affinity for the antibody CD105, not an initiation of stem cell differentiation.
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7.3 Conclusions
The present chapter enables the establing of the effect of oxidative stress on the
identity of hMSCs through the use of flow cytometry. This technique allows the
performance of an in depth and overall analysis of the effects of ROS in treated
hMSCs following several light dosages.
The porphyrinic nanoplatforms were successfully internalized in hMSCs and en-
abled to recreate an intracellular controlled oxidative environment, which produce
very promising results. Lethal dosages of ROS in hMSCs maintained the charac-
teristic surface marker expression, positive for CD29 and CD105 and negative for
CD45 and CD34. Means of cellular viability by necrosis or apoptosis allowed the
establishment of a response to the several ROS insults imposed on hMSCs upon
activation of porphyrinic nanoplatforms by several light dosages. The major limit-
ation of the present study was to estimate the amount of ROS produced upon each
light dosage, information that would allow the establishment of cellular tolerance
versus the deleterious effects of ROS.
A wide number of investigations have sought to establish the implications of ROS
in stem cell differentiation and high levels of ROS are hypothesized to be associated
with high metabolic demands and oxygen consumption for stem cell differentiation.
The present study has shown that hMSCs have maintained identity even when ex-
posed to high oxidative stress levels. Further investigation and reproduction of
these results at different cellular passages and analysis of surface markers such as
adiponectin/Acrp30 and Leptin/OB (adipogenesis differentiation) CD44 (chondro-
genesis differentiation) and fibronectin (Osteogenesis differentiation) would bring
greater knowledge about the role of ROS in stem cell differentiation and its thera-
255
peutics applications.
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Chapter 8
Conclusions and Future
Perspectives.
The main goal of the present research project was the development and charac-
terization of a nanotool for monitoring the impact of ROS on the undifferentiated
state of MSCs. In order to achieve this, firstly it was theorized that by exploiting
the principle of photodynamic therapy using photosensitizers it would be possible
to achieve the endogenous generation of ROS. In addition, its combination with
a biocompatible polymeric matrix would allow it to control the photosensitiser
activity at its intracellular location but also serve as a sensing platform.
Polyacrylamide nanoparticles have been widely accepted as resourceful and
flexible tools to measure and investigate cellular signalling pathways. Thus, it was
envisaged that would be possible the development of stable multifunctionalized
nanoplatforms to act as carriers of photosensitizers (not interfering with its
photophysical properties) based on previous approaches.
257
The synthesis of dually functionalised nanoparticles.
The development of mono and dually functionalised nanoparticles was suc-
cessfully achieved by revisiting and combining previous approaches: (i) alkyne
functionalities allowed the introduction of chemical reactivities exploiting the click
chemistry principle for further conjugation; (ii) a trimethylammonium function-
ality would bring a facilitated cellular uptake and intracellular targeting. These
approaches successfully generated stable multifunctionalized nanoplatforms. A
limiting factor in this work was the characterising the number of functionalities
introduced and its location. The aleatory nature of polyacrylamide polymerisation
compromises the functionalization location, at the surface of nanoparticles or
entrapped in the matrix.
The conjugation of porphyrinic moities with functionalised nanoplat-
forms
The major concerns in the development of conjugates are, how to maintain
their final characteristics and stability, but also consider their interaction with
biological microenvironment. The incorporation of photosensitizers was achieved
based on approaches: (i) Porphyrins conjugated to alkyne/trimethylammonium
functionalised NPs conferring to porphyrins surface conjugation; (ii) porphyrins
monomers attached to the polymeric matrix and therefore entrapped, protecting
the photosensitizer from the intracellular micro environment. Characterisation
of these nanoplatforms suggested the successful development of porphyrinic
nanoplatforms. The main obstacles found at this stage were in relation to the
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photodynamic efficacy of photosensitizers conjugated and entrapped, but also
regarding the concentration of photosensitisers combined with the polymeric
nanoplatforms. A route for further investigation of these parameters could be by
photophysical studies where the determination of quantum yields of fluorescence,
singlet oxygen and fluorescence lifetimes could bring better knowledge of these
nanoplatforms.
Delivery of nanoplatforms to hMSCs
A limiting factor in the use of nanoparticles as carriers, is an inadequate
cellular delivery of these systems, which impacts on the development of new thera-
peutic agents and biomedical tools. In this study, it was envisaged that polymeric
nanoparticles, due to their flexible matrix, could incorporate ligands that would
promote internalization and intracellular targeting. The dual functionalisation
of polyacrylamide nanoparticles with trimethyl ammonium and porphyrins
accomplished a non-invasive nanoplatform capable of being internalized and
preferentially accumulated at mitochondria.
The main aim of the project was to investigate the impact of and increased
oxidative stress as consequence of ROS production. An increase in oxidative
stress leads to alterations in cell homoeostasis and viability. Thus, to achieve an
effective nanotool for ROS generation, dark toxic effects would not be acceptable.
Flow cytometric analysis indicated the absence of dark toxicity was successfully
accomplished for entrapped and conjugated porphyrins nanoplatforms.
The main limitations found for this approach were to clearly show the intracel-
lular location of nanoparticles, this was a consequence of the diffraction limited
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resolution-microscopy. The developments in super-resolution microscopy will
provide new insights on nanoparticle co-localization, thus more studies would
provide better information of the exact location of these nanosystems.
Porphyrinic nanoplatforms generating ROS in hMSCs.
The development of a non-invasive nanosystem to generate and evaluate the
real time impact of ROS in cells, required the establishment of traceable levels
of these species. Regardless of the short lifetimes of ROS, the development of
fluorochromes responsive and specific for these species have greatly increased over
the last couple of years. Therefore, it was anticipated that oxidative stress increase
could be measured as a means of hydrogen peroxide production. A hydrogen
peroxide specific switchable fluorochrome was allowed to identify the successful
production of reactive oxygen species in hMSCs using porphyrin-nanoparticle
conjugates. In addition, the presence of a “blast zone” also confirmed the efficient
increase in oxidative stress with a major impact on cell viability. Unfortunately,
porphyrinic entrapped nanoplatforms did not show the same evidence, as only
a very small production of ROS was attained. The latest finding was most
probably a consequence of photosensitizer entrapment and interaction with the
polyacrylamide matrix. Porphyrinic nanoplatform conjugates were then found as
excellent candidates for in situ ROS generation.
As the major aim of the project was to provide a controlled generation of ROS,
it was anticipated that it would be necessary to control the level of toxicity of
porphyrins. Therefore, the solution was to decrease the amount of porphyrin con-
jugated to nanoparticles until they reached non-toxic levels upon light exposure.
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A small and controlled increase in oxidative stress would then be achieved by
cumulative light exposure. This methodology allowed the successful development
of a nanotool with the ability to generate oxidative stress in a controlled manner.
Live cell fluorescence microscopy allowed the ability to successfully follow the
controlled increase in oxidative stress by hydrogen peroxide production. This
technology is a major advance for monitoring, diagnostics and therapeutics in
ROS related diseases.
The main limitations of this study were to establish the non-toxic concentration
of porphyrins at the surface of nanoparticles. This was a consequence of not yet
being possible to determine the exact number of functionalisations on the nano-
particles and consequently the amount of porphyrin bonded. This problem was
overcome by titrating porphyrin with functionalised nanoparticles and evaluating
the phototoxic effects upon porphyrin activation. A second major limitation was
to quantify/establish the efficiency of porphyrin to generate singlet oxygen, either
for entrapped or conjugated porphyrin nanoparticles. Photophysical studies such
as, quantum yields of fluorescence, singlet oxygen and fluorescence lifetimes could
bring better knowledge of these nanoplatforms.
Impact of ROS in hMSCs surface identity
As a proof of the concept, the recently developed ROS generator nanotool was
used to investigate the impact of this species on the surface marker expression of
hMSCs. Flow cytometry analysis provides single cell analysis in a large population
of cells. To investigate the impact of ROS, it was envisaged that treated hMSCs
could be submitted to cumulative light dosages ( low damage to lethal dosages)
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and investigate the variations on its characteristic surface markers. This approach
allowed successful verification that during ROS insults, hMSCs maintain their
characteristic identity. The latest findings were supported by surface marker
expression of two generations of hMSCs, submitted to nanoplatform treatment
and oxidative stress insults. Cellular viability by necrosis or apoptosis allowed
following with insults of ROS imposed to hMSCs upon activation of porphyrinic
nanoplatforms by several light dosages. The impact of ROS in hMSCs was
successfully investigated.
The major limitations of the present study were that to estimate the amount of
ROS produced upon each light dosage, information would be needed that allow
to establish cellular scavenge versus deleterious effects of ROS.
Further investigations and reproduction of these results at different cellular
passages and analysis of surface markers, such as adiponectin/Acrp30 and
Leptin/OB (adipogenesis differentiation); CD44 (chondrogenesis differentiation)
and fibronectin (Osteogenesis differentiation), would bring higher knowledge
about the role of ROS in stem cell differentiation and its therapeutics applications.
In summary, the knowledge acquired from these nanosystems led to the
successful development of a nanotool for the endogenous generation of ROS in a
controlled manner. Such a system offers the possibility to investigate real time
responses to ROS effects. Furthermore, it also provides the study of single cell
and metabolic pathways in great detail by the use of a non-invasive system. Thus,
it can greatly contribute to the development of basic science in the field of ROS
and to uncover potential therapeutic targets in related diseases.
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Appendix A
Analytical data Monomers
(B)- N -Propargyl acrylamide
White solid; 1H NMR (δ, 400MHz, CDCl3): 6.32(dd, J=17.2 and 1.6 Hz, 1H,
CH2,trans CH); 6.10 (dd, J=17.2 and 10.4 Hz, 1H, CH CH2), 5.79 (Bs, 1H,
NH), 5.69 (dd, J=10.4 and 1.2 Hz, 1H, CH2,cis CH, 4.14(dd, J=5.2 and 2.4 Hz,
1H, CH2 NH), 2.25 (t, J= 2.4 Hz, 1H, CH C);
13C NMR (δ, 100MHz,
CDCl3): 165.1 (C), 130.1 (CH), 127.3 (CH2), 79.3 (C), 71.8 (CH), 29.3 (CH2);
m/z found 110.1333 (MH+) calc. 110.1327
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Appendix B
Analytical data Porphyrins
(10)- 5-4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-[(4-methylpyridynium)yl]
porphyrinato copper(II)trichloride
Red solid; 1H NMR (δ, 400MHz, DMSO-d6): 9.55-9.52(6H, 10+15+20-m-
Ar); 9.16 (br, 4H, β-H); 9.07-9.00 (m, 10H, β-H and 10+15+20-o-Ar); 8.38
(2H, d, J=9.2), 8.32 (2H, d, J=9.2), 4.75-4.74 (9H, m, s, CH3); 3.75-3.73 (4H,
m,CONHCH2CH2OCH2); 3.65-3.62 (2H, m, CONHCH2CH2COCH2); 3.49 (2H, t,
J=4.7 COCH2CH2NH3); -3.02 (2H, s, pyrrole NH)
13C NMR (δ, 100MHz, DMSO-d6): 166.1; 156.5; 156.4; 144.2; 143.0; 134.2; 134.1;
132.1; 126.1; 121.9; 115.4; 114.7; 69.0; 68.8; 50.1; 47.8. m/z : C49H45N11O2Cu
found 819.4056 [M-3Cl+H]+) calc. 819.3741 UV/vis (H2O): λ(%):425 (100);
549(6.9); 590(1.4); logǫ425: 5.16; Rt(min): 10.45 ; M.p: >300
◦C
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(11)- 5-(4-isothiocyanatophenyl)-10,15,20-tris-[(4-N-methylpyridinium)yl]
porphyrinato zinc(II)trichloride
Green solid; 1H NMR (δ, 400MHz, DMSO-d6): 9.33-9.31 (6H, 10+15+20-m-
Ar); 9.13-9.11 (4H, m, β-H); 9.03-8.99 (4H, β-H) 8.91-8.89 (6H, 10+15+20-o-Ar);
8.54 (2H, d, J=8.3, 5-o-Ar), 8.40 (2H, d, J=8.3, 5-m-Ar), 4.8 (9H, s, CH3)
13C NMR (δ, 100MHz, DMSO-d6): 172.2; 161.3; 151.8; 150.3; 149.9; 144.8; 136.2;
134.7; 134.1; 133.6; 133.3; 132.8; 129.7; 116.8
m/z : C45H33N8SZn found 781.2476 [M-3Cl+H]
+) calc. 781.1824
UV/vis (H2O): λ(%): 435 (100); 565(8.6); 607(5.5); logǫ435: 5.09; Rt(min): 6.50
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(13)- 5-4-[2-(azidoethoxy)ethyl]phenyl-10,15,20-tris-[(4-methylpyridynium)yl]
porphyrinato zinc(II)trichloride
Green solid; 1H NMR (δ, 400MHz, DMSO-d6): 9.35-9.31 (6H, m, 10+15+20-m-
Ar); 9.12 (4H, s, β-H); 9.01-8.97 (4H, s, β-H) 8.92-8.88 (6H, m, 10+15+20-o-Ar);
8.27-8.21 (4H, m, 5-o-Ar and 5-m-Ar), 4.79 (9H, s, CH3), 3.78-3.72 (6H,
m,CONHCH2CH2OCH2); 3.42 (2H, t,J=9.2 ROCH2CH2N3)
13C NMR (δ, 100MHz, DMSO-d6): 167.3; 158.5; 149.3; 147.4; 146.9; 143.9; 142.0;
141.9; 132.7; 131.8; 131.2; 130.6; 130.4; 129.6; 123.9; 121.5; 113.9; 113.1; 68.1;
67.6; 49.1; 38.2
m/z : C49H42N11N2Zn found 880.3026 [M-3Cl]
+) calc. 880.2800
UV/vis (H2O): λ(%): 434 (100); 564(7.2); 606(3.2); logǫ435: 5.26; Rt(min): 6.15
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Appendix C
Analytical data probe for ROS
detection
(B)- 4-trifluoromethyl coumarin pinacol boronate
Yellow solid; 1H NMR (δ, 400MHz, DMSO-d6): 7.73 (dd, J=8 Hz, J=1.7
Hz, 1H, C6 H); 7.70 (dd, J=8 Hz, J=0.8 Hz, 1H, C5 H); 7.66 (s, 1H,
C8 H); 7.13 s, 1H, C3 H); 1.32 (s, 12H)
13C NMR (δ, 100MHz, DMSO-d6): 158.56; 153.54; 139.33; 124.67; 123.36; 122.74;
120.63; 119.09; 119.03; 115.73; 84.89; 25.01
m/z : found 382.1761 [MH+ + 42]) calc. 382.1432; Rt(min): 5.28
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